Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3016543	li-leuk	e6/l (e6/l)	7125	10260	2.03%
3016543	li-leuk	— (—)	2197	2999	100.00%	Distribution not available
3016543	li-leuk-3	e6/l (e6/l)	227	243	0.00%
3016543	li-leukosyytit,likvor	— (—)	33	35	100.00%	Distribution not available
3016543	li-leukosyytit,likvor	e6/l (e6/l)	23	26	0.00%
3016543	li-leuk-3	— (—)	8	9	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Implicit viral Sepsis

832

1950

4.46

323.31

1.5

1.4

22.70

28.68

e6/l

0.26

644

1523

Unspecific neurodegenerative disorder

995

1661

4.25

322.35

1.2

1.4

12.46

34.95

e6/l

1.41

760

1300

Focal epilepsy

749

1663

4.78

313.27

1.6

1.7

22.92

22.15

e6/l

0.04

601

1258

Disorders of optic nerve and visual pathways

489

747

7.30

310.93

1.4

1.7

17.73

27.32

e6/l

0.46

380

567

Dizziness and giddiness

1676

4329

3.15

307.65

1.4

1.5

14.99

39.72

e6/l

3.60

1327

3419

Postprocedural disorders of nervous system

543

485

13.29

307.65

1.3

1.2

16.83

24.63

e6/l

0.42

437

370

Intracranial trauma

1269

1249

7.35

307.65

1.5

1.4

20.49

15.78

e6/l

0.29

975

931

Cerebrovascular diseases (FINNGEN)

1179

1713

5.15

307.65

1.9

1.3

33.27

23.16

e6/l

0.90

915

1301

Demyelinating diseases of the central nervous system

687

662

12.48

307.65

1.2

1.4

30.41

26.35

e6/l

0.08

534

498

Other degenerative diseases of the nervous system

1545

490

26.06

307.65

1.2

1.1

19.07

11.96

e6/l

0.35

1173

367

Episodal and paroxysmal disorders

2549

4796

2.76

307.65

1.4

1.5

19.54

38.77

e6/l

2.40

2001

3660

Any mental disorder

2418

4696

2.63

307.65

1.4

1.5

31.22

35.16

e6/l

0.17

1864

3637

STROKE

1515

3137

3.40

307.65

1.8

1.3

29.32

31.91

e6/l

0.14

1177

2379

Symptoms and signs involving the nervous and musculoskeletal systems

2243

4626

5.14

307.65

1.4

1.5

15.12

30.74

e6/l

1.63

1838

3507

Inflammatory diseases of the central nervous system

637

615

12.42

307.65

1.9

1.4

217.36

18.64

e6/l

5.06

497

473

Organic, including symptomatic, mental disorders

1613

2218

5.45

307.65

1.3

1.4

12.67

35.87

e6/l

2.04

1227

1718

Migraine

1359

3220

3.54

307.65

1.3

1.5

13.97

38.16

e6/l

2.99

1077

2454

Visual disturbances and blindness

1391

4523

3.18

307.65

1.4

1.5

22.01

33.05

e6/l

0.58

1083

3499

Degenerative diseases of the nervous system

929

1453

4.90

307.65

1.2

1.4

9.30

20.47

e6/l

1.14

694

1147

Other demyelinating diseases of the central nervous system

354

272

16.66

307.65

1.2

1.5

9.10

14.43

e6/l

0.67

263

218

Alzheimer’s disease (Early onset), excluding more controls

224

65.84

307.65

1.1

2.26

17.75

e6/l

0.54

171

Hydrocephalus

905

393

31.98

307.65

2.4

1.4

19.78

23.29

e6/l

0.09

757

294

Malaise and fatigue

1362

2495

4.55

307.65

1.4

18.02

24.87

e6/l

0.49

1045

1921

Other headache syndromes

1137

3082

3.82

307.65

1.3

1.4

12.68

40.45

e6/l

3.43

878

2340

Dementia, including avohilmo

1208

1872

4.63

307.65

1.2

1.4

10.83

35.20

e6/l

1.84

920

1461

Neurological diseases

2479

1735

7.44

307.65

1.5

22.92

21.92

e6/l

0.08

1932

1290

Visual disturbances

1331

4214

3.28

307.65

1.4

1.5

22.68

32.34

e6/l

0.46

1039

3260

Alzheimer’s disease (Late onset), excluding more controls

400

123

22.45

307.65

1.2

6.43

21.35

e6/l

1.00

301

Any dementia, excluding more controls

974

1270

5.53

307.65

1.2

1.4

8.54

33.94

e6/l

2.31

751

992

Other neurological diseases

2605

4209

5.13

307.65

1.7

1.3

25.21

35.42

e6/l

0.71

2082

3207

Any dementia

993

1565

4.59

307.65

1.2

1.4

8.47

23.59

e6/l

1.79

767

1227

Headache

2627

3455

6.41

307.65

1.5

1.4

29.04

25.08

e6/l

0.23

2086

2620

Alzheimer disease, excluding more controls

664

160

29.43

307.65

1.2

10.65

17.15

e6/l

0.34

504

124

Condition for Implicit Sepsis (Organ dysfunction codes)

2667

5010

3.80

307.65

1.4

15.49

34.80

e6/l

2.67

1991

3908

Mood disorders, excluding more controls

2118

4575

2.83

307.65

1.4

30.05

35.55

e6/l

0.27

1622

3552

Other symptoms and signs involving the nervous and musculoskeletal systems

1608

3227

5.30

307.65

1.4

1.5

15.67

35.03

e6/l

1.44

1349

2442

Disturbances of skin sensation

987

2405

4.34

307.65

1.2

1.4

8.59

30.40

e6/l

3.14

761

1855

Implicit Sepsis

2396

4854

3.74

307.65

1.4

16.30

33.64

e6/l

2.09

1812

3766

Cerebrovascular diseases

1859

4062

3.32

307.65

1.7

1.3

42.05

26.94

e6/l

1.00

1454

3135

Dementia

1126

1633

4.95

307.65

1.2

1.4

11.41

39.51

e6/l

1.90

863

1275

Condition for Implicit Sepsis (Organ dysfunction codes)

2554

4844

3.86

307.65

1.4

15.44

34.04

e6/l

2.44

1911

3790

Epilepsy

1055

2111

5.25

307.65

1.7

1.6

25.76

36.20

e6/l

0.49

842

1598

Other symptoms and signs involving cognitive functions and awareness

2036

2439

8.20

307.65

1.3

1.4

16.99

37.12

e6/l

1.73

1496

1930

Encephalitis

323

196

22.51

307.65

1.7

1.4

92.59

8.38

e6/l

1.59

242

151

Convulsions, not elsewhere classified

802

1302

6.42

307.65

1.7

1.4

31.08

17.02

e6/l

0.39

606

979

General symptoms and signs

2935

3801

3.99

307.65

1.4

34.28

25.11

e6/l

0.65

2297

2893

Viral infections of the central nervous system

480

595

9.27

307.65

1.5

1.4

66.18

29.27

e6/l

2.41

392

458

Neurological diseases, wide definition

987

394

13.11

307.65

1.7

1.5

28.74

12.56

e6/l

1.47

767

288

Normal-pressure hydrocephalus

617

236

38.94

307.65

1.9

1.2

6.70

51.93

e6/l

1.02

528

177

Concussion

1050

1226

7.19

307.65

1.4

20.14

15.37

e6/l

0.26

815

916

Implicit Sepsis

2075

4647

3.48

307.65

1.4

18.07

28.97

e6/l

1.06

1600

3579

Abnormalities of gait and mobility

497

692

7.86

307.65

1.6

1.5

12.48

27.94

e6/l

0.81

390

514

Other mental disorders due to brain damage and dysfunction and to physical disease

450

587

8.34

307.65

1.3

1.4

3.69

28.18

e6/l

1.71

354

461

Viral infections of the central nervous system

464

556

9.66

307.65

1.5

1.4

68.18

30.93

e6/l

2.22

380

427

Symptoms and signs involving cognition, perception, emotional state and behaviour

3218

5237

4.37

307.65

1.3

1.5

14.65

39.47

e6/l

4.38

2443

4082

MS-disease / Multiple Sclerosis

570

537

12.74

307.65

1.1

1.4

34.95

22.77

e6/l

0.21

445

412

Fever of other and unknown origin

1343

3099

3.97

307.65

1.8

1.4

50.38

24.87

e6/l

1.27

1079

2369

Other encephalitis

310

183

23.40

307.65

1.7

1.4

92.94

8.53

e6/l

1.49

231

143

Stroke, including SAH

1438

3441

3.12

306.29

1.9

1.3

48.48

27.83

e6/l

1.17

1136

2661

Focal epilepsy, strict definition

702

1530

4.88

300.68

1.6

23.90

22.21

e6/l

0.08

566

1151

Abnormal findings on diagnostic imaging of central nervous system

339

354

11.37

299.00

1.4

1.8

47.74

20.33

e6/l

0.32

251

282

Polyneuropathies and other disorders of the peripheral nervous system

704

1546

4.83

298.63

1.8

1.4

15.64

22.90

e6/l

0.57

555

1176

Anxiety disorders, excluding more controls

1794

4347

2.74

297.42

1.4

35.19

34.43

e6/l

0.02

1344

3365

Psychiatric diseases

2063

4009

2.63

291.08

1.4

1.5

26.99

37.37

e6/l

0.58

1580

3114

Cerebral cysts

334

355

10.74

288.83

1.6

1.3

9.72

32.60

e6/l

0.80

274

275

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

707

609

5.95

287.04

1.5

28.63

38.44

e6/l

0.34

535

462

Delirium, not induced by alcohol and other psychoactive substances

399

534

7.98

282.53

1.3

1.4

19.73

30.54

e6/l

0.31

291

418

Focal epilepsy, mode (most common among epilepsy diagnosis)

662

1455

4.84

280.64

1.6

1.7

25.47

19.62

e6/l

0.36

531

1104

Alzheimer disease, including avohilmo

830

1423

4.26

272.94

1.2

1.3

14.15

22.28

e6/l

0.52

636

1125

Implicit bacterial Sepsis

1021

2616

3.48

271.27

1.5

1.4

19.89

25.19

e6/l

0.27

796

2066

Use of anticholinesterases

787

1508

4.27

270.05

1.2

1.3

9.40

25.93

e6/l

1.63

594

1194

N06DA Anticholinesterases

787

1508

4.27

270.05

1.2

1.3

9.40

25.93

e6/l

1.63

594

1194

Mood [affective] disorders

2282

6495

2.32

268.60

1.4

28.35

31.97

e6/l

0.19

1740

5043

Mood disorders

2284

6502

2.32

267.60

1.4

28.30

31.93

e6/l

0.19

1743

5049

Other and unspecified hydrocephalus

205

114

25.04

266.33

3.0

1.3

25.40

7.68

e6/l

1.43

170

Meningitis

319

360

10.35

264.80

1.9

1.4

358.50

23.97

e6/l

4.22

256

279

Depression

2152

6317

2.36

264.46

1.4

29.12

30.98

e6/l

0.09

1645

4895

Traumatic subdural haemorrhage

269

221

12.15

259.58

1.7

1.1

29.32

10.84

e6/l

0.67

203

170

Alzheimer’s disease, strict definition

604

1018

5.09

259.21

1.2

1.3

5.10

24.77

e6/l

2.42

451

804

Viral Sepsis

603

1323

4.79

255.40

1.6

1.3

28.54

21.20

e6/l

0.33

485

1025

Pain, not elsewhere classified

663

1574

4.36

252.59

1.4

14.40

25.29

e6/l

0.68

542

1212

Other antidepressants

2157

4721

2.38

252.20

1.3

1.4

21.41

36.44

e6/l

1.08

1646

3656

Implicit viral Sepsis

599

1322

4.76

251.85

1.6

1.3

28.75

21.22

e6/l

0.34

481

1024

Benign intracranial hypertension

161

45.86

251.23

1.4

1.3

9.35

4.00

e6/l

0.53

135

Infections, IBD-co-morbidities

316

204

11.42

248.70

1.8

1.4

11.37

9.03

e6/l

0.16

250

146

Alzheimer disease

717

1241

4.38

247.95

1.2

1.3

10.25

22.64

e6/l

1.00

545

984

Implicit bacterial Sepsis

914

2419

3.45

242.19

1.6

1.4

17.09

26.12

e6/l

0.53

722

1903

Viral encephalitis, not elsewhere classified/unspecified

195

123

20.92

237.05

1.7

1.4

46.15

10.77

e6/l

3.40

167

Aneurysms, operations, SAH

513

1051

5.17

236.50

2.5

1.2

65.95

23.11

e6/l

3.31

422

813

Depression or dysthymia

1319

2528

2.94

235.26

1.4

1.5

20.70

41.69

e6/l

1.59

1017

1955

Bacterial Sepsis

1008

2777

3.19

233.53

1.6

1.4

45.87

24.99

e6/l

0.74

800

2178

Communicating hydrocephalus

197

131

19.59

232.73

3.8

1.6

35.28

6.65

e6/l

1.99

155

Other and unspecified polyneuropathies, also in other diseases

575

1312

4.63

232.43

1.4

17.96

23.22

e6/l

0.30

454

999

Nontraumatic intracranial haemmorrhage

531

1151

4.82

227.83

2.8

1.3

95.01

25.95

e6/l

2.34

435

894

Syncope and collapse

880

2294

3.36

223.34

1.5

1.3

18.59

25.12

e6/l

0.31

688

1782

Alzheimer’s disease (Early onset)

224

196

12.72

220.54

1.1

1.2

2.26

36.24

e6/l

1.36

171

158

Stroke, excluding SAH

1230

3299

2.79

216.76

1.7

1.4

37.20

29.34

e6/l

0.28

962

2559

Care involving use of rehabilitation procedures

1448

5515

2.47

211.37

1.5

27.34

27.96

e6/l

0.02

1187

4214

Anxiety disorders

1940

6263

2.20

204.91

1.4

33.40

29.33

e6/l

0.15

1456

4850

Neurotic, stress-related and somatoform disorders

1922

6236

2.20

202.71

1.4

26.99

31.38

e6/l

0.21

1443

4826

Parkinson's disease, excluding more controls

212

173

11.90

200.77

1.3

1.2

3.97

13.67

e6/l

1.24

174

135

Migraine without aura

564

1432

4.10

197.02

1.4

1.5

13.57

40.34

e6/l

1.77

442

1083

Migraine with aura

630

1748

3.73

193.42

1.3

1.4

12.54

43.61

e6/l

2.14

507

1332

Other soft tissue disorders, not elsewhere classified

1963

5408

2.16

191.46

1.5

23.55

30.83

e6/l

0.42

1540

4155

Symptoms and signs involving the skin and subcutaneous tissue

1513

6586

2.30

189.83

1.4

14.07

31.55

e6/l

2.80

1172

5095

Diplopia

430

922

4.96

188.25

1.4

15.99

26.49

e6/l

0.65

339

709

Subarachnoid haemorrhage

345

615

5.99

186.24

3.0

1.3

88.42

25.54

e6/l

3.42

292

475

Optic neuritis

245

309

9.08

185.72

1.2

1.5

9.07

13.08

e6/l

0.53

183

251

Anxiety (asthma-related co-morbidities)

1344

4344

2.45

185.20

1.4

25.14

32.73

e6/l

0.30

990

3386

Autoimmune diseases excluding thyroid diseases

2140

5724

2.07

183.77

1.3

1.5

24.49

33.22

e6/l

0.54

1653

4400

Other meningitis

159

113

18.61

181.50

2.0

1.2

373.12

4.93

e6/l

2.66

130

Dorsalgia

1985

5087

2.12

180.50

1.3

1.4

18.77

33.01

e6/l

2.00

1594

3861

Obstructive hydrocephalus

143

22.26

179.78

2.5

1.9

30.63

6.79

e6/l

1.20

115

Recurrent or chronic depression

826

1892

3.14

177.76

1.4

29.38

38.83

e6/l

0.36

636

1463

General examination and investigation of persons without complaint and reported diagnosis

1305

2714

2.55

177.51

1.4

24.17

32.10

e6/l

0.48

1105

1992

Autoimmune diseases excluding thyroid diseases, strict definition

2061

5549

2.07

175.78

1.3

1.5

21.70

29.86

e6/l

0.54

1592

4272

Parkinson's disease, strict definition, excluding more controls

188

160

11.52

175.50

1.4

1.2

4.26

14.31

e6/l

1.16

155

124

Bacterial infection, other or unspecified

1103

3788

2.59

175.28

1.9

1.3

46.69

21.60

e6/l

1.07

873

2928

Pain in limb

1682

5247

2.18

173.17

1.5

25.91

31.01

e6/l

0.23

1315

4027

Persons encountering health services for specific procedures and health care

2176

6637

2.00

173.10

1.5

1.4

28.07

29.13

e6/l

0.06

1709

5076

Disorders of thyroid, IBD co-morbidities

277

247

8.05

172.05

1.4

1.3

53.58

13.31

e6/l

1.03

210

185

Autoimmune diseases related-to ILD

1738

7236

2.09

168.91

1.3

1.4

37.13

28.70

e6/l

0.34

1359

5594

Motor neuron disease

62.97

168.44

1.1

8.17

38.67

e6/l

0.42

Bacterial infection, other or unspecified

1169

4103

2.46

166.84

1.9

1.4

45.47

22.84

e6/l

1.01

930

3162

ILD medications: immunosuppressive drugs

1367

5705

2.27

165.86

2.0

1.4

35.93

27.06

e6/l

0.30

1068

4376

Low back pain

1498

4907

2.23

165.38

1.3

1.4

19.63

33.75

e6/l

1.87

1187

3722

Viral meningitis

214

265

9.28

164.82

1.4

105.52

8.37

e6/l

11.08

186

204

Sequelae of cerebrovascular disease

701

1942

3.20

164.05

2.0

1.3

37.06

27.27

e6/l

0.47

571

1513

Motor neuron disease (with DMD)

51.29

163.35

1.1

1.8

8.13

34.71

e6/l

0.43

Cerebral palsy and other paralytic syndromes

384

848

4.82

162.30

1.6

15.28

23.82

e6/l

0.46

280

650

Ischaemic Stroke, excluding all haemorrhages

1056

3107

2.59

162.10

1.5

1.4

22.95

35.97

e6/l

0.79

829

2418

Other dorsopathies, not elsewhere classified

1964

5101

2.04

161.31

1.3

1.4

26.10

33.02

e6/l

0.40

1575

3873

Malignant neoplasm of brain, including Hilmo

244

360

7.55

160.46

2.0

1.4

54.82

35.04

e6/l

0.33

191

294

All anxiety disorders

1363

4840

2.27

159.92

1.4

25.01

33.15

e6/l

0.33

1007

3758

Anaemias

516

843

4.11

159.16

1.9

1.2

13.54

10.49

e6/l

0.45

390

671

Status epilepticus

183

193

10.65

158.82

1.7

1.8

22.42

56.41

e6/l

0.53

154

147

Other disorders of optic [2nd] nerve and visual pathways

281

487

6.35

157.61

1.6

1.8

24.12

31.05

e6/l

0.18

223

377

Use of donepezil

426

986

4.29

156.81

1.2

1.3

3.77

27.23

e6/l

2.72

331

780

Lower back pain or/and sciatica

2048

6958

1.95

155.97

1.3

1.4

19.12

33.78

e6/l

2.30

1639

5331

Papilloedema, unspecified

170

169

12.21

155.96

1.5

1.3

21.79

11.84

e6/l

0.37

140

134

Medical observation and evaluation for suspected diseases and conditions

1268

2715

2.43

154.88

1.5

1.4

14.72

32.09

e6/l

1.72

1034

1993

ILD medications

2213

6332

1.92

154.38

1.7

1.4

38.20

25.86

e6/l

0.60

1727

4857

Nerve, nerve root and plexus disorders

2036

6480

1.95

153.29

1.3

1.4

37.51

28.02

e6/l

0.44

1622

4968

Depression medications

655

943

3.57

152.27

1.4

1.1

14.64

10.79

e6/l

0.61

484

750

Certain infectious and parasitic diseases

1861

4617

2.05

151.68

1.6

1.3

47.86

19.79

e6/l

1.92

1447

3530

Alzheimer’s disease (Atypical or mixed), excluding more controls

143

17.31

149.19

1.3

1.1

26.89

33.45

e6/l

0.09

123

Subjective visual disturbances

618

2006

3.19

148.22

1.3

1.5

12.81

31.91

e6/l

1.63

478

1536

Other anxiety disorders

1039

3790

2.43

144.87

1.4

27.68

31.56

e6/l

0.11

774

2939

Dementia in Alzheimer disease

326

553

5.13

143.97

1.2

1.3

16.85

30.65

e6/l

0.45

283

443

Malignant neoplasm of brain

190

240

9.02

143.78

1.9

1.2

62.46

44.10

e6/l

0.21

149

195

Pain (limb, back, neck, head abdominally)

1313

2897

2.30

142.60

1.6

1.5

17.10

39.69

e6/l

2.15

1023

2200

Other bacterial diseases

1779

6187

1.96

138.68

1.9

1.4

47.94

25.24

e6/l

1.47

1402

4749

Used for control exclusion in common control thyroid runs

2000

5315

1.93

138.31

1.4

1.5

17.05

30.70

e6/l

2.24

1543

4082

Selective serotonin reuptake inhibitors

1795

4761

1.99

138.18

1.3

1.4

19.86

36.44

e6/l

1.98

1392

3683

Intracranial injury

1170

5071

2.22

135.73

1.5

21.66

31.66

e6/l

0.68

887

3940

Alzheimer’s disease (Late onset)

420

913

3.98

135.61

1.2

1.3

6.76

22.80

e6/l

1.47

315

726

Abnormal involuntary movements

356

859

4.35

133.81

1.5

1.4

8.22

32.06

e6/l

1.99

272

645

Primary_lymphoid and hematopoietic malignant neoplasms

551

1780

3.21

133.24

3.2

1.3

27.77

22.89

e6/l

0.17

444

1374

Opioids

1869

5077

1.94

132.48

1.3

1.4

25.80

29.01

e6/l

0.16

1448

3918

Malignant neoplasm of eye, brain and central nervous system

205

311

7.33

131.40

2.0

1.4

59.06

36.10

e6/l

0.33

159

253

Use of rivastigmine

322

729

4.58

130.43

1.2

1.3

18.97

23.61

e6/l

0.13

237

581

Provisional assignment of new diseases of uncertain etiology

1078

4894

2.24

129.00

1.5

1.4

13.77

31.99

e6/l

2.56

796

3836

Codes for special purposes

1078

4900

2.24

128.61

1.5

1.4

13.77

31.97

e6/l

2.56

796

3842

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

582

1966

3.02

128.56

1.3

1.4

15.79

29.40

e6/l

1.52

434

1536

Dorsopathies

1908

5153

1.91

128.27

1.3

1.5

23.37

33.00

e6/l

0.93

1517

3914

Bleeding

1516

5447

2.01

128.24

1.9

1.4

47.76

28.57

e6/l

1.16

1182

4191

Substance abuse, excluding more controls

963

3521

2.37

127.81

1.4

33.62

37.91

e6/l

0.11

738

2726

Memory loss

251

473

5.62

127.54

1.3

15.02

32.46

e6/l

0.52

154

364

Sciatica+with lumbago

990

3996

2.32

126.98

1.3

1.4

17.43

33.79

e6/l

1.83

799

2989

Examination and observation for other reasons

1076

2699

2.34

126.60

1.4

27.64

32.19

e6/l

0.14

856

1981

Other special examinations and investigations of persons without complaint or reported diagnosis

1199

2715

2.27

126.32

1.5

1.4

28.77

32.09

e6/l

0.13

957

1993

Pain in joint

1018

2783

2.37

126.07

1.3

1.4

20.68

41.26

e6/l

1.56

789

2112

Covid-19 confirmed case

763

3017

2.59

125.71

1.6

1.4

15.03

22.07

e6/l

0.61

551

2366

Cardiovascular diseases (excluding rheumatic etc)

1340

3676

2.13

125.63

1.6

1.4

29.92

22.22

e6/l

0.49

1060

2789

Extrapyramidal and movement disorders

747

2934

2.61

124.78

1.3

1.4

7.39

30.08

e6/l

3.66

551

2283

Guillain-Barre syndrome

122

105

14.34

123.44

1.4

1.2

9.88

9.09

e6/l

0.04

Other bacterial diseases

1869

6471

1.86

122.44

1.8

1.4

52.86

22.33

e6/l

1.93

1461

4966

Nausea and vomiting

593

2054

2.91

121.19

1.8

1.6

19.10

32.01

e6/l

0.80

454

1575

Autoimmune diseases

2044

5760

1.83

120.82

1.3

1.5

19.00

33.03

e6/l

2.05

1580

4428

Use of other anti-dementia drugs

466

1157

3.43

120.73

1.2

1.3

6.39

24.57

e6/l

2.02

380

912

Use of memantine

466

1157

3.43

120.73

1.2

1.3

6.39

24.57

e6/l

2.02

380

912

Spirochaetal infections, other/unspecified

285

649

4.70

116.35

1.2

1.4

33.19

26.61

e6/l

0.25

208

501

Benzodiazepine use

1859

7131

1.82

115.88

1.4

26.94

31.21

e6/l

0.20

1428

5523

Bell's palsy

333

852

4.10

115.82

1.5

1.4

39.69

16.36

e6/l

0.89

253

639

Explicit Sepsis

775

2973

2.48

115.64

2.3

1.4

63.96

25.55

e6/l

1.36

623

2319

Tramadol

1445

4529

1.99

114.95

1.3

1.4

23.57

30.07

e6/l

0.30

1104

3499

Parasetamol

1391

3483

2.05

114.62

1.5

1.4

24.66

29.71

e6/l

0.32

1084

2633

Personality disorders, excluding more controls

533

1849

2.96

113.23

1.3

1.4

7.81

30.04

e6/l

5.06

403

1445

First line medication for Crohn's disease

2041

6262

1.78

113.18

1.8

1.3

39.67

24.23

e6/l

0.89

1600

4795

Injuries to the head

2032

7178

1.76

111.41

1.5

1.4

22.25

32.11

e6/l

1.05

1566

5554

Diseases of the eye and adnexa

1539

3994

1.96

111.10

1.6

1.4

27.25

34.16

e6/l

0.43

1196

3063

Any gastric operation

1484

3807

1.98

111.05

1.8

1.2

22.57

35.04

e6/l

0.90

1136

2954

GASTRO-related operations

1484

3807

1.98

111.05

1.8

1.2

22.57

35.04

e6/l

0.90

1136

2954

Any reimbursement code in KELA

1163

2720

2.18

110.72

1.7

1.3

23.25

30.23

e6/l

0.40

895

2066

Pain in throat and chest

1584

5066

1.90

110.55

1.3

1.4

20.76

38.40

e6/l

1.92

1226

3881

Other intervertebral disc disorders

1453

4532

1.96

110.04

1.3

1.4

25.20

34.87

e6/l

0.48

1190

3433

Other disorders of fluid, electrolyte and acid-base balance

600

2132

2.75

109.97

1.5

35.99

29.06

e6/l

0.13

491

1696

Cardiovascular diseases

1243

3238

2.10

109.90

1.6

1.4

24.40

21.23

e6/l

0.19

965

2464

Metabolic disorders

1700

5676

1.85

109.50

1.4

1.5

34.06

31.58

e6/l

0.09

1283

4429

Other disorders of urethra and urinary system

1280

4661

2.01

109.13

1.5

1.4

28.23

26.55

e6/l

0.06

971

3633

Viral hepatitis, IBD co-morbidity

107

12.61

108.31

1.8

1.3

29.26

8.59

e6/l

1.27

Migraine without aura and triptan purchases

440

1413

3.23

107.81

1.4

15.15

23.88

e6/l

0.82

348

1090

Circumscribed brain atrophy

114

108

12.17

107.22

1.1

1.3

2.72

60.61

e6/l

0.65

ILD medications: prednisolone, methylprednisolone, prednisone

1947

6211

1.77

107.21

1.5

1.4

36.14

26.01

e6/l

0.49

1528

4767

Codeine

1684

4995

1.85

106.24

1.3

1.4

39.13

29.07

e6/l

0.33

1303

3849

Hypothyroidism (congenital or acquired)

501

896

3.22

105.21

1.4

1.2

28.14

10.26

e6/l

0.97

393

714

1592

5233

1.87

104.90

1.6

1.4

36.33

26.39

e6/l

0.61

1231

4014

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1592

5233

1.87

104.90

1.6

1.4

36.33

26.39

e6/l

0.61

1231

4014

Other reaction to severe stress, and adjustment disorders

774

3362

2.35

103.70

1.5

1.4

19.94

30.35

e6/l

0.58

596

2600

Nonorganic sleeping disorders, excluding more controls

414

1311

3.25

103.39

1.3

1.4

5.35

27.28

e6/l

3.99

309

1030

Spondylopathies

1334

4098

1.97

103.10

1.3

1.4

31.60

35.67

e6/l

0.18

1075

3086

Disorders of ocular muscles, binocular movement, accommodation and refraction

961

4528

2.15

102.86

1.6

1.5

31.22

30.86

e6/l

0.01

760

3467

Secondary parkinsonism, excluding more controls

27.16

102.69

1.4

4.63

24.24

e6/l

0.50

Schizophrenia or delusion, excluding more controls

560

2078

2.73

102.45

1.2

1.4

50.96

37.07

e6/l

0.21

420

1617

Unspecified dementia

208

348

5.54

102.41

1.2

3.47

40.68

e6/l

1.54

180

283

Hypothyroidism, levothyroxine purchases

494

892

3.19

102.39

1.4

1.2

27.24

10.29

e6/l

0.89

388

711

Hypothyroidism and >3 levothyroxin purchases

494

892

3.19

102.39

1.4

1.2

27.24

10.29

e6/l

0.89

388

711

Influenza and pneumonia

1910

7052

1.74

101.77

1.6

1.4

32.27

29.73

e6/l

0.13

1489

5411

Non-invasive ventilation

481

1477

2.98

101.15

1.5

1.4

53.70

16.11

e6/l

1.42

415

1142

Speech disturbances, not elsewhere classified

250

588

4.48

97.57

1.3

1.4

20.81

28.23

e6/l

0.17

187

457

Liquid cancers, helper endpoint

740

2804

2.35

96.51

2.7

1.4

25.86

26.66

e6/l

0.03

590

2216

Migraine with aura and triptan purchases

409

1345

3.15

96.28

1.3

1.4

11.11

23.71

e6/l

1.97

331

1034

Non-Hodgkin lymphoma, all, including Hilmo

327

941

3.63

95.77

1.8

1.3

39.90

25.57

e6/l

0.34

269

736

Abnormalities of breathing

1616

5263

1.80

95.21

1.4

1.5

20.49

37.54

e6/l

1.19

1291

4034

Hard cardiovascular diseases

1467

4775

1.86

94.96

1.6

1.5

27.74

33.87

e6/l

0.36

1166

3623

Lumbar disc prolapse

1104

4313

1.99

92.87

1.3

1.4

26.28

35.94

e6/l

0.36

901

3260

Hypo-osmolality and hyponatraemia

357

1098

3.34

92.73

1.4

1.5

24.29

35.31

e6/l

0.32

287

871

Paralytic strabismus

218

487

4.76

91.14

1.6

1.5

20.02

27.92

e6/l

0.22

172

372

Benign neoplasm of meninges

273

722

3.97

90.85

1.6

1.3

65.48

24.24

e6/l

0.96

206

544

Persons encountering health services in other circumstances, wide

2037

6317

1.68

90.53

1.4

1.5

26.12

31.68

e6/l

0.42

1537

4929

Benign neoplasm: Cerebral meninges

258

658

4.13

90.44

1.5

1.3

68.26

25.11

e6/l

0.94

194

499

Oedema, not elsewhere classified

479

1742

2.76

90.34

1.3

24.46

24.84

e6/l

0.01

365

1337

Intracerebral haemorrhage

260

666

4.04

89.87

2.6

1.3

93.33

23.80

e6/l

0.86

203

516

Cerebral aneurysm, nonruptured

237

574

4.35

89.03

1.8

1.3

33.33

32.32

e6/l

0.02

192

444

Persons encountering health services for examination and investigation

1091

2715

2.04

88.76

1.4

19.59

32.09

e6/l

0.84

859

1993

Neuromuscular dysfunction of bladder

246

614

4.21

88.68

1.5

1.4

27.13

30.65

e6/l

0.10

191

473

Non-follicular lymphoma

252

642

4.13

88.41

2.0

1.4

22.86

25.26

e6/l

0.06

215

497

Septicaemia

729

3082

2.25

87.58

2.3

1.4

51.90

21.57

e6/l

1.63

588

2389

Soft tissue disorders

1808

5483

1.72

87.30

1.5

28.47

30.70

e6/l

0.09

1396

4211

Transient ischemic attack

820

3114

2.17

87.13

1.4

11.15

35.48

e6/l

2.91

649

2414

Symptoms and signs involving the circulatory and respiratory systems

1796

5290

1.72

86.74

1.4

1.5

25.63

37.39

e6/l

0.70

1408

4053

Spondylosis

894

3552

2.08

86.10

1.3

1.4

32.57

34.53

e6/l

0.05

716

2684

Other diseases of urinary system

1730

5714

1.72

86.07

1.4

35.56

27.41

e6/l

0.32

1323

4454

Diffuse large B-cell lymphoma

164

304

5.86

85.61

1.6

1.3

18.30

34.27

e6/l

0.37

143

250

Diffuse large B-cell lymphoma, including Hilmo

164

304

5.86

85.61

1.6

1.3

18.30

34.27

e6/l

0.37

143

250

Diffuse large B-cell lymphoma, helper endpoint

164

304

5.86

85.61

1.6

1.3

18.30

34.27

e6/l

0.37

143

250

Use of teriflunomide

13.75

85.23

1.1

1.3

147.45

9.69

e6/l

0.50

All pneumoniae

1774

7108

1.69

85.10

1.6

1.4

30.43

30.21

e6/l

0.01

1375

5462

Asthma

1330

3783

1.86

84.91

1.3

1.4

37.98

28.82

e6/l

0.28

1035

2872

Hypertensive diseases (excluding secondary)

966

2753

2.07

84.70

1.4

43.40

23.55

e6/l

0.67

731

2087

Systemic atrophies primarily affecting the central nervous system

154

273

6.13

84.32

1.6

1.5

6.28

40.96

e6/l

0.94

122

218

Other septicaemia

654

2768

2.32

84.27

2.4

1.4

34.61

22.28

e6/l

0.74

527

2141

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

173

338

5.37

84.14

1.4

1.3

43.59

34.90

e6/l

0.09

126

268

Pneumonias (Asthma/COPD co-morbidities)

1759

7089

1.68

84.07

1.6

1.4

30.66

30.24

e6/l

0.02

1363

5445

Traumatic subarachnoid haemorrhage

15.11

84.00

1.5

1.2

15.51

3.72

e6/l

1.23

Asthma (mode)

1308

3804

1.86

83.70

1.3

1.4

38.36

29.25

e6/l

0.27

1023

2888

Inflammatory bowel disease treatment related agents

1998

6877

1.64

83.45

1.7

1.4

34.06

27.39

e6/l

0.35

1581

5264

Symptoms and signs involving the digestive system and abdomen

1721

5064

1.72

83.45

1.5

21.50

37.36

e6/l

1.70

1339

3894

Oral corticosteroids

1846

6629

1.67

83.33

1.4

30.44

27.68

e6/l

0.12

1474

5074

Asthma, excluding more controls

1297

3672

1.86

82.57

1.3

1.4

38.34

29.26

e6/l

0.26

1008

2788

Pneumonia, organism unspecified

1567

6439

1.73

82.50

1.6

1.4

32.67

30.14

e6/l

0.12

1216

4950

Certain infectious and parasitic diseases

1253

3361

1.89

82.20

1.5

1.4

29.81

15.79

e6/l

1.37

945

2610

Other and unspecified degenerative diseases of nervous system

106

131

8.96

81.30

1.3

3.25

71.75

e6/l

0.92

107

Complications of surgical and medical care, not elsewhere classified

1696

6976

1.68

81.25

1.6

1.4

37.09

29.38

e6/l

0.37

1324

5387

Other/unspecified dorsalgia

657

2923

2.27

81.24

1.3

1.4

13.65

30.63

e6/l

1.94

509

2216

Codeine or tramadol medication

1944

6542

1.64

80.98

1.3

1.4

40.49

26.16

e6/l

0.62

1510

5069

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1709

7036

1.67

80.23

1.6

1.4

33.23

30.37

e6/l

0.14

1324

5411

Strabismus

568

2412

2.41

80.07

1.6

17.16

22.63

e6/l

0.53

455

1840

Enlarged lymph nodes

284

846

3.44

78.35

1.5

1.4

17.64

14.53

e6/l

0.10

220

642

Bacterial meningitis

140

246

6.24

77.58

2.0

1.4

501.07

8.26

e6/l

2.74

113

189

Small fibre neuropathy

126

200

7.01

77.57

1.3

5.57

49.66

e6/l

0.83

101

155

Hemiplegia

164

332

5.27

77.22

1.6

1.4

6.54

36.50

e6/l

0.98

123

260

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1670

6993

1.66

76.90

1.8

1.4

24.22

32.26

e6/l

0.41

1309

5377

Other extrapyramidal and movement disorders in other diseases

455

1793

2.61

75.90

1.3

1.4

9.68

35.41

e6/l

2.31

323

1391

Hypertension, essential

1340

4310

1.78

75.28

1.4

51.74

28.75

e6/l

0.86

1018

3344

Undefined dementia

208

467

4.22

75.05

1.2

1.3

3.47

30.90

e6/l

1.48

180

376

L04AA Selective immunosuppressants

486

1991

2.51

74.82

1.7

1.5

47.82

29.77

e6/l

0.28

383

1502

Second line medication for Crohn's disease

1035

5668

1.85

73.50

2.1

1.4

29.51

31.19

e6/l

0.05

821

4377

Cervicobrachial syndrome

424

1640

2.65

73.39

1.3

1.4

13.27

36.37

e6/l

1.43

351

1220

COPD/asthma related infections

1719

5237

1.66

73.22

1.5

1.4

48.20

26.38

e6/l

1.07

1335

4018

COPD/asthma/ILD related infections

1719

5237

1.66

73.22

1.5

1.4

48.20

26.38

e6/l

1.07

1335

4018

Dysphagia

451

1802

2.56

72.94

1.4

36.92

35.28

e6/l

0.03

340

1397

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1860

6311

1.62

72.92

1.4

1.5

28.15

31.70

e6/l

0.17

1402

4924

Symptoms and signs involving speech and voice

602

2734

2.25

72.75

1.3

1.4

23.55

32.57

e6/l

0.32

450

2111

L04AX Other immunosuppressants

1006

5487

1.86

72.40

2.1

1.4

18.84

31.70

e6/l

1.46

795

4235

Complications of medical and surgical care

1234

6568

1.75

71.49

1.6

1.4

40.38

28.13

e6/l

0.70

948

5100

Other disorders of central nervous system

12.24

71.06

1.6

1.3

345.47

6.43

e6/l

1.39

Antihypertensive medication - note that there are other indications

1163

3399

1.84

71.04

1.5

18.17

26.30

e6/l

0.76

884

2626

Asthma, unspecified (mode), excluding more controls

871

3352

1.97

71.03

1.4

53.20

26.03

e6/l

0.68

661

2546

Cystitis

1411

4950

1.71

70.22

1.4

34.55

25.56

e6/l

0.38

1075

3866

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1060

5276

1.82

70.19

1.4

24.50

32.65

e6/l

0.27

802

4096

Fall on same level

1957

6821

1.58

70.00

1.4

1.5

29.18

30.59

e6/l

0.06

1500

5278

Asthma, unspecified (mode)

881

3445

1.95

69.98

1.4

52.42

25.76

e6/l

0.67

671

2617

Abdominal and pelvic pain

1651

5063

1.65

69.46

1.4

1.5

23.74

37.37

e6/l

1.31

1294

3893

Other and unspecified visual disturbances

249

749

3.47

68.28

1.2

1.4

62.05

23.57

e6/l

0.36

183

574

Dental caries

491

2020

2.39

67.81

2.3

1.4

28.87

30.68

e6/l

0.05

385

1555

Invasive ventilation

207

556

3.93

67.66

2.1

1.7

91.56

28.08

e6/l

1.03

163

430

Other disorders of eye and adnexa

330

1176

2.90

67.46

1.4

1.5

13.61

27.29

e6/l

1.20

244

891

Symptoms and signs involving the urinary system

1243

5545

1.73

66.96

1.5

1.4

24.01

33.44

e6/l

0.66

964

4288

Asthma (only as main-diagnosis), excluding more controls

1141

3672

1.80

66.33

1.4

31.03

29.26

e6/l

0.05

912

2788

Somatoform disorder

347

1280

2.79

66.27

1.2

1.4

15.09

28.45

e6/l

0.91

267

987

Meningitis, viral

22.11

66.19

1.5

1.3

166.93

2.96

e6/l

4.50

Asthma (only as main-diagnosis)

1154

3783

1.78

65.87

1.4

30.89

28.82

e6/l

0.06

921

2872

ILD differential diagnosis

1306

3804

1.74

65.76

1.5

1.4

22.17

29.25

e6/l

0.44

1000

2888

Bipolar affective disorders

389

1524

2.62

65.75

1.3

1.4

18.79

23.61

e6/l

0.19

298

1187

COPD differential diagnosis

1306

3805

1.74

65.71

1.5

1.4

22.17

29.24

e6/l

0.44

1000

2889

Cervicalgia

375

1447

2.65

65.27

1.3

1.4

9.77

31.89

e6/l

1.32

294

1083

Tick-borne viral encephalitis

20.39

65.14

1.1

99.70

3.37

e6/l

3.05

Endovascular or surgical operations to intracerebral aneurysms

165

387

4.49

64.81

2.1

1.2

53.10

35.43

e6/l

0.46

143

304

Tick-borne viral encephalitis

22.88

64.52

1.1

92.11

3.46

e6/l

2.56

Other pulmonary diagnosis

1306

3826

1.73

64.46

1.4

32.01

28.66

e6/l

0.11

1003

2908

Unspecified mental disorder

747

3854

1.97

63.99

1.2

1.4

49.71

31.50

e6/l

0.39

556

2983

Excluding asthma or asthma-COPD overlap

1302

3826

1.72

63.58

1.5

1.4

22.77

28.66

e6/l

0.35

998

2908

Diseases of the musculoskeletal system and connective tissue

966

2596

1.89

63.50

1.7

1.6

25.38

30.41

e6/l

0.22

742

1960

1845

6136

1.57

62.94

1.5

1.4

42.68

27.24

e6/l

0.78

1469

4717

Other general symptoms and signs

126

241

5.42

62.12

1.8

12.17

15.72

e6/l

0.25

183

Bronchitis

1764

7179

1.56

61.74

1.5

1.4

23.39

31.60

e6/l

0.71

1403

5519

Triptan medication for migraine, single purchase ok

1336

5490

1.67

61.73

1.3

1.4

29.93

33.58

e6/l

0.12

1041

4203

Migraine, single triptan purchase ok & required. ICD-code if available is included

1336

5490

1.67

61.73

1.3

1.4

29.93

33.58

e6/l

0.12

1041

4203

Symptoms and signs concerning food and fluid intake

188

501

3.86

61.38

1.6

1.4

44.46

15.76

e6/l

0.58

158

372

Hypertensive diseases

1328

4504

1.68

61.26

1.4

1.5

50.66

27.73

e6/l

0.87

1022

3487

Disorders of lipoprotein metabolism and other lipidaemias

1253

4614

1.70

61.25

1.3

1.4

29.59

34.75

e6/l

0.25

904

3594

Somnolence, stupor and coma

120

226

5.61

61.22

1.6

10.71

44.56

e6/l

0.65

100

174

Hypertension

1326

4496

1.68

61.18

1.4

1.5

50.63

27.76

e6/l

0.86

1021

3483

Other disorders of lacrimal gland

610

2990

2.08

60.58

1.4

19.43

33.37

e6/l

1.01

490

2290

Viral infections characterized by skin and mucous membrane lesions

744

3906

1.93

60.42

1.7

1.5

35.71

28.23

e6/l

0.54

579

3015

Caries of dentine

431

1786

2.40

60.41

1.9

1.4

32.83

33.39

e6/l

0.01

343

1379

304

1100

2.85

60.35

1.7

1.4

26.08

26.10

e6/l

0.00

221

855

Acute upper respiratory infections of multiple and unspecified sites

1264

5673

1.67

59.79

1.6

1.4

18.51

25.72

e6/l

0.82

1005

4343

Implicit fungal Sepsis

159

388

4.29

59.19

1.5

1.3

5.27

19.66

e6/l

1.01

123

305

Use of hypnotics and sedatives

1748

6520

1.55

58.69

1.4

28.60

30.19

e6/l

0.06

1364

5030

Diarrhoea and gastroenteritis of presumed infectious origin

1187

6463

1.67

58.45

1.4

29.84

28.11

e6/l

0.05

920

4970

Myalgia

435

1893

2.35

58.36

1.3

1.4

16.74

37.75

e6/l

1.49

336

1445

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

582

2846

2.09

58.28

1.3

1.4

15.79

22.40

e6/l

0.67

434

2202

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

112

128

6.30

57.41

1.2

1.4

33.40

10.00

e6/l

0.67

100

Other lack of coordination

9.25

57.25

1.4

6.93

14.35

e6/l

0.39

Acute upper respiratory infections

1664

6669

1.55

56.32

1.5

1.4

45.07

27.55

e6/l

0.83

1325

5121

Radiculopathy

282

1021

2.83

55.74

1.3

1.4

27.79

31.34

e6/l

0.06

229

766

Intestinal infectious diseases

1547

7599

1.56

55.68

1.5

1.4

27.59

29.45

e6/l

0.08

1214

5845

Other diseases of spinal cord

161

6.40

55.57

2.4

1.2

40.95

39.48

e6/l

0.01

124

Dementia in other diseases classified elsewhere

110

209

5.54

55.54

1.2

2.63

56.66

e6/l

1.16

161

Non-selective monoamine reuptake inhibitors

551

2580

2.09

55.50

1.4

14.27

38.56

e6/l

2.76

429

1995

All kidney diseases

1613

7180

1.55

55.46

1.5

1.4

41.24

26.94

e6/l

0.63

1253

5537

Viral infections characterized by skin and mucous membrane lesions

1416

7736

1.58

55.05

1.5

1.4

29.17

30.36

e6/l

0.08

1098

5971

Behavioural syndromes associated with physiological disturbances and physical factors

1520

6956

1.56

54.87

1.4

33.66

29.84

e6/l

0.14

1154

5382

Substance abuse

963

5287

1.73

54.40

1.4

33.62

32.78

e6/l

0.02

738

4084

Acute lymphocytic leukaemia

12.81

54.34

13.2

1.2

9.62

6.80

e6/l

0.13

Acute lymphocytic leukaemia, including Hilmo

12.81

54.34

13.2

1.2

9.62

6.80

e6/l

0.13

Acute lymphocytic leukaemia, helper endpoint

12.81

54.34

13.2

1.2

9.62

6.80

e6/l

0.13

Retention of urine

531

2090

2.12

53.83

1.5

1.4

21.45

21.88

e6/l

0.02

415

1640

Sleep disorders (combined)

1808

6303

1.52

53.82

1.4

30.45

30.34

e6/l

0.00

1379

4895

Diagnoses used for exclusion with ILD

434

1953

2.27

53.80

1.6

1.4

49.61

22.98

e6/l

0.42

333

1519

Disorders of adult personality and behaviour

564

2810

2.05

53.71

1.3

1.4

7.69

25.51

e6/l

5.62

424

2174

Endocrine, nutritional and metabolic diseases

1370

4321

1.62

53.59

1.5

22.97

29.35

e6/l

0.45

1046

3352

Mental and behavioural disorders due to psychoactive substance use

985

5391

1.71

53.34

1.4

33.02

32.56

e6/l

0.01

753

4159

Kela-code for severe mental illness

650

3411

1.94

53.11

1.2

1.4

46.02

29.48

e6/l

0.32

481

2628

Pure hypercholesterolaemia

1082

4214

1.69

52.90

1.3

1.4

26.29

31.06

e6/l

0.26

786

3285

Exclusions for E4_PCOS_BROAD

367

1553

2.43

52.74

1.5

1.8

69.27

22.34

e6/l

0.69

285

1178

Poisoning by medicine

444

2041

2.23

52.41

1.2

1.4

10.18

24.06

e6/l

2.41

321

1575

Poisoning by drugs, medicaments and biological substances

477

2258

2.16

52.21

1.3

1.4

11.99

22.97

e6/l

1.71

349

1739

Post-traumatic stress disorder

204

641

3.30

52.14

1.3

1.5

36.14

21.07

e6/l

0.22

146

506

Factors influencing health status and contact with health services

466

1021

2.32

52.12

1.5

1.3

30.07

28.41

e6/l

0.03

364

748

Brain meningioma, including Hilmo

145

365

4.20

52.08

1.8

1.3

108.08

21.63

e6/l

1.28

118

287

Other functional intestinal disorders

754

3855

1.84

52.06

1.5

1.6

14.33

30.16

e6/l

2.35

586

2983

Shoulder lesions

1172

4329

1.66

51.99

1.4

21.43

33.80

e6/l

1.01

950

3327

Visual field defects

186

554

3.49

51.88

1.7

1.4

21.25

25.80

e6/l

0.15

151

438

Diarrhoea and gastroenteritis of presumed infectious origin

1638

7157

1.52

51.63

1.4

27.47

29.88

e6/l

0.10

1249

5518

Other specific joint derangements/joint disorders

1251

5040

1.62

51.51

1.3

1.5

19.19

29.29

e6/l

1.06

969

3849

Asthma, hospital admission 2, infections

954

5535

1.71

51.50

1.4

1.5

44.79

25.37

e6/l

0.53

759

4279

Asthma-related infections

954

5535

1.71

51.50

1.4

1.5

44.79

25.37

e6/l

0.53

759

4279

Personality disorders

533

2643

2.06

51.48

1.3

1.4

7.81

27.61

e6/l

4.74

403

2041

Fibromyalgia

198

616

3.32

51.40

1.2

1.3

8.00

30.17

e6/l

2.10

155

462

Systemic connective tissue disorders

569

2892

2.00

51.11

1.3

1.4

14.54

30.12

e6/l

1.56

442

2249

Brain meningioma

141

354

4.22

50.84

1.8

1.3

111.37

20.73

e6/l

1.31

114

278

severe traumatic brain injury, does not include concussion

366

1570

2.38

50.82

1.6

1.4

24.82

23.50

e6/l

0.04

267

1216

Nonorganic sleeping disorders

414

1875

2.26

50.75

1.3

1.5

5.35

25.57

e6/l

4.74

309

1443

Spinal stenosis

707

2891

1.88

50.59

1.4

18.36

35.94

e6/l

1.39

567

2187

Dissociative [conversion] disorders

118

260

4.81

50.33

1.2

1.6

14.09

11.13

e6/l

0.11

202

Diseases of the myoneural junction and muscle

247

884

2.88

50.20

1.7

1.5

12.97

22.85

e6/l

0.61

200

682

Sleep disorders

1444

6806

1.55

49.93

1.3

1.4

35.00

29.40

e6/l

0.21

1094

5268

Progressive vascular leukoencephalopathy

154

6.10

49.72

1.2

1.3

3.50

63.56

e6/l

0.93

123

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

956

5652

1.69

49.64

1.7

1.4

46.47

25.50

e6/l

1.15

741

4397

Disorders of eyelid, lacrimal system and orbit

1333

6509

1.57

49.56

1.5

1.4

19.73

31.18

e6/l

1.46

1025

5053

Herpesviral [herpes simplex] infections

250

907

2.85

49.56

1.6

1.5

53.40

25.51

e6/l

1.57

209

693

Renal tubulo-interstitial diseases

1368

6586

1.56

49.49

1.5

1.4

43.20

26.56

e6/l

0.63

1060

5090

Neoplasms

1352

4554

1.59

49.24

2.0

1.3

32.37

26.19

e6/l

0.31

1015

3566

Complications of procedures, not elsewhere classified

1268

6707

1.58

49.10

1.6

1.4

31.65

29.51

e6/l

0.10

985

5181

All influenza

438

2057

2.17

48.81

1.6

1.5

26.16

23.40

e6/l

0.08

358

1581

Exposure to unspecified factor

1603

7730

1.50

48.75

1.4

1.5

28.49

30.04

e6/l

0.06

1175

6040

Disorders of lacrimal system

688

3770

1.85

48.67

1.5

1.4

21.09

32.88

e6/l

0.99

552

2906

Complications of other internal prosthetic devices, implants and grafts

117

264

4.70

48.49

2.9

1.4

17.29

24.43

e6/l

0.21

212

Cluster headache, strict

183

5.53

48.38

1.3

1.2

4.13

16.01

e6/l

1.45

138

Acute tubulo-interstitial nephritis

988

5158

1.67

48.33

1.5

39.20

24.55

e6/l

0.53

774

3995

Specific personality disorders

462

2228

2.12

48.20

1.3

1.4

8.59

24.11

e6/l

3.89

357

1723

Certain disorders involving the immune mechanism

362

1586

2.34

48.10

2.4

1.5

43.77

23.74

e6/l

0.25

277

1213

Constipation

1371

6164

1.55

47.95

1.4

1.5

38.54

28.14

e6/l

0.34

1034

4795

Other diseases of intestines

1728

6652

1.49

47.87

1.4

1.5

29.27

30.92

e6/l

0.06

1323

5162

Benign neoplasm of brain and other parts of central nervous system

165

481

3.60

47.83

1.9

1.5

43.90

30.43

e6/l

0.23

126

365

Other sleep disorders

200

653

3.15

47.78

1.3

1.4

28.87

27.53

e6/l

0.02

165

494

Oxycodone

579

2723

1.95

47.75

1.6

1.4

22.21

30.88

e6/l

0.53

466

2115

Non-Hodgkin lymphoma, all

116

263

4.66

47.74

1.8

1.3

81.80

38.05

e6/l

0.41

219

Ocular pain

203

673

3.14

47.58

1.5

1.6

11.31

22.09

e6/l

0.88

156

519

Psychotic depression

117

268

4.51

47.15

1.4

1.5

4.48

30.07

e6/l

1.41

219

Falls/tendency to fall

1745

5912

1.49

47.14

1.4

1.5

29.97

30.41

e6/l

0.02

1346

4570

Other acute disseminated demyelination

9.15

46.93

1.3

8.67

7.60

e6/l

0.09

Mental and behavioural disorders due to alcohol, excluding acute intoxication

717

4019

1.80

46.66

1.3

1.4

36.41

32.64

e6/l

0.08

552

3072

Mental and behavioural disorders due to alcohol

822

4623

1.73

46.48

1.3

1.4

32.55

33.07

e6/l

0.01

631

3567

Frontotemporal dementia, wide, incl. Pick's disease

15.70

46.37

1.1

1.77

3.42

e6/l

1.43

Focal brain injury

113

6.69

46.35

1.8

1.2

21.53

8.46

e6/l

0.96

Other medical care

679

3373

1.83

46.31

1.7

1.4

44.16

26.77

e6/l

0.69

509

2598

Persons encountering health services in other circumstances

656

3588

1.84

46.25

1.5

22.78

33.95

e6/l

0.69

492

2802

Cluster headache, wide

199

5.17

45.96

1.3

4.76

15.05

e6/l

1.29

151

Alcohol abuse, main dg, excluding more controls

247

927

2.72

45.63

1.2

1.4

59.75

30.34

e6/l

0.24

185

736

Intestinal infectious diseases

1811

7136

1.46

45.63

1.4

27.43

31.26

e6/l

0.18

1402

5519

Pain in thoracic spine

273

1079

2.59

45.47

1.3

1.4

8.90

30.48

e6/l

1.03

226

801

Speech and linguistic disorders, excluding more controls

180

531

3.29

45.46

2.1

19.54

24.12

e6/l

0.23

140

412

Alcohol use disorder, Swedish definition

864

4720

1.70

45.32

1.3

1.4

33.70

33.01

e6/l

0.02

664

3638

Third [oculomotor] nerve palsy

115

7.00

45.29

1.4

1.3

15.31

12.26

e6/l

0.15

Acute sinusitis

850

4673

1.70

45.23

1.4

51.01

27.61

e6/l

0.75

678

3580

Paraplegia, diplegia of upper limbs

139

6.26

44.90

1.8

1.5

34.40

11.08

e6/l

0.62

108

Schizophrenia, schizotypal and delusional disorders

563

2982

1.92

44.87

1.2

1.4

50.73

28.81

e6/l

0.39

422

2288

Alzheimer’s disease (Atypical or mixed)

145

400

3.69

44.61

1.3

26.67

36.73

e6/l

0.15

124

324

Schizophrenia or delusion

560

2970

1.92

44.46

1.2

1.4

50.96

29.06

e6/l

0.38

420

2278

Any death

908

3906

1.68

44.34

1.7

1.4

45.38

30.68

e6/l

0.66

733

2997

Unspecified fall

786

4542

1.73

44.26

1.4

1.5

26.01

28.89

e6/l

0.12

589

3530

Gastrointestinal diseases

1025

3124

1.66

44.04

1.7

1.4

19.73

35.83

e6/l

1.18

778

2444

Rare circulating lymphoid malignancy, including Hilmo

212

5.02

43.95

10.2

1.2

10.32

42.26

e6/l

0.64

182

736

4215

1.75

43.95

1.4

1.5

52.91

26.31

e6/l

0.59

597

3240

Zoster [herpes zoster]

309

1317

2.40

43.72

1.7

1.4

19.38

25.79

e6/l

0.41

235

1025

Dyspnoea

1380

6788

1.51

43.64

1.4

21.08

30.24

e6/l

0.47

1112

5199

909

5009

1.66

43.54

1.3

1.4

31.59

32.85

e6/l

0.03

694

3873

Other and unspecified nonorganic psychotic disorders

383

1794

2.18

43.22

1.2

1.4

51.81

25.67

e6/l

0.35

288

1387

951

5177

1.63

42.97

1.3

1.4

31.01

33.27

e6/l

0.06

729

4004

Any operation in hilmo

15.84

42.97

1.2

1.0

12.47

40.07

e6/l

0.32

Sixth [abducent] nerve palsy

103

232

4.74

42.95

1.5

1.7

27.37

43.71

e6/l

0.23

182

Frontotemporal dementia

16.52

42.91

1.1

1.81

3.74

e6/l

1.54

Other diseases of blood and blood-forming organs, wide

382

1794

2.17

42.79

2.3

1.5

40.31

25.11

e6/l

0.21

317

1368

Asthma (diagnoses ohter than nonallergic)

1365

7583

1.51

42.72

1.4

1.5

41.26

24.70

e6/l

0.64

1065

5857

Follow-up examination after treatment for conditions other than malignant neoplasms

625

2243

1.86

42.62

1.3

1.4

17.80

28.45

e6/l

0.89

470

1657

Cervicocranial syndrome

203

715

2.92

42.50

1.2

1.4

12.31

18.65

e6/l

0.44

164

542

Cervical disc disorders

527

2788

1.92

42.06

1.5

1.4

30.98

32.61

e6/l

0.05

433

2089

Brain glioblastoma and astrocytoma

114

6.76

42.05

1.7

1.2

43.35

6.73

e6/l

1.12

Encephalopathy

10.04

42.05

1.8

1.6

3.42

10.42

e6/l

0.72

Alcohol use disorder, ICD-based

655

3715

1.79

41.75

1.3

1.4

37.44

29.81

e6/l

0.15

500

2837

Other viral diseases

666

3768

1.78

41.69

1.7

1.5

25.53

28.41

e6/l

0.14

509

2893

Other complications of surgical and medical care, not elsewhere classified

208

757

2.84

41.10

1.5

1.4

35.88

20.36

e6/l

0.44

170

582

Triptan medication for migraine, min. 3 purchases

963

4587

1.62

40.96

1.3

1.4

26.55

28.72

e6/l

0.06

764

3509

Other spirochaetal diseases

496

2609

1.93

40.47

1.2

1.4

38.18

31.08

e6/l

0.27

364

2006

Unknown and unspecified causes of morbidity

124

333

3.83

40.33

1.3

1.5

23.70

11.79

e6/l

0.47

106

254

Disorders of vestibular function (Vertigo)

690

3949

1.74

40.08

1.3

1.4

29.28

34.15

e6/l

0.16

550

3035

Insomnia

1369

6745

1.49

40.07

1.3

1.4

36.75

29.23

e6/l

0.28

1031

5227

Other spirochaetal diseases

490

2582

1.93

39.78

1.2

1.4

38.57

31.32

e6/l

0.27

359

1983

Suicide or other Intentional self-harm

448

2294

1.99

39.65

1.2

1.4

12.19

22.89

e6/l

1.64

322

1768

Other heart diseases

745

2841

1.73

39.64

1.4

1.5

42.08

23.92

e6/l

0.77

578

2168

Disorders of other endocrine glands

701

4043

1.73

39.62

1.5

44.61

28.76

e6/l

0.36

540

3125

Spirochaetal infections, other/unspecified

488

2572

1.93

39.60

1.2

1.4

37.63

31.43

e6/l

0.23

358

1976

Lyme disease

485

2556

1.93

39.37

1.2

1.4

37.91

31.37

e6/l

0.24

355

1965

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

514

2726

1.89

39.37

2.5

1.4

12.92

27.33

e6/l

1.67

394

2118

Other external causes of accidental injury

1280

4226

1.53

39.30

1.4

1.5

20.69

34.80

e6/l

1.24

959

3295

Injuries to the abdomen, lower back, lumbar spine and pelvis

606

3384

1.79

39.20

1.4

13.56

30.14

e6/l

2.13

460

2641

Other CVD (FINNGEN)

199

545

2.90

38.93

1.5

1.3

8.31

12.66

e6/l

0.26

153

410

Benign neoplasm: Pituitary gland, craniopharyngeal duct

134

391

3.59

38.90

1.5

154.29

34.15

e6/l

0.63

105

308

Generalized anxiety disorder

304

1356

2.29

38.76

1.2

1.4

12.00

29.28

e6/l

2.02

225

1056

Use of peginterferon beta-1a

15.15

38.51

1.0

1.2

13.41

2.50

e6/l

1.98

Other disorders of binocular movement

168

5.27

38.46

1.5

174.77

15.58

e6/l

0.51

125

Other intracranial haemorrhages

152

5.41

38.43

2.2

1.3

41.97

64.60

e6/l

0.19

119

Other viral diseases

527

2871

1.86

38.19

1.8

1.6

23.95

24.35

e6/l

0.02

409

2201

Other acute lower respiratory infections

805

4702

1.65

38.16

1.5

21.87

30.38

e6/l

0.54

630

3642

Postviral fatigue syndrome

10.14

38.12

1.2

1.6

1.03

2.19

e6/l

1.35

Hypothyroidism, drug reimbursement

209

533

2.81

38.10

1.3

1.2

46.00

7.85

e6/l

0.85

160

435

Herpesviral [herpes simplex] infections

439

2265

1.97

38.03

1.5

1.4

43.04

25.75

e6/l

1.13

355

1760

External causes of morbidity and mortality

1047

3339

1.58

37.57

1.5

1.4

23.49

36.14

e6/l

0.78

790

2586

Other symptoms and signs involving general sensations and perceptions

214

4.55

37.53

1.2

1.4

18.54

46.13

e6/l

0.45

165

Hyperkinetic disorders, excluding more controls

218

812

2.63

37.23

1.2

1.8

11.77

20.46

e6/l

1.04

167

647

Diseases of the respiratory system

987

3111

1.60

37.21

1.5

1.4

29.64

29.36

e6/l

0.01

751

2363

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

856

5365

1.61

37.16

1.7

1.4

51.04

26.49

e6/l

1.25

662

4168

Use of levodopa decarboxylase inhibitor

215

840

2.62

36.83

1.3

3.43

27.41

e6/l

2.26

176

654

Panic disorder

277

1216

2.33

36.72

1.2

1.4

7.86

22.94

e6/l

3.52

214

952

Brachial plexus disorders

193

717

2.77

36.70

1.2

1.4

11.82

21.42

e6/l

0.62

158

541

Rotator cuff syndrome

872

3909

1.62

36.50

1.3

1.4

31.76

32.19

e6/l

0.01

707

3018

Accidents

1263

4226

1.51

36.48

1.4

1.5

20.71

34.80

e6/l

1.23

952

3295

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

542

3037

1.81

36.18

1.5

1.6

72.37

26.56

e6/l

0.95

407

2344

Genitourinary diseases

951

2999

1.60

35.95

1.5

1.6

29.97

26.91

e6/l

0.11

728

2318

Diseases of the ear and mastoid process

1813

6538

1.40

35.72

1.5

1.4

46.84

24.38

e6/l

1.22

1411

5020

Other systemic involvement of connective tissue (FG)

395

1984

1.99

35.47

1.3

1.4

15.02

28.90

e6/l

0.88

301

1543

Superficial injury of head

375

1879

2.03

35.27

1.5

1.6

17.70

22.57

e6/l

0.34

283

1465

Hypopituitarism

171

612

2.90

35.08

1.6

2.3

52.48

25.70

e6/l

0.40

145

463

Asthma, hospital admissions 3, pneumonia

528

2960

1.80

34.85

1.6

1.5

20.28

22.77

e6/l

0.15

415

2303

Asthma-related pneumonia or sepsis

528

2960

1.80

34.85

1.6

1.5

20.28

22.77

e6/l

0.15

415

2303

Vascular dementia

116

315

3.62

34.79

1.4

1.3

6.83

37.86

e6/l

0.97

253

Asthma-related pneumonia

526

2951

1.80

34.64

1.6

1.5

20.33

22.83

e6/l

0.15

414

2295

Diseases of inner ear

772

4651

1.62

34.44

1.3

1.4

29.25

32.38

e6/l

0.11

614

3574

Sarcoidosis

246

1059

2.38

34.28

1.6

1.4

59.58

26.62

e6/l

0.28

187

810

Phobic anxiety disorders

250

1081

2.36

34.25

1.5

10.83

27.55

e6/l

1.57

192

846

Other joint disorders

1408

5151

1.45

34.11

1.3

1.5

25.72

28.99

e6/l

0.13

1112

3933

Asthma, including avohilmo

1809

7382

1.38

34.09

1.3

1.5

32.69

28.71

e6/l

0.15

1402

5699

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

184

695

2.73

33.94

1.3

1.4

8.88

18.95

e6/l

0.81

142

542

Diseases of oesophagus, stomach and duodenum

1609

6875

1.41

33.93

1.3

1.5

28.13

32.20

e6/l

0.16

1247

5309

Lymphoid leukaemia

124

376

3.44

33.88

8.5

1.3

7.89

33.00

e6/l

0.88

102

294

Other strabismus

389

2000

1.97

33.76

1.6

1.7

16.62

23.30

e6/l

0.61

313

1522

Hypotension

241

1034

2.37

33.65

1.5

1.4

7.44

23.71

e6/l

1.54

187

804

Other necrotizing vasculopathies (FG)

123

375

3.40

33.24

1.3

1.4

15.48

10.14

e6/l

0.27

288

Use of galantamine

126

390

3.32

33.10

1.2

1.3

3.76

33.28

e6/l

1.30

319

Emotionally unstable personality disorder

251

1109

2.32

32.94

1.2

1.4

9.96

21.36

e6/l

2.13

190

854

Other and unspecified nerve root and plexus disorders, also in other diseases

323

1577

2.09

32.78

1.3

1.4

52.37

18.84

e6/l

0.46

271

1177

Parkinson's disease, including avohilmo

237

1025

2.36

32.59

1.3

3.82

26.16

e6/l

2.56

195

779

Finngen Rheumatological endpoints

1504

6076

1.42

32.55

1.3

1.4

27.19

30.28

e6/l

0.18

1166

4678

Panhypopituitarism

108

6.00

32.49

2.0

1.5

40.89

52.84

e6/l

0.09

Persistent mood disorders

304

1456

2.12

32.45

1.3

1.4

26.27

33.49

e6/l

0.19

224

1137

ILD medications: azathioprine

264

1198

2.25

32.41

1.6

1.4

17.16

24.75

e6/l

0.38

206

912

Other disorders of nervous system

123

382

3.33

32.23

1.7

1.2

16.49

26.00

e6/l

0.23

287

Persons encountering health services for specific procedures, not carried out

169

628

2.77

32.18

1.3

1.5

35.30

26.43

e6/l

0.14

110

479

Secondary parkinsonism+Parkinsonism in other disease

155

4.91

31.72

1.4

1.3

4.54

67.47

e6/l

0.99

124

Abnormalities of heart beat

524

2958

1.76

31.71

1.3

1.4

10.11

36.32

e6/l

3.99

406

2281

Hypothyroidism, strict autoimmune

1010

4416

1.52

31.68

1.3

1.4

14.81

31.59

e6/l

3.01

792

3401

Secondary parkinsonism

152

4.94

31.49

1.4

1.3

4.63

68.24

e6/l

1.00

123

Osteopathies and chondropathies

810

4855

1.57

31.35

1.6

1.4

18.48

34.61

e6/l

1.91

630

3757

Sequelae of external causes of morbidity and mortality

392

2079

1.92

31.34

1.6

1.4

55.60

29.61

e6/l

0.38

295

1593

Agranulocytosis

208

869

2.46

31.10

2.6

1.4

65.26

29.47

e6/l

0.29

175

659

Optic atrophy

117

5.62

30.86

1.9

23.17

12.19

e6/l

0.26

Optic atrophy

118

5.60

30.61

1.9

23.17

12.41

e6/l

0.25

Use of glatiramer acetate

119

5.55

30.34

1.1

1.7

8.47

5.01

e6/l

1.15

Other and unspecified myopathies

156

575

2.79

30.20

1.8

1.5

13.49

27.04

e6/l

0.59

129

451

Other degenerative diseases of the basal ganglia

109

5.78

30.07

1.3

1.2

2.36

87.80

e6/l

0.93

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

384

1817

1.91

29.93

1.7

16.64

18.35

e6/l

0.14

298

1394

Injury, poisoning and certain other consequences of external causes

824

2626

1.58

29.87

1.6

1.4

23.94

38.99

e6/l

0.75

627

1985

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

310

1546

2.05

29.82

1.2

1.4

11.12

24.90

e6/l

1.55

221

1199

Dental pulpitis, including avohilmo

1420

6613

1.40

29.80

1.3

1.4

29.29

29.77

e6/l

0.02

1064

5114

Polyuria

327

1661

2.00

29.74

1.3

1.4

32.65

24.02

e6/l

0.19

260

1288

Other systemic involvement of connective tissue

400

2173

1.87

29.66

1.3

1.4

14.79

32.13

e6/l

1.24

306

1686

Abnormal findings on examination of blood, without diagnosis

646

3667

1.63

29.61

1.4

52.22

24.50

e6/l

0.67

485

2844

Other CVD

266

1258

2.15

29.36

1.5

1.4

9.45

24.65

e6/l

1.61

207

981

Acute bronchitis

579

3432

1.67

29.28

1.5

21.32

26.80

e6/l

0.29

448

2666

Sleep apnoea

1358

6278

1.41

29.28

1.4

21.47

34.09

e6/l

1.48

1066

4828

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

644

2477

1.66

29.27

1.5

1.3

30.94

19.04

e6/l

0.50

508

1885

Obesity related asthma

520

3064

1.72

29.19

1.3

1.4

69.29

27.74

e6/l

0.68

423

2363

Other and unspecified drugs and medicaments

168

657

2.63

28.99

1.4

1.5

9.42

25.67

e6/l

0.86

131

503

Brain glioblastoma

6.34

28.96

1.7

1.2

46.78

5.41

e6/l

0.86

Open wound of head

742

4609

1.56

28.67

1.5

17.96

32.47

e6/l

1.39

573

3587

Diffuse brain injury

6.93

28.52

1.9

1.2

20.07

5.08

e6/l

0.93

Other and unspecified mood [affective] disorders

142

514

2.84

28.47

1.4

1.5

36.92

23.61

e6/l

0.42

105

403

Injuries to the thorax

629

3913

1.62

28.44

1.3

1.4

16.79

28.24

e6/l

0.69

481

3033

Injuries to the neck

382

2076

1.87

28.39

1.3

1.4

8.58

23.46

e6/l

3.10

301

1603

Bacterial pneumoniae

560

2973

1.68

28.31

1.7

1.4

25.78

26.66

e6/l

0.03

433

2297

Sleep apnoea, including avohilmo

1450

6515

1.39

28.26

1.4

23.46

32.85

e6/l

0.91

1136

5019

Azathioprine

264

1270

2.12

28.03

1.6

1.4

17.16

19.88

e6/l

0.13

206

966

Cramp and spasm

113

365

3.23

27.98

1.4

1.5

4.92

36.82

e6/l

1.22

285

Bacterial pneumonia, not elsewhere classified

531

2787

1.69

27.93

1.7

1.4

24.81

26.35

e6/l

0.06

410

2159

Other necrotizing vasculopathies

137

493

2.87

27.86

1.3

1.4

16.48

28.52

e6/l

0.39

105

380

Benign neoplasm of other and unspecified endocrine glands

226

1027

2.25

27.80

1.4

99.52

23.05

e6/l

0.65

167

783

Other problems related to primary support group, including family circumstances

228

1012

2.24

27.66

4.1

1.5

12.50

18.46

e6/l

0.58

180

771

Asthma, hospital admissions , main diagnosis only

1214

7642

1.41

27.63

1.4

1.5

29.88

28.96

e6/l

0.03

973

5861

Other disorders of bladder

182

755

2.46

27.60

1.3

11.60

30.04

e6/l

0.98

146

586

Chronic lower respiratory diseases

1824

7297

1.34

27.59

1.4

1.5

31.62

29.32

e6/l

0.08

1423

5620

Arthropathies

1416

5175

1.39

27.48

1.4

1.5

25.16

29.01

e6/l

0.24

1096

3948

Other and unspecified anaemias

550

3177

1.67

27.47

1.8

1.4

36.65

25.76

e6/l

0.19

420

2468

Leukaemia of unspecified cell type

7.82

27.32

7.5

1.2

1.52

2.80

e6/l

1.02

Other anaemias

552

3197

1.66

27.02

1.8

1.4

36.62

25.93

e6/l

0.19

421

2484

Other metabolic disorders

225

1033

2.22

26.95

1.5

1.4

46.10

23.93

e6/l

0.41

169

817

Other viral diseases, not elsewhere classified

444

2548

1.76

26.95

1.9

1.6

31.38

21.71

e6/l

0.44

338

1959

Persons with potential health hazards related to communicable diseases

623

3894

1.60

26.75

1.6

1.5

20.00

26.12

e6/l

0.52

453

3008

Disorders of refraction and accommodation

433

2478

1.76

26.70

1.7

1.6

20.78

23.91

e6/l

0.22

338

1881

Cough

581

3405

1.63

26.61

1.7

1.5

16.69

37.82

e6/l

2.39

445

2606

Bacterial pneumonia (organism specified)

604

3420

1.62

26.59

1.7

1.4

25.92

30.66

e6/l

0.22

470

2652

Viral pneumonia

216

981

2.25

26.58

1.5

24.17

16.49

e6/l

0.29

178

749

Zoster [herpes zoster]

671

4245

1.57

26.43

1.5

1.4

21.49

31.93

e6/l

0.78

512

3288

Disorders of sclera, cornea, iris and ciliary body

796

5314

1.51

26.38

1.4

36.71

27.56

e6/l

0.40

634

4097

Rheumatism, unspecified

213

965

2.25

26.35

1.3

20.02

42.84

e6/l

0.84

166

734

Other and unspecified types of non-Hodgkin lymphoma, hilmo

277

3.50

26.27

1.7

1.3

13.96

40.22

e6/l

0.61

218

Aplastic and other anaemias

589

3421

1.62

26.26

1.8

1.4

35.11

24.94

e6/l

0.19

450

2664

Other symptoms and signs involving the urinary system

177

743

2.44

26.23

1.7

1.5

22.85

17.68

e6/l

0.20

133

585

Lesion of lateral popliteal nerve

104

332

3.25

26.21

1.2

1.4

62.20

9.77

e6/l

0.52

254

Irregular menses

743

3848

1.54

25.90

1.4

1.3

22.01

27.12

e6/l

0.34

580

2953

Benign neoplasm: Brain, supratentorial

113

5.25

25.82

2.2

1.6

15.54

11.79

e6/l

0.15

Fungal Sepsis

251

3.61

25.79

1.7

1.3

4.77

22.67

e6/l

0.79

202

Abnormal findings in cerebrospinal fluid

12.90

25.78

1.8

1.3

200.35

3.00

e6/l

0.54

Drug-induced neutropenia

141

538

2.71

25.68

2.1

1.4

12.90

31.71

e6/l

0.81

123

406

Cardiac arrhythmias

856

3737

1.50

25.63

1.3

1.4

36.25

30.51

e6/l

0.20

666

2831

Trigeminal neuralgia

117

405

2.98

25.60

1.4

1.5

9.99

13.46

e6/l

0.32

301

Cluster headache, strict, including avohilmo

112

379

3.07

25.58

1.3

1.4

3.61

14.26

e6/l

2.17

292

Volume depletion

145

560

2.64

25.58

1.4

1.6

27.90

13.70

e6/l

0.27

115

449

Implicit fungal Sepsis

229

3.74

25.54

1.7

1.3

4.79

24.43

e6/l

0.79

184

Other infectious diseases

159

644

2.53

25.50

1.5

10.25

27.36

e6/l

0.98

124

504

Parkinson's disease

212

973

2.22

25.40

1.3

3.97

25.72

e6/l

2.34

174

748

Benign paroxysmal vertigo

400

2280

1.78

25.38

1.4

30.45

31.90

e6/l

0.03

322

1757

Pneumonitis due to solids and liquids

136

512

2.72

25.31

1.5

35.73

28.23

e6/l

0.10

106

406

Dermatitis

877

5996

1.47

25.29

1.5

1.4

23.61

30.06

e6/l

0.45

693

4634

Other and unspecified dermatitis

747

4966

1.52

25.29

1.6

1.4

21.54

28.88

e6/l

0.52

584

3835

Neuralgia and neuritis, unspecified

104

340

3.16

25.17

1.7

1.4

9.29

38.90

e6/l

0.93

258

Dermatitis and eczema

1626

7599

1.33

24.77

1.4

26.22

30.75

e6/l

0.31

1266

5863

Hypokalaemia

183

799

2.34

24.77

1.7

1.4

70.16

22.66

e6/l

0.35

152

633

Transport accidents

672

3756

1.55

24.74

1.3

1.4

13.06

34.63

e6/l

2.72

517

2929

Type 2 diabetes, wide definition

1099

4994

1.42

24.59

1.4

30.18

37.45

e6/l

0.34

856

3852

Disorders of psychological development

237

1063

2.11

24.58

1.9

2.0

15.99

19.83

e6/l

0.26

185

812

Vocal cord dysfunction

195

779

2.28

24.58

1.5

61.32

26.55

e6/l

0.51

148

617

Irritable bowel syndrome

420

2453

1.73

24.46

1.2

1.4

9.47

33.01

e6/l

2.72

320

1902

Cluster headache, wide,, including avohilmo

114

401

2.94

24.30

1.3

1.4

4.15

16.31

e6/l

2.22

309

Other viral diseases, not elsewhere classified

317

1704

1.89

24.29

2.0

1.7

29.71

21.46

e6/l

0.30

246

1314

Hypothyreosis and Thyroxine purchase for inclusion criteria

1324

6380

1.37

24.24

1.3

1.4

37.43

26.32

e6/l

0.46

1028

4933

Substance use, excluding alcohol

322

1747

1.87

24.16

1.5

1.4

28.66

25.28

e6/l

0.14

237

1348

Chronic sinusitis

627

4052

1.56

24.15

1.3

1.4

22.38

34.60

e6/l

0.72

486

3100

Other and unspecified paralytic syndromes

5.75

23.96

1.3

1.2

4.54

5.51

e6/l

0.10

Functional dyspepsia

394

2278

1.75

23.82

1.4

8.91

25.53

e6/l

3.29

311

1764

Infections of the skin and subcutaneous tissue

856

5864

1.46

23.70

1.9

1.4

31.48

31.96

e6/l

0.01

677

4500

Diabetes insipidus

7.00

23.62

1.6

1.2

378.00

7.23

e6/l

0.49

Other bacterial intestinal infections

327

1797

1.84

23.51

1.7

1.4

13.40

21.16

e6/l

0.57

244

1373

Coxibs

388

1137

1.81

23.44

1.3

1.5

15.24

45.92

e6/l

1.97

294

888

Other and unspecified effects of external causes

442

2653

1.69

23.32

1.2

1.6

15.80

22.02

e6/l

0.62

334

2036

Thrombocytopenia, unspecified

131

507

2.66

23.19

2.7

1.5

56.66

28.87

e6/l

0.25

110

390

Hypothyroidism, other/unspecified

1274

6165

1.37

23.13

1.3

1.4

38.17

26.74

e6/l

0.45

987

4755

Other bacterial intestinal infections

258

1322

1.98

23.03

1.8

1.4

15.18

20.91

e6/l

0.31

201

1009

Undetermined asthma, excluding more controls

195

901

2.20

22.98

1.5

1.4

78.89

19.17

e6/l

0.48

158

695

Statin medication

1011

4016

1.42

22.75

1.4

22.12

35.58

e6/l

1.07

766

3099

Sequelae with surgical and medical care as external cause

295

1588

1.89

22.73

1.7

1.4

64.74

24.87

e6/l

0.48

223

1219

Disorders of the thyroid gland

1352

6560

1.35

22.58

1.4

37.05

28.27

e6/l

0.35

1056

5061

Other infectious diseases

135

537

2.58

22.57

1.5

11.44

28.42

e6/l

0.76

105

419

Undetermined asthma

195

908

2.18

22.55

1.5

1.4

78.89

19.72

e6/l

0.47

158

701

Other shoulder lesions

160

688

2.38

22.52

1.3

13.32

31.23

e6/l

0.96

119

514

Speech and linguistic disorders

184

804

2.25

22.52

2.1

19.27

19.78

e6/l

0.02

142

607

Postprocedural endocrine and metabolic disorders, not elsewhere classified

198

932

2.16

22.37

1.5

1.3

49.74

25.27

e6/l

0.39

145

736

Emotional disorders starting during childhood or adolecense, excluding more controls

292

3.16

22.30

3.2

2.2

22.47

18.09

e6/l

0.14

226

Secondary and unspecified malignant neoplasm of lymph nodes

142

585

2.49

22.05

1.8

1.3

51.63

29.94

e6/l

0.23

110

465

Temporomandibular joint disorders, including avohilmo

670

4427

1.51

21.88

1.4

37.25

27.99

e6/l

0.20

521

3428

Coagulation defects, purpura and other haemorrhagic conditions

295

1611

1.86

21.75

2.1

1.6

35.83

22.46

e6/l

0.27

247

1227

Fracture of skull and facial bones

322

1805

1.81

21.75

1.4

20.60

30.81

e6/l

0.72

232

1397

Sequelae of injuries, of poisoning and of other consequences of external causes

357

2066

1.75

21.61

1.6

1.4

51.49

26.70

e6/l

0.35

278

1574

Benign neoplasms

1453

6046

1.33

21.58

1.4

28.98

28.79

e6/l

0.01

1123

4686

Fracture of lumbar spine and pelvis

285

1540

1.87

21.54

1.5

1.4

11.49

25.07

e6/l

1.36

212

1202

Dislocation, sprain and strain of joints and ligaments at neck level

261

1377

1.93

21.49

1.3

1.5

8.00

23.26

e6/l

2.11

208

1064

Congenital malformations of the nervous system

199

3.73

21.47

2.0

3.4

40.43

6.83

e6/l

0.94

144

Inflammatory diseases of female pelvic organs

871

4495

1.44

21.39

1.3

1.4

12.63

33.53

e6/l

3.74

669

3482

Type of accident

428

2609

1.66

21.30

1.6

1.5

28.02

26.72

e6/l

0.04

355

2007

Injuries to the ankle and foot

1051

6809

1.38

21.28

1.4

42.93

29.34

e6/l

0.37

820

5234

Parkinson's disease, strict definition

188

885

2.16

21.23

1.4

1.3

4.26

27.08

e6/l

2.19

155

686

Supplementary factors related to causes of morbidity and mortality classified elsewhere

461

2865

1.63

21.22

1.6

1.5

26.90

30.37

e6/l

0.10

374

2205

172

3.90

21.19

1.4

1.5

19.88

11.71

e6/l

0.27

136

Enthesopathies of lower limb, excluding foot

299

1654

1.83

21.08

1.3

1.4

18.58

35.06

e6/l

0.83

228

1239

Polyarthropathies

952

4432

1.41

21.02

1.4

1.5

25.69

31.14

e6/l

0.31

755

3384

Vascular dementia (subcortical)

112

4.60

20.92

1.4

1.3

3.00

42.47

e6/l

0.78

Fasciculation

5.77

20.83

1.3

1.2

1.45

11.75

e6/l

0.62

KRA_PSY_EATING, excluding more controls

135

554

2.47

20.83

1.2

1.5

13.09

23.53

e6/l

0.76

105

438

Manic episode

183

3.75

20.82

1.1

1.3

68.92

14.24

e6/l

0.50

146

Alcohol dependence

372

2203

1.71

20.69

1.3

1.4

12.59

25.70

e6/l

1.70

287

1705

Mixed and other personality disorders

150

654

2.35

20.56

1.2

1.4

5.12

20.75

e6/l

2.75

107

490

Fracture of rib(s), sternum and thoracic spine

396

2389

1.68

20.52

1.4

8.80

26.29

e6/l

3.46

313

1852

Heterophoria

152

669

2.33

20.39

1.6

1.8

14.90

21.35

e6/l

0.32

127

510

Other and unspecified tonsillitis

526

2848

1.57

20.26

1.5

1.4

44.11

26.96

e6/l

0.31

399

2195

Hypersomnia

5.03

20.24

1.2

2.76

14.38

e6/l

0.97

Hyperlipidaemia, other/unspecified

467

2702

1.61

20.22

1.3

1.4

34.15

31.50

e6/l

0.06

353

2153

Specific development disorders of speech and language

131

522

2.49

20.13

1.9

2.5

22.20

13.41

e6/l

0.42

101

386

Other/unspecified cytomegaloviral diseases

134

4.28

20.06

2.0

1.3

3.26

10.59

e6/l

0.75

106

Exclusions for E4_PCOS_CONSORTIUM

1064

4874

1.38

20.03

1.4

1.5

38.31

26.75

e6/l

0.40

826

3773

Visual impairment including blindness (binocular or monocular)

110

422

2.67

19.84

1.5

1.6

6.56

28.16

e6/l

0.86

327

Viral infections of central nervous system, not elsewhere classified/unspecified

4.91

19.73

1.4

1.2

23.03

5.10

e6/l

1.59

Other disorders of ear

1278

6315

1.33

19.70

1.5

51.12

24.90

e6/l

1.06

1004

4862

Acute alcohol intoxication

355

2108

1.70

19.58

1.2

1.4

44.88

26.63

e6/l

0.21

264

1637

Diseases of the skin and subcutaneous tissue

1470

5643

1.31

19.52

1.5

1.4

32.04

30.45

e6/l

0.06

1158

4342

Other arthritis (FG)

435

2724

1.61

19.44

1.3

1.4

50.43

31.84

e6/l

0.29

339

2107

Covid-19 suspected case

344

2032

1.72

19.40

1.3

1.5

10.34

23.88

e6/l

2.01

271

1571

Lung diseases due to external agents

182

877

2.11

19.36

1.5

1.4

29.74

22.05

e6/l

0.15

138

700

Other enthesopathies

400

2458

1.64

19.31

1.2

1.4

15.80

37.18

e6/l

2.03

315

1884

Paracetamol or NSAID medication

244

624

1.99

19.26

1.8

1.9

13.07

56.98

e6/l

1.62

192

492

Cytomegalovirus infection, IBD co-morbidity

147

4.01

19.23

1.9

1.2

3.19

10.00

e6/l

0.76

115

Other specified/unspecified arthritis

383

2332

1.66

19.20

1.3

1.4

55.42

29.86

e6/l

0.38

300

1794

Malignant neoplasm, wide definition for exclusion

1271

5627

1.33

19.20

2.2

1.3

41.54

28.58

e6/l

0.49

939

4389

Hyperosmolality and hypernatraemia

5.53

19.19

1.5

1.4

1.85

4.00

e6/l

1.01

Exposure to other specified factors

1086

7432

1.35

19.16

1.4

36.33

28.38

e6/l

0.26

809

5761

Social phobias

145

642

2.30

19.14

1.6

1.5

9.28

19.10

e6/l

1.62

104

506

Early lumbar disc prolapse, operated

160

738

2.21

19.10

1.2

1.4

22.14

20.42

e6/l

0.06

132

563

Immunodeficiency with predominantly antibody defects

190

3.59

19.07

2.5

1.6

6.35

14.36

e6/l

0.61

146

Voice disturbances

363

2187

1.68

18.99

1.2

1.4

24.79

34.02

e6/l

0.23

271

1688

Ptosis of eyelid

166

780

2.17

18.95

1.5

10.01

23.70

e6/l

0.99

133

589

Inflammatory disease of uterus

235

1250

1.91

18.95

1.2

1.4

7.83

24.31

e6/l

2.62

182

964

Retrobulbar neuritis in diseases classified elsewhere

9.32

18.93

1.0

1.3

8.00

2.44

e6/l

1.53

Monoplegia

106

4.63

18.84

1.4

1.2

5.57

12.16

e6/l

0.45

Nystagmus and other irregular eye movements

102

4.72

18.82

1.7

2.2

16.23

6.22

e6/l

0.60

Restless leg syndrome

203

1031

2.00

18.78

1.4

10.98

25.80

e6/l

1.39

143

794

Allergic asthma (mode), excluding more controls

330

1900

1.72

18.76

1.4

18.92

22.53

e6/l

0.13

265

1442

Injuries to the wrist and hand

1437

7698

1.30

18.75

1.3

1.5

28.46

30.56

e6/l

0.08

1090

5977

Intracranial and intraspinal abscess and granuloma

5.88

18.69

3.1

1.2

242.30

14.80

e6/l

0.66

Allergic asthma (mode)

330

1906

1.71

18.56

1.4

18.92

22.85

e6/l

0.14

265

1447

Gastro-oesophageal reflux disease

929

5856

1.38

18.55

1.3

1.5

30.53

31.70

e6/l

0.03

716

4538

Injuries to the shoulder and upper arm

1153

7005

1.33

18.50

1.5

1.4

35.23

31.76

e6/l

0.10

914

5402

Superficial injury of abdomen, lower back and pelvis

236

1268

1.89

18.43

1.4

1.5

13.57

24.67

e6/l

0.91

183

966

Iridocyclitis

323

1903

1.72

18.42

1.3

1.4

30.39

17.00

e6/l

0.37

252

1444

Speech therapy

353

2130

1.68

18.38

1.4

16.50

28.95

e6/l

0.76

283

1642

Disorders of speech understanding and production

100

374

2.72

18.37

1.9

2.9

27.49

11.92

e6/l

0.65

273

Cytomegaloviral disease

152

3.87

18.34

1.9

1.3

3.19

9.35

e6/l

0.70

119

Disorders of synovium and tendon

703

4300

1.44

18.32

1.4

29.99

31.24

e6/l

0.05

559

3299

Alcohol abuse, main dg

247

1350

1.86

18.29

1.2

1.5

59.75

22.12

e6/l

0.33

185

1044

Chronic apical periodontitis

1594

7118

1.28

18.07

1.4

50.01

25.41

e6/l

1.13

1216

5537

Viral infections of central nervous system, not elsewhere classified/unspecified

5.25

17.92

1.5

1.2

27.07

5.98

e6/l

1.52

Sequelae of injuries of head

102

398

2.64

17.91

1.6

1.5

5.90

33.75

e6/l

1.15

313

Unspecified acute lower respiratory infection

227

1217

1.89

17.86

1.4

1.6

26.68

22.81

e6/l

0.09

183

949

Explicit bacterial Sepsis

141

635

2.26

17.85

2.2

1.4

212.03

22.49

e6/l

1.35

116

494

Congenital malformations, deformations and chromosomal abnormalities

857

5938

1.38

17.83

1.5

1.4

31.06

29.87

e6/l

0.05

664

4577

Disturbance of activity and attention

211

1083

1.94

17.81

1.3

1.9

11.87

20.35

e6/l

0.95

164

836

Osteoporosis

314

1726

1.72

17.80

1.8

1.4

17.68

35.93

e6/l

1.00

240

1354

Acute alcohol intoxication, ICD10

303

1772

1.73

17.79

1.2

1.4

49.70

28.41

e6/l

0.21

224

1370

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

303

2.89

17.77

1.4

1.3

14.39

35.58

e6/l

0.50

240

Erysipelas

899

5012

1.38

17.69

1.4

1.3

38.92

26.20

e6/l

0.56

706

3845

Need for other prophylactic measures

112

460

2.51

17.68

2.5

1.7

12.66

31.85

e6/l

0.71

354

Dystonia

102

401

2.62

17.64

1.4

1.5

3.40

29.34

e6/l

1.24

308

Problems related to lifestyle

170

829

2.09

17.63

1.5

41.31

19.41

e6/l

0.31

133

650

Pain and other conditions associated with female genital organs and menstrual cycle

320

1744

1.71

17.61

1.3

12.41

23.87

e6/l

1.27

248

1369

Monoamine oxidase A inhibitors

156

736

2.15

17.61

1.2

1.3

12.84

28.56

e6/l

0.99

118

568

Somnolence

5.02

17.60

1.8

4.06

7.49

e6/l

0.39

Fall on and from stairs and steps

362

2225

1.65

17.56

1.3

1.5

23.00

28.06

e6/l

0.18

271

1713

Arnold-Chiari syndrome

5.46

17.56

2.1

2.0

76.52

6.96

e6/l

1.02

Any event in cancer register

1321

5983

1.31

17.53

2.1

1.3

60.03

22.99

e6/l

1.60

995

4658

Other nutritional deficiencies

935

6517

1.36

17.43

1.3

1.4

58.54

23.10

e6/l

1.00

713

5022

Unspecified/other endometriosis

165

800

2.10

17.41

1.3

11.12

16.50

e6/l

0.51

127

635

Bacterial intestinal infections, IBD co-morbidities

248

1379

1.82

17.34

1.8

1.4

12.74

25.90

e6/l

0.89

191

1060

Dentofacial anomalies [including malocclusion]

1009

6055

1.35

17.30

1.5

1.4

31.68

29.95

e6/l

0.05

781

4668

Vascular syndromes of brain in cerebrovascular disorders

212

3.25

17.21

1.5

1.3

8.27

53.72

e6/l

0.96

169

Other disorders of optic disc

4.63

17.19

1.4

1.1

19.93

8.77

e6/l

0.29

Venous thromboembolism

663

4497

1.43

17.04

1.6

1.3

28.53

32.51

e6/l

0.16

527

3488

Disorders of muscles

150

708

2.16

16.96

1.2

1.4

7.29

27.76

e6/l

1.43

114

536

Deforming dorsopathies

351

2159

1.64

16.95

1.3

1.5

9.64

32.35

e6/l

2.11

280

1626

Atypical facial pain

351

2.70

16.91

1.3

1.4

19.36

11.60

e6/l

0.18

261

Purpura and other haemorrhagic conditions

200

1049

1.94

16.88

2.3

1.5

42.54

24.97

e6/l

0.24

167

807

Secondary uncertain malignant neoplasm

181

918

2.00

16.83

1.7

1.3

42.26

25.00

e6/l

0.25

148

717

Erysipelas

668

4156

1.43

16.82

1.4

1.3

43.02

23.33

e6/l

0.77

534

3192

Non-allergic asthma (mode)

247

1370

1.80

16.80

1.3

1.4

21.24

19.07

e6/l

0.10

199

1051

Urticaria and erythema

526

3552

1.49

16.76

1.6

1.5

24.53

30.98

e6/l

0.28

416

2735

Nonpyogenic thrombosis of intracranial venous system

5.77

16.69

1.7

1.2

11.87

7.00

e6/l

0.23

Dementia due to Parkinsons disease, excluding more controls

13.73

16.55

1.3

1.1

1.90

32.60

e6/l

0.58

Congenital malformations, deformations and chromosomal abnormalities

927

6366

1.35

16.51

1.5

1.4

30.65

30.34

e6/l

0.01

716

4915

Malignant neoplasm

1199

5438

1.31

16.37

2.2

1.3

42.57

29.18

e6/l

0.47

880

4233

Diaphragmatic hernia

450

2964

1.53

16.19

1.3

1.4

11.35

28.17

e6/l

2.54

338

2310

Non-allergic asthma (mode), excluding more controls

247

1386

1.78

16.18

1.3

1.4

21.24

18.61

e6/l

0.12

199

1063

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

713

4975

1.40

16.17

1.4

1.5

26.98

33.97

e6/l

0.30

579

3802

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

129

586

2.25

16.15

1.9

1.5

36.85

17.60

e6/l

0.85

460

Other disorders of glucose regulation and pancreatic internal secretion

141

664

2.17

16.11

1.7

1.8

18.54

29.77

e6/l

0.39

114

510

Soft tissue disorders related to use, overuse and pressure

341

2111

1.63

16.09

1.2

1.4

20.86

33.38

e6/l

0.51

258

1622

Hypermobility syndrome

105

438

2.47

16.06

1.3

1.5

26.14

18.86

e6/l

0.17

332

Other congenital malformations of nervous system

4.99

15.99

2.1

2.3

76.52

6.52

e6/l

1.03

Hyperkinetic disorders

220

1189

1.84

15.82

1.2

2.0

11.71

19.61

e6/l

0.91

168

915

Other heart diseases, wide

1351

6469

1.28

15.79

1.4

1.5

34.58

29.27

e6/l

0.25

1055

4949

Adrenocortical insufficiency

262

2.93

15.77

1.5

1.6

27.73

32.33

e6/l

0.07

198

Propionic acid derivatives

391

1225

1.62

15.75

1.5

1.7

25.82

43.75

e6/l

0.52

301

956

Schizoaffective disorder

136

639

2.18

15.68

1.2

1.5

5.07

23.09

e6/l

1.97

100

486

Appendectomy

910

6528

1.34

15.60

1.3

1.4

19.49

31.52

e6/l

1.38

722

5008

Haemorrhage from respiratory passages

421

2476

1.54

15.60

1.6

1.5

29.67

39.37

e6/l

0.28

324

1927

Mycoses

1182

7980

1.29

15.59

1.4

32.84

29.58

e6/l

0.10

892

6199

Paralytic ileus and intestinal obstruction

319

1961

1.64

15.46

1.4

8.37

25.58

e6/l

2.42

256

1520

Diseases of pulp and periapical tissues, including avohilmo

1476

6046

1.27

15.43

1.4

1.5

22.64

27.00

e6/l

0.34

1144

4712

Malignant immunoproliferative diseases

5.66

15.42

1.5

1.3

7.64

21.69

e6/l

0.50

Symptoms and signs involving appearance and behaviour

6.02

15.35

1.7

1.3

4.95

8.28

e6/l

0.21

Use of pramipexole

278

1656

1.70

15.31

1.3

1.4

9.53

32.17

e6/l

1.65

211

1285

Other facial nerve disorders

187

3.28

15.25

1.2

37.31

11.16

e6/l

0.45

141

Disorders of brain, other and unspecified

5.74

15.20

2.2

1.2

25.04

2.91

e6/l

0.92

Other disorders of eyelid

522

3413

1.47

15.18

1.4

26.82

30.94

e6/l

0.15

396

2661

Other disorders of skin and subcutaneous tissue

886

5900

1.34

15.17

1.5

1.4

27.50

29.75

e6/l

0.12

677

4589

Myasthenia gravis

107

4.14

15.10

1.4

1.3

2.68

11.07

e6/l

0.70

Superficial injury of lower leg

351

2224

1.59

15.10

1.3

1.5

45.57

23.59

e6/l

0.26

262

1712

Hypoglycaemia, other or unspecified

118

532

2.27

15.08

1.7

1.9

15.92

26.89

e6/l

0.33

413

Excessive vomiting in pregnancy

142

690

2.10

15.00

1.3

10.65

20.77

e6/l

0.83

103

527

Mental disorders, not otherwise specified

146

717

2.08

14.99

1.1

1.5

52.48

22.99

e6/l

0.33

106

553

Chorioretinal inflammation

210

3.12

14.99

1.4

1.3

10.75

23.55

e6/l

0.38

166

Pulmonary heart disease

352

2235

1.59

14.96

1.6

1.4

19.13

30.98

e6/l

0.60

277

1723

Autonomic disorders

126

3.80

14.88

1.4

1.1

33.32

6.98

e6/l

0.53

Behavioural disorders, excluding more controls

121

3.85

14.86

1.2

2.0

29.58

12.05

e6/l

0.53

Intestinal stricture

376

2430

1.56

14.81

1.5

1.4

9.44

30.75

e6/l

2.43

303

1872

Diseases of the digestive system

565

3942

1.44

14.81

1.4

1.5

17.30

29.76

e6/l

0.81

438

3045

Pulmonary embolism

352

2241

1.58

14.80

1.6

1.4

19.13

31.09

e6/l

0.61

277

1729

Tetraplegia

6.30

14.76

2.6

2.4

50.43

3.86

e6/l

0.60

Sleep disorders, other/unspecified

250

2.89

14.68

1.2

1.6

4.80

11.67

e6/l

0.96

203

6-mercaptopurine

250

2.89

14.68

10.0

1.6

162.70

18.10

e6/l

0.45

200

Anterior Iridocyclitis

284

1722

1.67

14.67

1.3

1.4

32.83

19.67

e6/l

0.31

225

1318

Lesion of ulnar nerve

190

1030

1.87

14.54

1.3

1.4

21.92

19.92

e6/l

0.07

157

774

Other and unspecified iron deficiency

417

2766

1.52

14.52

1.4

1.5

44.15

22.70

e6/l

0.33

324

2132

Other specified disorders of muscle

152

3.46

14.50

1.2

1.4

3.69

25.56

e6/l

0.54

117

Alcohol withdrawal state with delirium

112

503

2.28

14.48

1.3

1.4

7.35

24.15

e6/l

0.74

392

Mental and behavioural disorders due to opioids

303

2.69

14.47

2.1

1.5

24.20

14.25

e6/l

0.40

243

Disorders of skin appendages

663

4798

1.39

14.42

1.4

31.78

28.72

e6/l

0.06

535

3681

Mental and behavioural disorders due to sedatives or hypnotics

121

562

2.20

14.41

1.3

1.5

12.79

29.71

e6/l

0.81

443

Cauda equina syndrome

4.42

14.40

1.3

1.2

3.50

7.85

e6/l

0.68

Dental caries, including avohilmo

984

3811

1.33

14.36

1.6

1.4

22.25

29.77

e6/l

0.66

741

2987

DVT of lower extremities and pulmonary embolism

489

3344

1.47

14.35

1.5

1.4

26.85

31.04

e6/l

0.14

388

2603

Attention to artificial openings

253

2.85

14.35

2.7

1.8

105.08

43.65

e6/l

0.55

194

Disorders of conjunctiva

1154

7246

1.28

14.25

1.5

20.97

30.89

e6/l

1.05

875

5610

Other noninfective gastroenteritis and colitis

338

2155

1.58

14.14

1.4

1.6

24.02

27.28

e6/l

0.10

259

1657

Acetic acid derivatives and related substances

345

1115

1.62

14.13

1.3

1.5

19.32

45.97

e6/l

1.46

259

867

Transplanted organ and tissue status

160

830

1.96

14.09

3.6

1.6

7.45

25.41

e6/l

1.36

117

627

SLE (Finngen)

207

3.04

14.02

1.3

1.7

17.30

20.35

e6/l

0.12

161

Diseases of oral cavity, salivary glands and jaws

776

2928

1.37

13.99

1.6

1.4

14.41

26.13

e6/l

1.85

597

2284

Other diseases of upper respiratory tract

1508

6307

1.25

13.98

1.4

1.5

26.60

33.63

e6/l

0.47

1174

4832

Asthma and allergy

190

1029

1.84

13.94

1.4

25.86

23.54

e6/l

0.05

162

775

Other disorders of bone

283

1738

1.65

13.93

1.4

25.26

24.53

e6/l

0.03

219

1339

Asthma and allergy, excluding more controls

190

1030

1.84

13.90

1.4

25.86

22.97

e6/l

0.06

162

773

Caries of dentine, including avohilmo

1062

4176

1.31

13.80

1.5

22.66

29.03

e6/l

0.56

806

3255

Fourth [trochlear] nerve palsy

148

3.46

13.75

1.9

1.2

8.85

32.60

e6/l

0.54

113

Injuries to the knee and lower leg

1656

7475

1.23

13.74

1.3

1.5

24.07

31.43

e6/l

0.40

1293

5777

Disturbances of smell and taste

220

2.94

13.74

1.4

1.5

15.82

46.00

e6/l

0.53

172

Thiamine deficiency

6.69

13.72

1.1

1.4

1.54

9.81

e6/l

0.60

Other symptoms and signs involving the circulatory and respiratory systems

106

476

2.27

13.69

1.4

1.5

15.61

21.44

e6/l

0.23

362

Diseases of male genital organs

673

2444

1.40

13.62

1.3

1.6

34.07

34.46

e6/l

0.01

515

1878

Other congenital malformations of circulatory system

190

3.12

13.61

2.5

1.3

27.20

26.60

e6/l

0.01

146

Protozoal diseases

206

3.02

13.59

1.6

1.3

4.50

51.96

e6/l

0.99

164

Acute appendicitis, no complications

778

5806

1.34

13.59

1.4

15.53

34.09

e6/l

2.67

609

4458

Disorders of lens

842

3946

1.34

13.58

1.4

13.48

36.27

e6/l

3.54

646

3023

Conjunctivitis

1054

6857

1.29

13.57

1.5

21.92

31.63

e6/l

0.91

797

5310

Nonhereditary hypogammaglobulinemia

4.86

13.54

1.4

1.0

2.32

6.69

e6/l

0.51

Acute and subacute iridocyclitis

265

1614

1.66

13.50

1.3

1.4

34.12

15.80

e6/l

0.45

211

1229

All influenza (not pneumonia)

214

1231

1.76

13.47

1.5

1.6

42.40

17.30

e6/l

0.50

170

933

Agoraphobia

212

2.96

13.46

1.2

1.4

10.89

21.18

e6/l

0.75

167

Varicella [chickenpox]

436

2.33

13.44

2.1

2.3

57.20

7.41

e6/l

1.70

335

Other and unspecified disorders of binocular movement

6.03

13.42

2.1

2.0

58.32

2.34

e6/l

0.66

Unspecified haematuria

488

2803

1.45

13.36

1.5

1.4

15.68

32.46

e6/l

1.40

383

2187

Contact with and exposure to communicable diseases

466

3206

1.46

13.33

1.4

1.5

22.03

26.29

e6/l

0.26

353

2481

Disorders of mineral metabolism

122

587

2.12

13.26

1.4

1.5

18.43

18.65

e6/l

0.01

464

Diseases of liver

433

2954

1.48

13.24

1.4

17.42

32.37

e6/l

1.33

318

2294

Pulmonary heart disease, diseases of pulmonary circulation

369

2436

1.53

13.23

1.6

1.4

21.33

31.29

e6/l

0.48

289

1886

Degeneration of the brain due to alcohol

127

3.61

13.22

1.1

1.4

13.06

74.17

e6/l

0.71

102

Algoneurodystrophy

248

2.79

13.21

1.3

1.5

18.33

9.66

e6/l

0.23

190

Beningn neoplasm: Meninges, unspecified

104

3.95

13.20

1.8

1.2

10.32

13.85

e6/l

0.17

Trochanteric bursitis

179

983

1.84

13.18

1.2

1.4

14.02

42.51

e6/l

1.33

133

748

Temporal arteritis

237

2.83

13.17

1.2

24.31

42.47

e6/l

0.27

189

Diseases of arteries, arterioles and capillaries (FINNGEN)

285

1212

1.64

13.14

1.5

1.2

37.29

24.96

e6/l

0.30

231

913

Disorders of optic nerve, not elsewhere classified

133

3.53

13.07

1.4

1.2

3.09

11.69

e6/l

0.92

106

Giant cell arteritis with polymyalgia rheumatica

238

2.82

13.07

1.2

24.31

42.23

e6/l

0.27

188

Pneumonia due to other infectious organisms, not elsewhere classified

216

2.91

13.04

1.7

1.5

48.36

13.77

e6/l

0.57

175

Pneumocystosis

124

3.64

13.00

1.8

1.2

4.31

11.28

e6/l

0.60

Keratitis

468

3253

1.45

12.99

1.4

40.88

26.50

e6/l

0.54

376

2494

L04AD Calcineurin inhibitors

176

968

1.85

12.99

2.7

1.8

11.06

21.56

e6/l

0.63

125

731

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

539

3825

1.41

12.97

1.3

1.5

21.97

28.44

e6/l

0.24

416

2927

Carpal tunnel syndrome

743

4900

1.34

12.96

1.3

1.4

63.18

24.57

e6/l

0.92

607

3737

Anti-inflammatory and antirheumatic products, non-steroids

376

1226

1.55

12.91

1.4

1.7

25.29

43.75

e6/l

0.53

291

956

Streptococcal septicaemia

119

573

2.11

12.91

2.4

1.4

148.59

11.57

e6/l

1.42

448

Giant cell arteritis

268

2.69

12.90

1.2

22.56

40.30

e6/l

0.30

211

Use of dimethyl fumarate

4.83

12.88

1.0

1.1

13.79

4.56

e6/l

1.75

Other/unspecified disorders of vestibular function

280

2.65

12.86

1.2

1.4

80.59

13.80

e6/l

0.60

223

Noninfective enteritis and colitis

621

4534

1.38

12.84

1.4

1.5

36.50

31.53

e6/l

0.09

472

3510

Other respiratory disorders and diseases

237

1421

1.68

12.82

1.6

1.5

11.30

22.49

e6/l

0.99

180

1076

Other diseases of the respiratory system

237

1421

1.68

12.82

1.6

1.5

11.30

22.49

e6/l

0.99

180

1076

Spondyloarthritis

233

1391

1.69

12.81

1.3

1.4

64.23

18.89

e6/l

1.02

190

1054

Use of fingolimod

4.73

12.64

1.2

1.7

12.61

4.56

e6/l

1.49

Infections with a predominantly sexual mode of transmission

569

3828

1.39

12.59

1.5

1.3

24.48

28.14

e6/l

0.21

429

2973

Special screening examination for infectious and parasitic diseases

305

1423

1.59

12.56

1.4

1.3

20.70

35.60

e6/l

0.64

206

1022

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

115

554

2.12

12.53

1.3

1.5

9.61

33.69

e6/l

1.29

433

Special screening examination for other diseases and disorders

135

687

1.99

12.52

1.4

17.46

24.49

e6/l

0.35

110

495

Nutritional anaemias

591

4145

1.38

12.52

1.4

35.31

28.46

e6/l

0.13

467

3226

Kela reimbursement Agammaglobulinemia (D80-84)

5.26

12.39

3.6

1.5

4.48

8.47

e6/l

0.29

Diseases of pulp and periapical tissues and dental caries

876

3420

1.32

12.31

1.6

1.4

21.48

27.17

e6/l

0.43

662

2690

Abnormal blood-pressure reading, without diagnosis

329

2.46

12.22

1.3

1.6

14.31

26.58

e6/l

0.42

255

Polycystic ovarian syndrome, consortium definition

962

4422

1.30

12.20

1.4

1.3

32.74

29.25

e6/l

0.10

757

3412

Candidiasis

386

2621

1.49

12.17

1.4

44.78

23.36

e6/l

0.29

297

2026

Cutaneous abscess, furuncle and carbuncle

351

2338

1.52

12.16

1.5

1.4

19.71

27.09

e6/l

0.46

277

1797

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1340

7055

1.24

12.15

1.8

1.4

28.51

28.42

e6/l

0.00

1030

5434

Chronic rhinitis, nasopharyngitis and pharyngitis

429

2973

1.45

12.14

1.4

1.5

19.20

35.01

e6/l

0.87

332

2286

Disorders of choroid and retina

990

5504

1.28

12.10

1.4

26.87

33.21

e6/l

0.20

744

4273

Excessive, frequent and irregular menstruation

545

2126

1.41

12.05

1.3

1.4

17.87

23.39

e6/l

0.44

422

1677

Adverse effects, not elsewhere classified

285

1819

1.58

12.04

1.3

1.6

18.84

25.29

e6/l

0.42

222

1391

Missing teeth due to accident, extraction or parodontitis

718

5101

1.33

12.03

1.4

17.41

35.30

e6/l

1.85

548

3951

Other and unspecified injuries of head

103

483

2.17

12.02

1.4

1.7

7.75

34.08

e6/l

1.35

380

Weight loss

143

755

1.93

12.02

1.7

1.6

32.52

26.05

e6/l

0.10

118

580

Enterocolitis due to Clostridium difficile

139

727

1.94

11.98

2.1

1.5

4.35

23.94

e6/l

1.61

108

566

Leisure time condition

249

1541

1.63

11.97

1.6

1.5

12.67

22.56

e6/l

0.86

209

1183

Other obstetric conditions, not elsewhere classified

484

2161

1.44

11.95

1.3

23.75

22.93

e6/l

0.03

374

1696

Hypothyroidism, strict autoimmune, 3 medication purchases required

1105

5921

1.27

11.94

1.3

1.4

14.31

27.36

e6/l

2.90

869

4585

Other disorders of adrenal gland

352

2.39

11.90

1.6

1.7

32.95

25.53

e6/l

0.14

263

Hernia of abdominal wall, postoperative

209

1237

1.71

11.90

1.4

1.2

17.46

27.57

e6/l

0.32

165

965

Urticaria

422

2928

1.45

11.90

1.6

1.5

20.07

32.06

e6/l

0.58

328

2256

Iron deficiency anaemia

505

3561

1.41

11.89

1.4

1.5

39.41

24.45

e6/l

0.26

392

2768

Diabetic neuropathy

136

705

1.95

11.86

1.5

1.4

34.05

19.50

e6/l

0.35

110

534

Amenorrhoea

118

586

2.05

11.85

1.4

42.64

19.39

e6/l

0.53

469

Abnormal weight loss

132

682

1.97

11.84

1.3

1.6

35.67

24.88

e6/l

0.17

107

525

Obsessive-compulsive disorder

106

508

2.12

11.70

1.2

1.5

3.95

20.60

e6/l

3.80

407

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

109

528

2.10

11.70

1.2

1.4

83.04

27.69

e6/l

0.79

417

Panniculitis affecting regions of neck and back

229

2.73

11.69

1.3

1.4

30.18

21.98

e6/l

0.14

174

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

5.36

11.68

2.3

1.1

10.13

4.29

e6/l

0.42

Insulin, intermediate and long-acting

677

4945

1.34

11.66

1.5

1.4

20.66

29.67

e6/l

0.82

549

3831

Other or unspecified ileus, impaction or obstruction

221

1336

1.67

11.62

1.5

1.4

7.62

22.42

e6/l

1.90

177

1034

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

196

1151

1.72

11.55

1.7

1.3

40.00

25.90

e6/l

0.21

154

900

Superficial injury of hip and thigh

180

1031

1.76

11.55

1.2

1.4

11.25

23.20

e6/l

0.72

142

796

Other viral hepatitis

107

518

2.11

11.55

1.8

1.4

28.57

17.10

e6/l

0.52

398

Maternal care for other conditions predominantly related to pregnancy

302

1932

1.55

11.55

1.3

12.25

25.99

e6/l

0.91

223

1489

Acute pharyngitis

223

1345

1.66

11.49

1.6

1.5

8.74

21.96

e6/l

1.49

176

1019

Immunodeficiencies

384

2.30

11.41

2.2

1.9

5.39

20.63

e6/l

1.00

292

Other disorders starting during childhood or adolecense, excluding more controls

330

2.37

11.37

3.4

2.6

10.73

21.16

e6/l

0.81

248

Mycoses

339

2275

1.50

11.37

1.6

1.4

50.85

23.98

e6/l

0.34

272

1733

Oter anti-inflammatory and antirheumatic agents, non-steroids

257

872

1.64

11.36

1.2

1.5

21.98

53.59

e6/l

1.33

198

690

Chronic gastritis

309

2034

1.53

11.33

1.2

1.4

10.03

22.35

e6/l

1.46

240

1593

Hypermetropia

119

603

2.01

11.31

1.8

2.1

8.53

26.14

e6/l

0.96

450

Injuries to the hip and thigh

555

3680

1.37

11.28

1.4

23.43

29.82

e6/l

0.28

436

2853

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

471

2113

1.43

11.26

1.3

24.10

23.30

e6/l

0.03

366

1660

Lagophthalmos

4.35

11.24

1.7

1.2

188.86

15.91

e6/l

0.74

Mouth breathing

517

3751

1.39

11.23

1.4

1.5

10.25

29.79

e6/l

3.45

408

2864

Drug-induced polyneuropathy

4.67

11.21

13.5

1.7

8.95

6.98

e6/l

0.08

Other postsurgical states

105

511

2.10

11.18

2.0

1.7

8.46

31.90

e6/l

1.19

391

Myeloid leukaemia

168

3.01

11.17

3.1

1.2

8.31

39.16

e6/l

0.50

134

Maltreatment syndromes

427

2.20

11.09

1.1

1.6

5.96

20.24

e6/l

1.63

338

Spondylolisthesis/Spondylolysis

209

1262

1.67

11.08

1.2

1.4

9.06

32.61

e6/l

1.26

166

946

Internal derangement of knee

484

3471

1.40

11.01

1.3

1.4

11.23

28.83

e6/l

2.56

373

2646

Metatarsalgia

129

678

1.93

11.01

1.2

1.4

14.05

37.90

e6/l

1.26

509

Decubitus ulcer and pressure area

351

2.32

11.01

2.3

1.4

40.97

36.51

e6/l

0.07

277

Conjunctivitis (acute, non atopic)

386

2666

1.45

10.98

1.6

25.40

27.01

e6/l

0.06

301

2052

Other specified and unspecified personality disorders

139

750

1.88

10.97

1.3

1.5

6.29

31.45

e6/l

2.10

107

579

Lack of expected normal physiological development

3.61

10.97

2.7

1.8

37.11

31.17

e6/l

0.06

Asthma/COPD (KELA code 203)

1301

7280

1.23

10.96

1.3

1.5

32.03

29.38

e6/l

0.09

1018

5607

Viral and other specified intestinal infections

300

1930

1.53

10.95

1.5

1.6

18.67

23.12

e6/l

0.25

251

1480

Unspecified privation

152

844

1.83

10.93

1.1

1.5

14.85

26.91

e6/l

0.67

107

656

Pain associated with micturition

160

902

1.80

10.93

1.5

12.43

20.59

e6/l

0.68

122

690

Heart failure, not strict

915

4876

1.28

10.91

1.4

1.5

39.53

32.70

e6/l

0.23

732

3732

Symptoms and signs involving emotional state

181

2.89

10.90

1.1

2.0

25.84

11.22

e6/l

0.33

141

Varicella [chickenpox]

366

2.30

10.90

1.9

70.97

7.00

e6/l

1.78

286

Degeneration of nervous system due to alcohol

144

3.17

10.90

1.1

1.3

13.06

66.57

e6/l

0.68

114

Arthrosis

923

3962

1.28

10.88

1.3

1.4

31.25

32.73

e6/l

0.06

727

3020

Abnormal findings on diagnostic imaging of other body structures

182

1068

1.73

10.80

1.4

10.32

26.71

e6/l

1.43

130

821

Other enthesopathy of foot (+metatarsalgia)

136

732

1.88

10.80

1.2

1.4

13.55

36.20

e6/l

1.30

100

552

Oxicams

273

983

1.59

10.75

1.3

1.5

9.96

48.91

e6/l

2.54

218

780

Obesity and other hyperalimentation

844

6372

1.28

10.71

1.3

1.4

62.36

22.81

e6/l

1.04

653

4910

Assault

201

1215

1.68

10.69

1.3

1.5

11.26

23.99

e6/l

1.31

141

935

Ovarian cyst

491

2029

1.41

10.65

1.3

28.74

23.65

e6/l

0.26

380

1605

Fall on same level involving ice and snow

726

5591

1.31

10.62

1.4

38.11

31.56

e6/l

0.14

557

4325

Faecal incontinence

114

582

1.99

10.61

2.0

1.4

10.07

62.75

e6/l

1.47

452

Acute appendicitis

935

6938

1.27

10.60

1.3

1.4

15.97

31.45

e6/l

2.44

725

5338

Diseases of appendix

998

7192

1.26

10.60

1.3

1.4

16.45

30.60

e6/l

2.23

773

5555

Obesity

840

6358

1.28

10.58

1.3

1.4

62.63

22.84

e6/l

1.04

650

4902

Malnutrition

131

3.25

10.56

2.0

2.2

97.97

10.79

e6/l

0.44

101

Acute renal failure

247

1574

1.58

10.55

1.4

11.61

22.35

e6/l

0.94

184

1199

Other disorders of peripheral nervous system

5.53

10.53

1.2

1.1

1.47

2.79

e6/l

1.14

Viral hepatitis

118

613

1.96

10.50

1.8

1.5

26.25

31.14

e6/l

0.14

474

Other eating disorders

417

2.18

10.48

1.3

1.8

13.81

21.89

e6/l

0.34

323

Vascular dementia (undefined)

100

3.51

10.42

1.3

1.2

2.48

90.32

e6/l

0.94

Viral and other specified intestinal infections

389

2631

1.44

10.37

1.5

19.41

22.32

e6/l

0.19

316

2030

Failure and rejection of transplanted organs and tissues

3.65

10.36

3.6

1.2

3.00

8.16

e6/l

0.82

Endometriosis

469

1967

1.41

10.33

1.3

14.75

24.13

e6/l

1.08

362

1561

Adhesive capsulitis of shoulder

195

1180

1.67

10.31

1.4

1.3

25.64

35.57

e6/l

0.21

157

900

Appendicitis, broad definition

987

7162

1.25

10.20

1.3

1.4

15.92

30.72

e6/l

2.40

766

5526

Other gastritis (incl. Duodenitis)

260

1690

1.55

10.18

1.5

1.4

6.89

25.77

e6/l

3.40

209

1319

Convergence insufficiency and excess

104

3.53

10.17

1.3

1.1

5.07

3.89

e6/l

0.12

Early lumbar disc prolapse operation

165

960

1.74

10.16

1.2

1.4

26.88

18.39

e6/l

0.35

137

742

Emotional disorders and disorders of social functioning with onset specific to childhood

481

2.07

10.15

3.0

2.2

21.05

22.10

e6/l

0.03

359

Chronic diseases of tonsils and adenoids

1085

5532

1.24

10.14

1.3

1.5

15.95

35.37

e6/l

2.73

855

4196

Emotional disorders starting during childhood or adolescence

446

2.11

10.11

3.1

2.2

22.15

22.23

e6/l

0.00

330

Other diseases of hard tissues of teeth

736

2920

1.31

10.03

1.6

1.4

16.87

25.96

e6/l

1.18

552

2278

Nephropathy related operations

164

959

1.73

9.92

1.7

1.6

12.78

22.31

e6/l

0.59

120

731

Brain astrocytoma

5.87

9.91

1.7

1.1

34.29

2.48

e6/l

1.22

Brain astrocytoma, including Hilmo

5.87

9.91

1.7

1.1

34.29

2.48

e6/l

1.22

Diverticular disease of intestine

844

4238

1.28

9.84

1.3

1.4

30.87

32.42

e6/l

0.03

643

3301

Dental operations

782

3115

1.29

9.80

1.5

1.4

23.10

27.72

e6/l

0.29

607

2392

Fenamates

183

736

1.70

9.80

1.5

22.01

57.03

e6/l

1.30

144

574

Fracture of foot, except ankle

328

2257

1.47

9.78

1.5

54.43

22.97

e6/l

0.42

253

1721

Convergent concomitant strabismus

483

2.05

9.78

1.4

2.0

24.23

18.90

e6/l

0.21

370

Anankastic personality disorder

294

2.37

9.78

1.5

1.4

9.28

19.75

e6/l

0.66

228

Paroxysmal tachycardia

267

1468

1.53

9.71

1.3

1.4

35.01

25.24

e6/l

0.19

216

1111

Systemic lupus erythematosus

252

2.49

9.71

1.3

1.5

17.30

9.60

e6/l

0.48

194

Vitamin deficiency, wide

352

2.24

9.70

1.2

1.7

20.92

25.23

e6/l

0.10

282

Vitamin deficiency

352

2.24

9.70

1.2

1.7

20.92

25.23

e6/l

0.10

282

Insulin, combination of fast acting with intermediate-acting or long-acting

746

5325

1.29

9.70

1.5

1.4

19.15

31.74

e6/l

1.34

604

4126

Senile cataract

726

3437

1.30

9.68

1.4

13.95

38.38

e6/l

3.20

562

2637

Conductive and sensorineural hearing loss

956

5172

1.25

9.57

1.5

1.4

46.20

25.22

e6/l

0.78

759

3973

Diseases of middle ear and mastoid

779

5006

1.28

9.55

1.6

1.4

50.68

27.05

e6/l

0.68

613

3874

Other and unspecified immunodeficiencies with predominantly antibody defects

3.75

9.54

4.0

1.4

11.29

6.07

e6/l

0.30

GI-bleeding

352

2467

1.44

9.48

1.5

10.28

24.76

e6/l

2.05

272

1904

Viral pneumonia (unknown virus, not influenza)

105

544

1.96

9.46

1.5

31.17

32.59

e6/l

0.02

423

Schizophrenia

220

1404

1.58

9.43

1.2

1.4

36.79

25.15

e6/l

0.15

162

1089

Other diseases of the digestive system

354

2487

1.43

9.42

1.5

10.36

24.50

e6/l

1.97

269

1921

Misadventures to patients during surgical and medical care

181

1102

1.66

9.41

1.7

1.3

23.43

20.85

e6/l

0.08

138

858

Acute and transient psychotic disorders

166

989

1.70

9.40

1.3

1.4

29.82

26.60

e6/l

0.05

121

772

SLE, strict definition

244

2.48

9.39

1.3

1.4

17.96

13.16

e6/l

0.22

185

SLE, ICD10

244

2.48

9.39

1.3

1.4

17.96

13.16

e6/l

0.22

185

Mixed connective tissue disease

478

2.03

9.32

1.4

7.49

22.09

e6/l

1.19

364

Tubulo-interstitial nephritis, not specified as acute or chronic

457

2.04

9.32

1.4

158.66

23.59

e6/l

0.54

358

Obesity due to excess calories

618

4747

1.31

9.31

1.3

1.4

59.99

23.93

e6/l

0.84

486

3679

Other condition

197

1229

1.62

9.31

1.9

1.5

45.57

22.57

e6/l

0.40

163

944

Osteoporosis with pathological fracture (FG)

397

2.12

9.30

1.7

1.5

8.03

18.93

e6/l

0.98

303

Generalized epilepsy

327

2.25

9.24

1.5

1.9

5.09

14.28

e6/l

1.56

257

Secondary hypertension

493

1.99

9.22

1.5

1.4

12.96

16.26

e6/l

0.11

364

Disorders of gallbladder, biliary tract and pancreas

1268

6623

1.21

9.19

1.4

39.56

27.57

e6/l

0.43

952

5143

Insulin medication

745

4924

1.28

9.17

1.5

19.18

34.20

e6/l

1.53

603

3825

Disorders of acoustic nerve

194

2.66

9.11

1.7

1.2

87.70

29.26

e6/l

0.37

154

Other/unspecified enthesopathies of lower limb, excluding foot

475

2.01

9.09

1.2

1.5

13.46

21.26

e6/l

0.34

364

Scleritis and episcleritis

476

2.01

9.07

1.1

1.4

23.49

14.69

e6/l

0.22

363

Hyperhidrosis

127

3.05

9.05

1.1

1.7

20.78

11.33

e6/l

0.21

100

Dialysis, with operation codes

167

1008

1.68

9.02

1.7

1.6

12.85

21.50

e6/l

0.54

122

764

Disorders of calcium metabolism

418

2.07

8.88

1.5

1.6

17.33

15.42

e6/l

0.05

327

Transient global amnesia

102

535

1.93

8.86

1.2

1.4

12.80

32.50

e6/l

0.82

402

Elevated blood glucose level

114

621

1.86

8.83

1.7

115.76

27.78

e6/l

0.39

476

Other specified and unspecified disorders of eye and adnexa

251

2.41

8.83

1.4

22.85

10.88

e6/l

0.40

200

Other arthrosis

635

3392

1.30

8.83

1.4

41.63

29.53

e6/l

0.25

490

2596

Heartburn

140

811

1.75

8.80

1.3

1.4

5.17

33.22

e6/l

2.60

106

616

Childhood asthma (age<16), excluding more controls

176

845

1.65

8.78

1.5

1.4

11.50

25.76

e6/l

1.20

139

615

Intermittent heterotropia

101

531

1.94

8.74

1.6

2.4

16.43

15.31

e6/l

0.04

401

All chronic kidney diseases

621

3923

1.30

8.73

1.4

1.5

29.29

23.24

e6/l

0.28

490

3048

Mental retardation, excluding more controls

227

2.45

8.69

2.2

2.9

31.66

13.69

e6/l

0.42

166

Childhood asthma (age<16)

176

848

1.65

8.69

1.5

1.4

11.50

26.43

e6/l

1.28

139

618

Fracture of shoulder and upper arm

423

3105

1.37

8.67

1.6

1.4

30.75

27.59

e6/l

0.11

329

2405

Noninfectious colitis NAS

181

1128

1.62

8.62

1.4

1.6

9.98

23.46

e6/l

1.19

137

861

Personal history of risk-factors, not elsewhere classified

3.40

8.61

2.1

1.6

1.75

13.56

e6/l

0.86

Mental and behavioural disorders due to use of other stimulants, including caffeine

236

2.44

8.60

1.6

37.14

13.23

e6/l

0.83

186

Other specified/unspecified systemic involvement of connective tissue

417

2.05

8.59

1.4

8.46

22.74

e6/l

0.97

314

Eating disorders

160

968

1.67

8.55

1.2

1.5

12.10

21.28

e6/l

0.79

124

747

Acute myeloid leukaemia and myelodysplastic syndromes

116

3.11

8.53

2.5

1.2

11.03

67.68

e6/l

0.64

101

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

3.46

8.50

1.1

10.50

2.63

e6/l

0.44

Use of riluzole

8.43

8.47

1.0

1.2

1.25

3.20

e6/l

0.97

Chronic viral hepatitis

440

2.02

8.47

2.0

1.5

34.55

13.18

e6/l

1.02

343

Causalgia

107

3.20

8.37

1.2

1.6

4.00

3.61

e6/l

0.08

Haemorrhage, not elsewhere classified

150

2.78

8.32

2.6

1.3

52.86

7.25

e6/l

0.44

111

Hyperplasia of prostate

390

1594

1.40

8.31

1.3

19.16

31.52

e6/l

0.36

302

1238

Other female pelvic inflammatory diseases

205

1328

1.56

8.29

1.3

14.12

41.66

e6/l

1.47

165

1014

Lateral epicondylitis

162

992

1.65

8.29

1.2

1.3

24.85

32.75

e6/l

0.33

128

751

Assault by bodily force

120

678

1.80

8.29

1.2

1.5

9.99

16.42

e6/l

0.59

525

False labour

425

1944

1.37

8.27

1.2

1.3

15.11

27.79

e6/l

0.91

337

1506

Other and unspecified mononeuropathies, also in other diseases

192

2.56

8.23

1.4

1.5

7.82

8.54

e6/l

0.05

144

Unspecified visual impairment (binocular)

103

3.23

8.22

1.2

1.9

3.41

3.99

e6/l

0.14

Other specified/unspecified hearing loss

107

585

1.85

8.22

1.3

1.5

39.46

19.82

e6/l

0.26

456

Other abnormal immunological findings in serum

141

2.86

8.18

1.1

1.5

37.96

8.62

e6/l

0.39

112

Benign neoplasm: Cranial nerves

205

2.51

8.17

1.7

1.2

83.23

29.26

e6/l

0.36

159

Orchitis and epididymitis

108

593

1.84

8.16

1.5

1.6

70.85

24.17

e6/l

0.39

468

Cholecystectomy

853

5959

1.24

8.16

1.3

1.4

37.29

28.36

e6/l

0.24

648

4622

Rash and other nonspecific skin eruption

123

703

1.77

8.15

2.0

1.5

11.94

29.32

e6/l

0.93

532

Sensorineural hearing loss

878

4826

1.24

8.14

1.4

48.29

25.62

e6/l

0.77

693

3712

Benign neoplasm: Brain, infratentorial

4.59

8.13

2.3

2.2

24.31

3.45

e6/l

0.61

Episcleritis

406

2.03

8.10

1.1

1.4

26.52

12.18

e6/l

0.34

306

Disorders of vitreous body and globe

574

4273

1.30

8.10

1.4

28.56

34.92

e6/l

0.31

449

3293

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

354

2559

1.39

8.09

1.4

11.77

28.62

e6/l

2.72

279

1959

Complications of genitourinary prosthetic devices, implants and grafts

165

2.68

8.04

1.4

37.36

28.30

e6/l

0.11

131

Behavioural disorders

177

2.62

8.03

1.2

1.8

29.58

10.69

e6/l

0.59

138

Other maternal disorders predominantly related to pregnancy

740

3688

1.26

8.02

1.3

1.4

23.19

32.84

e6/l

0.67

588

2816

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

130

760

1.73

7.98

1.7

1.4

7.19

25.48

e6/l

1.47

106

597

Other fall from one level to another

291

2039

1.44

7.97

2.0

1.6

55.39

20.53

e6/l

0.44

231

1550

Corneal ulcer

239

1614

1.49

7.96

1.3

1.4

59.80

16.32

e6/l

1.22

198

1232

Persistent delusional disorders

102

556

1.86

7.93

1.2

1.4

13.28

29.97

e6/l

0.70

433

Superficial injury of wrist and hand

274

1902

1.45

7.92

1.4

1.5

32.06

22.35

e6/l

0.21

213

1471

Retinal detachments and breaks

383

2816

1.37

7.89

1.4

18.76

33.35

e6/l

0.88

284

2195

Reimbursement for rheumatic diseases

703

5587

1.26

7.86

1.3

1.4

33.22

30.99

e6/l

0.08

540

4326

Other and unspecified urticaria

260

1791

1.46

7.84

1.5

1.6

13.86

23.56

e6/l

0.70

208

1358

Fracture at wrist and hand level

436

3267

1.34

7.82

1.3

1.4

25.94

32.84

e6/l

0.21

342

2532

Otalgia

116

661

1.78

7.82

1.8

59.80

25.08

e6/l

0.40

507

Eating disorder

135

801

1.71

7.81

1.2

1.6

13.09

22.46

e6/l

0.65

105

620

Fentanyl

108

601

1.81

7.78

1.4

42.58

17.36

e6/l

0.48

466

Tinnitus

279

1951

1.44

7.75

1.3

1.4

58.41

19.96

e6/l

0.39

205

1506

Sequelae of injuries of neck and trunk

204

2.46

7.75

1.8

1.6

29.28

28.94

e6/l

0.00

156

Diseases of salivary glands

387

2861

1.36

7.72

1.3

1.4

8.92

31.38

e6/l

3.35

297

2218

Infections with a predominantly sexual mode of transmission

415

3097

1.35

7.71

1.5

1.3

25.48

27.61

e6/l

0.11

314

2402

Gingivitis and periodontal diseases

1351

5892

1.19

7.68

1.4

1.5

32.45

26.51

e6/l

0.22

1018

4613

Disorders of vitreous body

556

4177

1.29

7.67

1.4

22.59

35.65

e6/l

1.08

434

3216

Other/unspecified soft tissue disorders related to use, overuse and pressure

169

2.60

7.66

1.3

1.2

8.88

12.68

e6/l

0.24

130

Diabetic retinopathy, excluding more controls

277

1068

1.46

7.64

1.5

1.4

17.55

16.40

e6/l

0.07

216

825

Spondylopathies (FG)

182

1171

1.57

7.63

1.3

1.4

64.90

18.12

e6/l

0.89

149

901

Injuries to the elbow and forearm

891

6424

1.22

7.61

1.4

1.5

25.20

29.90

e6/l

0.33

688

4948

Early onset COPD, excluding more controls

206

1362

1.52

7.57

1.5

1.3

14.04

19.95

e6/l

0.49

161

1051

Spasmodic torticollis

225

2.37

7.56

1.2

1.5

2.51

14.99

e6/l

1.65

170

Mononeuritis multiplex

8.38

7.53

1.4

1.1

429.80

2.65

e6/l

—

Intentional self-harm by unspecified means

3.31

7.50

1.3

1.2

9.42

7.11

e6/l

0.12

Hyperfunction of pituitary gland

377

2.03

7.47

1.3

1.6

201.63

20.35

e6/l

0.49

289

Other/unspecified synovitis and tenosynovitis

137

827

1.67

7.47

1.2

1.4

29.20

31.47

e6/l

0.04

627

Insulin, fast-acting

437

3304

1.33

7.47

1.4

1.5

17.35

25.40

e6/l

0.78

353

2552

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

3.16

7.44

1.3

1.5

1.52

5.37

e6/l

0.77

Obesity, other/unspecified

435

3296

1.33

7.37

1.3

1.4

41.52

23.76

e6/l

0.26

328

2565

Other disorders of the musculoskeletal system and connective tissue

177

1142

1.57

7.35

1.4

12.68

27.73

e6/l

0.96

139

877

Vertical strabismus

247

2.28

7.35

2.0

1.7

19.21

35.74

e6/l

0.32

187

Sacroiliitis, not elsewhere classified

325

2.10

7.34

1.2

1.5

57.77

18.87

e6/l

0.55

245

Crohn disease

178

1152

1.56

7.30

1.4

1.5

22.55

24.57

e6/l

0.06

134

885

Anomalies of pupillary function

150

2.68

7.30

1.0

1.4

5.21

11.16

e6/l

0.42

116

Other arrhythmias

826

5086

1.23

7.29

1.3

1.4

36.86

27.49

e6/l

0.40

649

3912

Suppurative and unspecified otitis media

490

3343

1.31

7.28

1.9

1.4

24.90

20.42

e6/l

0.28

380

2563

Other hearing loss

277

1914

1.42

7.27

1.3

1.4

32.68

22.60

e6/l

0.25

220

1493

Other specified/unspecified inflammatory spondylopathies

320

2.10

7.25

1.3

1.4

16.17

27.63

e6/l

0.31

250

Cellulitis

269

1894

1.43

7.24

1.8

1.4

65.64

26.06

e6/l

0.45

210

1450

Ulcer of vagina/vulva

193

2.45

7.20

1.1

1.5

25.18

16.03

e6/l

0.18

146

Astigmatism

509

1.85

7.17

2.5

2.2

17.70

27.92

e6/l

0.27

395

Other acute viral hepatitis

3.15

7.16

1.0

1.3

28.91

9.05

e6/l

0.45

Meniscus derangement

669

3601

1.26

7.07

1.3

1.4

17.17

33.99

e6/l

1.50

520

2753

Malignant neoplasm of digestive organs

212

2447

0.68

7.07

1.4

12.70

25.82

e6/l

1.26

164

1924

Other diseases of intestine

163

1043

1.58

7.03

1.3

1.4

33.17

23.06

e6/l

0.20

130

800

Myositis

159

2.58

7.00

1.3

3.32

60.12

e6/l

0.88

125

Gonarthrosis [arthrosis of knee](FG)

904

4330

1.22

7.00

1.3

1.4

27.50

31.03

e6/l

0.17

703

3336

Use of amantadine

108

2.97

7.00

1.1

1.2

5.32

13.25

e6/l

0.57

Glaucoma

601

4103

1.27

6.99

1.4

22.02

31.21

e6/l

0.50

477

3167

Cholecystitis

154

975

1.59

6.95

1.2

1.3

12.58

19.96

e6/l

0.45

120

766

Menorrhagia

437

1834

1.33

6.89

1.3

1.4

25.11

24.27

e6/l

0.04

334

1456

Unspecified misadventure during surgical and medical care

403

1.94

6.87

1.8

1.5

33.33

31.81

e6/l

0.02

316

Hernia

1183

6720

1.18

6.87

1.4

1.5

33.24

31.05

e6/l

0.06

915

5216

Cholelithiasis, broad definition with cholecystitis

1066

6027

1.19

6.86

1.3

1.4

37.77

28.28

e6/l

0.29

811

4704

Tonsillectomy and adenotomy

793

4512

1.23

6.86

1.4

1.5

16.59

30.35

e6/l

1.61

619

3457

Vasomotor and allergic rhinitis

486

3709

1.29

6.81

1.3

1.5

22.54

35.11

e6/l

0.68

389

2833

Systemic lupus erythematosus, unspecified

217

2.31

6.80

1.2

1.4

13.30

11.38

e6/l

0.11

162

Conduct disorder

186

2.43

6.80

1.3

1.9

30.43

13.31

e6/l

0.50

143

Superficial injury of thorax

179

1180

1.53

6.78

1.2

1.4

39.39

23.20

e6/l

0.24

129

911

Reactive arthropathies, FINNGEN

519

1.82

6.77

1.2

1.5

105.60

12.69

e6/l

0.89

404

Insulin, fast-acting or short human

438

3362

1.31

6.77

1.4

1.5

17.35

25.38

e6/l

0.78

353

2598

Other diseases of pleura

476

3232

1.30

6.76

1.5

15.68

28.78

e6/l

0.96

358

2521

Atrial fibrillation and flutter

327

1545

1.38

6.75

1.4

1.3

40.10

22.65

e6/l

0.43

243

1172

Postzoster neuralgia

3.08

6.74

1.2

16.95

11.60

e6/l

0.19

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

367

2752

1.34

6.74

1.3

1.4

21.79

26.43

e6/l

0.17

267

2131

Poisoning by narcotics and psychodysleptics [hallucinogens]

116

2.85

6.73

3.1

1.4

57.67

20.28

e6/l

0.67

Hypogonadotropic hypogonadism

193

2.39

6.71

1.3

47.94

20.15

e6/l

0.47

143

Gout

274

1722

1.41

6.70

1.5

1.4

68.50

22.36

e6/l

0.54

211

1345

Amblyopia ex anopsia

318

2.05

6.64

1.7

2.5

27.46

10.13

e6/l

0.50

240

Injury of eye and orbit

179

1186

1.52

6.63

1.3

1.5

23.02

21.87

e6/l

0.04

140

919

Impingement syndrome of shoulder

262

1867

1.41

6.62

1.5

1.4

32.53

33.05

e6/l

0.01

225

1426

Motor disorders, excluding more controls

121

2.75

6.61

2.4

4.6

8.88

7.87

e6/l

0.05

Presbyopia

487

1.83

6.61

1.2

1.3

16.66

22.68

e6/l

0.20

363

Other embolism and thrombosis

152

973

1.58

6.59

1.4

44.47

21.54

e6/l

0.29

124

754

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

129

2.73

6.58

4.7

2.7

1.28

11.81

e6/l

1.31

106

Disorders of pituitary gland, other and/or unspecified

4.18

6.58

1.3

58.33

3.10

e6/l

0.46

Anogenital herpesviral [herpes simplex] infection

150

958

1.58

6.58

1.4

1.3

32.96

22.10

e6/l

0.42

115

740

Other cataract

486

2861

1.29

6.57

1.4

16.73

36.18

e6/l

1.46

382

2200

Other specified/unspecified dorsopathies

214

2.29

6.54

1.2

1.6

4.03

23.19

e6/l

0.68

162

Reactive arthropathies

112

666

1.70

6.54

1.2

1.4

91.27

15.50

e6/l

0.88

519

Tobacco use

418

1.90

6.51

1.3

1.4

70.45

33.65

e6/l

0.24

325

Necrosis of pulp, including avohilmo

741

6065

1.22

6.49

1.3

1.4

12.79

34.10

e6/l

4.26

573

4667

Endometriosis of pelvic peritoneum

210

1378

1.46

6.40

1.3

16.57

24.24

e6/l

0.44

159

1089

Impotence

329

2.01

6.40

1.5

1.4

7.24

23.40

e6/l

0.93

261

Procreative management

443

2857

1.30

6.38

1.6

26.69

38.00

e6/l

0.32

327

2155

Other coagulation defects

100

582

1.74

6.34

1.7

1.5

23.07

29.08

e6/l

0.16

454

Other neurotic disorders

296

2.06

6.34

1.3

1.4

6.83

24.19

e6/l

0.87

231

Gonarthrosis

757

3527

1.23

6.33

1.3

1.4

28.72

28.95

e6/l

0.01

593

2691

Drug-induced headache, not elsewhere classified

4.22

6.30

1.2

1.1

3.00

2.97

e6/l

0.01

Inflammatory diseases of prostate (prostatitis)

135

850

1.60

6.29

1.3

1.4

12.92

24.61

e6/l

0.85

106

674

Urolithiasis

354

2669

1.33

6.29

1.4

53.87

26.67

e6/l

0.39

272

2059

Ischemic heart diseases

1014

5129

1.19

6.29

1.3

1.5

26.24

35.30

e6/l

0.49

823

3892

Event of undetermined intent

525

1.78

6.26

1.5

1.6

19.99

29.31

e6/l

0.27

409

Budesonide

171

1138

1.52

6.23

1.6

1.3

91.47

21.12

e6/l

0.52

131

865

Other inflammation of eyelid

160

1050

1.54

6.23

1.7

1.4

3.57

27.36

e6/l

3.26

112

797

Viral pneumonia (known virus, not influenza)

181

2.38

6.23

1.9

2.1

15.83

25.13

e6/l

0.21

141

Renal failure

469

3243

1.28

6.23

1.4

1.5

13.71

28.85

e6/l

1.60

357

2533

Vestibular neuronitis

110

661

1.68

6.21

1.2

1.3

9.72

25.51

e6/l

0.95

510

Otitis media, unspecified

164

995

1.53

6.21

1.9

1.7

21.20

19.15

e6/l

0.05

122

752

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

286

2.07

6.18

1.3

1.6

21.22

19.22

e6/l

0.04

222

Medical abortion

784

3500

1.22

6.15

1.3

1.4

16.31

35.22

e6/l

2.27

595

2710

Sequelae of other external causes

413

1.87

6.09

1.6

1.5

33.91

34.17

e6/l

0.00

331

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

701

5601

1.22

6.06

1.4

21.42

30.04

e6/l

0.61

521

4325

Abnormal serum enzyme levels

318

2314

1.35

6.04

1.3

1.4

33.37

21.31

e6/l

0.24

232

1812

Mixed disorders of conduct and emotions, excluding more controls

159

2.44

6.01

1.3

2.2

40.00

10.88

e6/l

0.77

125

Toxic effects of substances chiefly nonmedicinal as to source

153

1004

1.54

5.99

1.3

1.6

18.69

23.46

e6/l

0.22

124

771

Drug-induced adrenocortical insufficiency

130

2.62

5.96

1.7

1.2

63.14

11.07

e6/l

0.88

Vitamin D deficiency

136

2.57

5.95

1.2

1.4

31.30

6.61

e6/l

0.70

109

Glaucoma suspect

378

2901

1.31

5.94

1.4

11.19

28.53

e6/l

2.02

311

2252

Other and unspecified erythematous conditions

217

2.21

5.94

1.4

1.8

3.43

13.33

e6/l

1.13

169

Candidiasis

165

1102

1.51

5.94

1.6

1.4

76.64

31.96

e6/l

0.27

134

819

Disease of hard tissues of teeth, NOS

672

2857

1.23

5.93

1.4

45.94

26.22

e6/l

0.44

506

2233

Cholelithiasis

1014

5931

1.18

5.92

1.3

1.4

39.62

28.19

e6/l

0.35

775

4632

Other retinal disorders

697

4460

1.22

5.91

1.5

1.4

29.02

30.91

e6/l

0.04

523

3475

Osteonecrosis

439

1.83

5.90

2.0

1.4

18.23

32.32

e6/l

0.32

343

Thyroiditis, ILD-related definition

138

888

1.57

5.90

1.3

1.4

42.68

22.74

e6/l

0.39

115

665

Lesion of radial nerve

251

2.11

5.87

1.3

1.4

8.26

10.46

e6/l

0.18

192

Rheumatoid arthritis

353

2407

1.32

5.86

1.2

1.4

26.93

31.47

e6/l

0.20

273

1845

Dermatographic urticaria

551

1.73

5.85

1.3

1.4

2.85

22.80

e6/l

3.82

424

Viral haemorrhagic fevers, not elsewhere classified/unspecified

195

1350

1.46

5.85

1.8

1.6

22.97

22.74

e6/l

0.01

145

1028

Other symptoms and signs involving the digestive system and abdomen

180

1228

1.48

5.82

1.6

1.5

19.24

46.23

e6/l

1.02

136

940

Glomerular diseases

207

1451

1.44

5.82

1.5

25.95

22.00

e6/l

0.11

157

1103

Personality and behavioural disorders due to brain disease, damage and dysfunction

3.15

5.82

1.8

1.3

26.07

16.67

e6/l

0.23

Type 1 diabetes

316

2370

1.34

5.81

1.5

27.60

26.24

e6/l

0.04

257

1835

Alcohol induced polyneuropathy

3.59

5.81

1.2

1.1

2.86

20.74

e6/l

0.75

Calcific tendinitis of shoulder

398

1.86

5.80

1.6

1.3

30.55

43.54

e6/l

0.23

300

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

200

2.25

5.78

1.3

1.6

14.31

7.20

e6/l

0.33

155

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1193

6574

1.17

5.78

1.4

29.63

32.11

e6/l

0.11

922

5080

Divergent concomitant strabismus

101

607

1.69

5.74

1.7

1.6

11.19

30.93

e6/l

1.03

464

Myopia

166

1119

1.50

5.74

1.4

1.6

32.34

25.19

e6/l

0.26

134

847

Other erythematous conditions

247

2.11

5.72

1.4

1.8

3.83

13.78

e6/l

1.23

194

Cerebral palsy

133

2.56

5.70

2.7

2.1

41.22

7.56

e6/l

0.45

Disorders of synovium and tendon in diseases classified elsewhere

115

2.67

5.70

1.3

1.2

14.80

4.41

e6/l

0.55

Collagenous colitis

114

708

1.63

5.69

1.4

1.5

46.69

29.15

e6/l

0.25

543

Pregnancy examination and test

224

981

1.43

5.69

1.3

1.2

20.19

29.51

e6/l

0.28

180

748

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

212

1500

1.42

5.68

1.3

1.4

14.74

23.72

e6/l

0.69

153

1147

Sicca syndrome [Sjögren]

104

632

1.67

5.66

1.4

1.3

3.71

32.52

e6/l

2.19

478

Diabetes mellitus

1335

6776

1.15

5.66

1.4

24.76

32.33

e6/l

0.50

1024

5246

Patent foramen ovale

196

2.26

5.66

1.2

3.0

8.03

9.32

e6/l

0.06

145

Allergic conjunctivitis

731

5926

1.21

5.62

1.5

1.4

20.71

29.37

e6/l

0.65

543

4583

Superficial injury of forearm

130

836

1.57

5.61

1.3

1.7

19.16

26.31

e6/l

0.27

104

642

Wegener granulomatosis

2.81

5.61

1.4

1.2

11.86

8.10

e6/l

0.21

Other maltreatment syndromes

256

2.08

5.61

1.4

19.55

13.75

e6/l

0.26

200

Acute suppurative otitis media

359

2573

1.31

5.60

2.1

1.5

30.51

20.26

e6/l

0.58

278

1975

Pyogenic arthritis

439

1.80

5.59

1.2

1.4

19.55

8.84

e6/l

0.37

342

Abnormal reflex

5.20

5.58

1.3

1.2

1.50

2.14

e6/l

—

Other congenital malformations

124

790

1.59

5.57

1.5

2.1

25.21

21.31

e6/l

0.10

601

Calculus of kidney and ureter

327

2485

1.32

5.56

1.4

55.00

27.38

e6/l

0.36

255

1921

Arthropod-borne viral fevers and viral haemorrhagic fevers

215

1530

1.42

5.56

1.8

1.6

20.94

24.24

e6/l

0.15

160

1166

Toxic effect of other and unspecified substances

2.86

5.55

1.7

1.3

1.28

8.79

e6/l

1.26

Malignant neoplasm of breast, including Hilmo

307

2631

0.75

5.55

1.3

19.99

36.25

e6/l

1.03

213

2059

Malignant neoplasm of breast, HER2-negative, including Hilmo

307

2631

0.75

5.54

1.3

19.99

36.25

e6/l

1.03

213

2059

Haemorrhage in early pregnancy

343

2555

1.31

5.54

1.2

1.3

10.89

37.18

e6/l

2.50

290

1954

Pedestrian injured in transport accident

515

1.73

5.53

1.1

1.5

5.90

31.21

e6/l

1.39

399

Disorders of tooth development and eruption

207

1180

1.43

5.52

1.7

1.4

11.61

29.34

e6/l

1.70

145

913

Acute lymphadenitis

471

1.77

5.51

2.1

1.6

12.51

22.79

e6/l

0.38

369

Chondrocostal junction syndrome [Tietze]

272

2.02

5.47

1.3

1.6

69.26

11.36

e6/l

0.67

213

Care involving dialysis

524

1.72

5.47

1.4

1.7

12.28

28.88

e6/l

0.61

397

Respiratory insufficiency

426

1.80

5.46

1.6

1.4

5.34

10.83

e6/l

0.83

327

Scleritis

2.83

5.45

1.1

2.00

3.43

e6/l

0.72

Malignant neoplasm of breast, HER2-negative

293

2547

0.75

5.45

1.4

1.3

20.07

37.11

e6/l

1.05

202

1993

Cushing syndrome

2.97

5.44

1.2

1.3

2.05

12.19

e6/l

0.72

Use of disulfiram, acamprosate or naltrexone

118

748

1.60

5.44

1.4

116.51

23.07

e6/l

0.41

577

Other skin changes

192

1346

1.44

5.42

1.4

35.57

29.59

e6/l

0.08

150

1039

Other peripheral vascular diseases

100

609

1.66

5.42

1.2

1.4

8.97

29.74

e6/l

1.01

472

Neovascular glaucoma

259

2.04

5.42

1.7

1.3

18.90

39.63

e6/l

0.34

206

Fracture of lower leg, including ankle

657

5378

1.21

5.41

1.4

1.5

16.69

34.77

e6/l

2.55

515

4128

Nonsuppurative otitis media

302

1967

1.34

5.41

1.8

1.5

78.87

18.28

e6/l

0.84

245

1508

Dissection of cerebral arteries, nonruptured

3.70

5.41

1.6

1.1

38.67

10.92

e6/l

0.35

Other congenital malformations of skin

322

1.93

5.41

1.8

1.9

47.00

10.42

e6/l

0.69

240

Continuous positive airway pressure

186

1087

1.45

5.41

1.6

37.08

12.86

e6/l

0.91

140

819

Arthropathies in other diseases classified elsewhere

253

2.05

5.39

1.8

1.4

83.25

11.63

e6/l

0.60

204

Diabetes medication

1336

6908

1.15

5.38

1.4

24.30

32.26

e6/l

0.54

1026

5340

Injury of muscle and tendon at shoulder and upper arm level

382

2979

1.29

5.37

1.3

1.4

28.45

26.31

e6/l

0.05

304

2296

L02BA Anti-estrogens

1325

0.58

5.37

1.4

28.26

32.50

e6/l

0.09

1024

Other diseases of oesophagus

104

641

1.64

5.36

1.3

1.4

56.80

26.87

e6/l

0.36

499

Other and unspecified syphilis

6.38

5.36

1.1

12.00

3.80

e6/l

—

Heart failure and antihypertensive medication

263

1262

1.37

5.34

1.4

21.67

25.06

e6/l

0.14

210

972

Dislocation, sprain and strain of joints and ligaments of thorax

227

2.11

5.33

1.3

1.4

4.26

25.49

e6/l

0.91

183

Other specified/unspecified soft tissue disorders

288

1.97

5.33

1.4

1.3

2.90

43.99

e6/l

1.21

216

Orthopaedic devices associated with adverse incidents

133

0.00

5.32

0.0

1.2

—

39.08

—

106

Iridocyclitis in diseases classified elsewhere

138

2.46

5.29

1.5

1.6

6.88

8.89

e6/l

0.15

107

Intentional self-harm by sharp object

195

2.20

5.28

1.3

1.4

7.53

7.17

e6/l

0.03

151

Bulimia nervosa (incl. atypical)

269

2.01

5.26

1.1

1.6

16.37

20.09

e6/l

0.13

209

Medicines for HER+ breast cancer

232

2990

0.73

5.26

1.3

1.4

11.78

39.57

e6/l

3.05

163

2317

Other diseases of liver

209

1497

1.41

5.25

1.4

27.34

24.21

e6/l

0.12

153

1148

Type 2 diabetes

1245

6322

1.15

5.25

1.4

23.84

33.17

e6/l

0.62

956

4888

Melanocytic naevi

351

2717

1.30

5.25

1.4

15.57

28.90

e6/l

1.04

275

2099

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

3.47

5.24

1.2

1.5

12.92

8.98

e6/l

0.14

Use of biperiden

390

1.82

5.24

1.4

27.33

35.58

e6/l

0.14

300

Abnormal findings on diagnostic imaging of lung

491

3790

1.25

5.23

1.4

15.75

30.98

e6/l

1.30

374

2962

Benign neoplasm of colon, rectum, anus and anal canal

681

4917

1.21

5.22

1.4

28.39

31.74

e6/l

0.15

527

3806

Diseases of peritoneum

116

740

1.58

5.21

1.5

1.4

3.81

25.99

e6/l

2.00

575

Other disorders of patella

209

1499

1.40

5.21

1.2

1.4

31.17

33.29

e6/l

0.04

170

1149

Other ill-defined and unspecified causes of mortality

464

1.74

5.20

1.3

12.32

30.31

e6/l

0.69

366

Carrier of infectious disease

164

2.31

5.20

1.5

1.7

18.81

11.20

e6/l

0.37

132

Malignant neoplasm of breast

301

2580

0.76

5.20

1.4

1.3

19.41

36.76

e6/l

1.12

210

2019

Diabetes, varying definitions

1321

6767

1.15

5.18

1.4

24.94

32.26

e6/l

0.48

1010

5239

Raynaud syndrome

111

703

1.60

5.16

1.3

1.4

4.03

29.90

e6/l

2.16

542

Hypoplasia of dental enamel

104

2.73

5.15

10.9

4.1

6.05

6.04

e6/l

0.00

Polyarthrosis

208

1385

1.40

5.13

1.5

1.4

26.80

25.34

e6/l

0.05

172

1061

Fissure and fistula of anal and rectal regions

272

2040

1.34

5.12

1.5

1.4

28.54

24.89

e6/l

0.13

208

1571

Meralgia paraesthetica

231

2.07

5.11

1.3

1.5

7.95

10.49

e6/l

0.14

172

Ankylosing spondylitis

100

619

1.63

5.10

1.4

1.5

71.07

19.07

e6/l

0.53

470

Ganglion

235

1726

1.37

5.07

1.3

49.92

39.37

e6/l

0.20

190

1316

Glaucoma secondary to other eye disorders

266

1.99

5.06

1.7

1.3

18.90

41.32

e6/l

0.38

207

Glomerulonephritis

119

770

1.56

5.04

1.6

29.25

24.95

e6/l

0.07

600

Phlebitis and thrombophlebitis (not including DVT)

247

1832

1.36

5.02

1.5

1.4

41.73

35.05

e6/l

0.10

190

1409

Effects of other external causes

233

2.06

5.01

1.2

1.5

18.21

17.09

e6/l

0.02

185

Chondropathies

189

1343

1.42

5.00

1.5

1.4

30.15

22.96

e6/l

0.22

143

1033

Fibroblastic disorders

223

1628

1.38

5.00

1.4

44.55

30.65

e6/l

0.26

176

1261

Acute laryngitis and tracheitis

155

1044

1.47

4.99

2.3

1.5

23.53

27.59

e6/l

0.10

120

790

Specific development disorders of scholastic skills

420

1.77

4.99

3.1

2.4

6.20

13.79

e6/l

0.99

314

Congenital iodine-deficiency syndrome/hypothyroidism

180

2.21

4.98

1.6

1.8

3.15

17.48

e6/l

1.49

135

Vertigo of central origin

2.73

4.97

1.0

1.2

3.56

3.91

e6/l

0.06

Thyrotoxicosis, other and/or unspecified

226

1656

1.37

4.97

1.5

1.4

62.99

32.81

e6/l

0.50

172

1266

Other diseases of anus and rectum

317

2434

1.31

4.97

1.3

1.4

15.61

26.52

e6/l

0.96

244

1883

Fitting and adjustment of other devices

344

2413

1.29

4.94

1.6

1.4

25.91

25.13

e6/l

0.02

297

1857

Hypercalcemia

311

1.90

4.93

1.2

1.5

20.36

41.87

e6/l

0.38

243

Striking against or struck by other objects

408

3243

1.26

4.92

1.3

1.6

24.45

25.32

e6/l

0.03

311

2484

Dermatitis due to substances taken internally

398

1.78

4.91

1.7

1.6

33.00

25.00

e6/l

0.16

315

Familial hypercholesterolemia

144

976

1.49

4.90

1.3

1.4

29.07

18.73

e6/l

0.36

118

774

Amyloidosis

137

2.39

4.88

1.3

1.2

14.00

27.96

e6/l

0.24

109

Previous suicide attempt

2.84

4.86

1.1

1.4

1.50

6.55

e6/l

0.83

Other and unspecified disorders of adult personality and behaviour

3.46

4.85

1.2

2.88

7.23

e6/l

—

Gout, FINNGEN

274

2069

1.33

4.84

1.5

1.4

68.50

24.07

e6/l

0.51

211

1603

Medial epicondylitis

236

2.02

4.83

1.3

1.4

5.58

13.65

e6/l

0.90

172

Solid cancers, helper endpoint

1052

5371

1.16

4.82

1.5

1.3

47.71

29.26

e6/l

0.61

766

4184

Superficial injury of shoulder and upper arm

135

907

1.50

4.82

1.3

1.5

112.10

25.16

e6/l

0.47

105

704

Methotrexate

159

1103

1.45

4.81

1.2

1.3

41.83

20.36

e6/l

0.49

124

840

Testicular hypofunction

223

2.06

4.81

1.2

1.5

5.11

29.20

e6/l

0.90

162

Other and unspecified coagulation defects

394

1.78

4.80

1.5

19.72

18.31

e6/l

0.04

308

Abnormal findings on antenatal screening of mother

116

756

1.55

4.79

1.3

1.4

9.36

19.09

e6/l

1.56

101

583

Fracture of femur

241

1624

1.35

4.78

1.5

1.4

18.96

22.90

e6/l

0.13

196

1254

Other specified/unspecified disorders of bone/cartilage

177

2.19

4.77

1.2

6.59

6.48

e6/l

0.01

133

Burns and corrosions

175

1239

1.42

4.76

1.6

19.01

21.29

e6/l

0.10

140

954

Other and unspecified intracranial injuries

177

2.18

4.76

3.6

1.4

17.93

55.76

e6/l

0.55

142

Myocarditis

300

1.89

4.75

1.9

1.3

8.65

10.20

e6/l

0.12

229

Other and unspecified mononeuropathies of upper limb

197

2.12

4.75

1.7

1.3

24.27

8.53

e6/l

0.44

142

Disorder of the sleep-wake schedule

139

2.36

4.75

1.5

1.9

11.15

9.07

e6/l

0.08

108

Overexertion and strenuous or repetitive movements

127

846

1.52

4.74

1.5

1.4

10.34

25.85

e6/l

1.14

656

Testicular dysfunction

259

1.96

4.73

1.2

1.4

5.28

29.07

e6/l

1.06

188

Dipeptidyl peptidase 4 (DPP-4) inhibitors

583

3863

1.21

4.72

1.4

1.3

26.41

31.75

e6/l

0.26

455

2989

Other disorders of white blood cells

404

1.76

4.69

2.8

1.6

8.28

30.43

e6/l

0.83

317

Amyloidosis, other/unspecified

109

2.54

4.68

1.2

4.00

35.65

e6/l

0.56

Acute mastoiditis

3.32

4.68

1.2

1.6

221.50

7.86

e6/l

0.47

Colorectal adenocarcinoma

1360

0.62

4.68

1.3

1.4

10.37

24.26

e6/l

1.05

1072

Car occupant injured in other and unspecified transport accidents

231

1719

1.35

4.64

1.4

13.57

21.98

e6/l

0.62

181

1328

Mental and behavioural disorders due to cannabinoids

261

1.95

4.64

1.7

1.5

37.70

13.91

e6/l

0.96

205

Benign neoplasm of other and ill-defined parts of digestive system

188

1354

1.40

4.63

1.3

35.66

23.94

e6/l

0.24

154

1047

Redundant prepuce, phimosis and paraphimosis

226

1660

1.36

4.61

1.4

1.6

30.11

32.73

e6/l

0.05

174

1293

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

297

1.88

4.60

1.7

1.6

18.36

17.25

e6/l

0.04

223

Gastric ulcer

170

1205

1.42

4.58

1.4

27.68

24.17

e6/l

0.12

133

938

Paralytic ileus

248

1.97

4.57

1.3

1.6

7.50

43.96

e6/l

0.85

191

Other disorders involving the immune mechanism, not elsewhere classified

221

2.03

4.55

8.3

1.6

19.66

22.99

e6/l

0.05

177

Unspecified nephritic syndrome

148

2.28

4.55

1.2

8.32

10.31

e6/l

0.12

119

275

1.90

4.55

1.3

1.2

6.93

34.20

e6/l

0.87

230

Benign neoplasm: Colon

562

4451

1.21

4.55

1.4

23.78

31.04

e6/l

0.44

445

3450

Viral haemorrhagic fevers, not elsewhere classified/unspecified

607

1.60

4.55

1.5

1.4

25.26

25.01

e6/l

0.01

472

Sulfasalazine

322

2516

1.29

4.54

1.3

49.02

31.32

e6/l

0.41

260

1914

Rosacea

138

944

1.47

4.54

1.3

4.54

28.02

e6/l

2.78

110

717

Poisoning by medicine, drug-induced

2.61

4.53

1.3

1.2

1.43

6.71

e6/l

1.10

Disorder of lipoprotein metabolism, unspecified

126

846

1.50

4.53

1.2

1.4

33.65

20.20

e6/l

0.20

668

Intestinal malabsorption

350

1.80

4.50

1.3

1.5

17.60

32.44

e6/l

0.32

266

Exophthalmic conditions

3.02

4.50

1.2

20.29

7.04

e6/l

0.32

Ulcer of lower limb, not elsewhere classified

141

970

1.46

4.49

1.7

1.4

33.83

25.18

e6/l

0.25

105

756

Viral conjunctivitis

163

2.20

4.43

1.4

1.8

2.96

12.20

e6/l

1.24

127

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

547

1.62

4.42

3.1

2.5

18.07

20.61

e6/l

0.09

414

Chronic periodontitis, including avohilmo

1176

6925

1.14

4.41

1.3

1.4

28.12

30.54

e6/l

0.07

878

5395

Examination and encounter for administrative purposes

244

1.95

4.41

1.3

1.5

10.68

33.79

e6/l

0.82

174

Vitreous haemorrhage

112

739

1.53

4.40

1.5

1.4

11.93

23.78

e6/l

0.56

571

Car occupant injured in noncollision transport accident

273

1.90

4.40

1.1

1.4

4.92

25.12

e6/l

1.04

218

Nummular dermatitis

581

1.60

4.39

1.8

1.4

39.00

21.63

e6/l

0.25

453

Nail disorders

102

660

1.56

4.39

1.5

133.26

26.33

e6/l

0.43

494

Periodontitis

1179

6932

1.14

4.38

1.3

1.4

27.97

30.51

e6/l

0.08

883

5400

Fracture of neck

413

1.72

4.36

1.3

11.40

31.45

e6/l

0.69

321

Arthropod-borne viral fevers and viral haemorrhagic fevers

112

741

1.53

4.35

1.4

22.26

24.68

e6/l

0.07

575

Other Crohn's disease

575

1.60

4.34

1.6

1.5

8.68

24.52

e6/l

1.24

441

Diseases of tongue

421

1.71

4.34

1.2

1.3

2.81

46.57

e6/l

2.03

334

Open wound of lower leg

170

1219

1.40

4.33

1.4

1.6

17.81

23.29

e6/l

0.31

140

931

Atopic dermatitis

745

5208

1.18

4.33

1.4

1.5

20.47

30.28

e6/l

0.81

566

3997

Thyrotoxicosis

276

2131

1.30

4.30

1.5

1.3

51.53

30.27

e6/l

0.42

213

1654

Hepatic failure, not elsewhere classified

261

1.91

4.30

1.3

1.4

3.00

43.11

e6/l

1.09

207

Ill-defined and unknown causes of mortality

522

1.62

4.28

1.3

11.87

27.25

e6/l

0.64

414

Dermatophytosis

724

6174

1.18

4.28

1.3

1.4

45.56

27.92

e6/l

0.40

539

4799

Ehlers-Danlos syndrome

2.63

4.28

1.3

1.4

3.38

5.40

e6/l

0.39

Complications following infusion, transfusion and therapeutic injection

102

2.52

4.27

1.2

1.1

5.85

12.65

e6/l

0.45

Residual foreign body in soft tissue

356

1.76

4.26

1.5

1.3

13.72

32.82

e6/l

0.54

274

Inflammatory bowel disease

376

3020

1.25

4.24

1.4

44.46

30.46

e6/l

0.18

285

2329

Syphilis

193

2.06

4.23

1.9

1.3

22.21

39.35

e6/l

0.27

153

Syphilis

193

2.06

4.23

1.9

1.3

22.21

39.35

e6/l

0.27

153

Other keratitis

137

950

1.45

4.23

1.5

1.4

13.46

16.42

e6/l

0.18

102

726

Adenomyosis (Endometriosis of uterus)

154

1091

1.42

4.22

1.4

1.3

20.32

26.58

e6/l

0.27

117

868

Other epidermal thickening

306

1.82

4.21

1.8

1.6

8.22

37.96

e6/l

0.88

246

Congenital malformations of the circulatory system

186

1320

1.38

4.20

1.8

2.0

13.92

21.96

e6/l

0.55

139

1002

Cardiac murmurs and other cardiac sounds

117

778

1.50

4.20

1.9

1.8

16.02

26.54

e6/l

0.47

578

Perineal laceration during delivery

122

1483

0.68

4.19

1.4

1.3

18.73

18.67

e6/l

0.00

1159

Respiratory disorders in diseases classified elsewhere

2.60

4.19

1.3

1.2

18.71

4.67

e6/l

0.82

Hypertrophic scar

411

1.70

4.17

1.4

1.6

1.90

20.15

e6/l

2.49

321

Other local infections of skin and subcutaneous tissue

119

805

1.49

4.17

2.6

1.5

30.76

22.44

e6/l

0.20

628

Follicular lymphoma, hilmo

271

1.87

4.17

1.6

1.3

6.08

41.57

e6/l

0.93

211

Other and unspecified injuries of wrist and hand

300

1.83

4.16

1.2

1.8

8.84

15.16

e6/l

0.40

231

Other and unspecified vaccines and biological substances

3.22

4.16

1.1

1.0

1.40

2.41

e6/l

—

Autoimmune hyperthyroidism

411

1.70

4.16

1.7

1.5

44.94

32.41

e6/l

0.21

315

Dislocation, sprain and strain of joints and ligaments of knee

753

5953

1.17

4.15

1.3

1.4

14.82

31.76

e6/l

2.97

580

4562

Disorders of breast

571

4347

1.20

4.14

1.4

21.43

32.82

e6/l

0.73

451

3358

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

293

1.83

4.14

1.5

1.3

11.59

38.68

e6/l

0.61

220

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

209

2.00

4.11

8.9

1.6

21.62

24.08

e6/l

0.04

167

Postmenopausal osteoporosis with pathological fracture

375

1.73

4.11

1.4

1.2

6.90

20.46

e6/l

1.54

289

Malignant neoplasm of breast, HER-positive

211

2183

0.75

4.10

1.3

1.4

12.62

37.94

e6/l

2.29

146

1711

Hyperprolactinaemia

266

1.87

4.08

1.1

1.5

279.83

12.15

e6/l

0.48

208

Polymyalgia rheumatica

123

842

1.47

4.06

1.3

1.4

19.22

27.14

e6/l

0.27

650

Hodgkin lymphoma, hilmo

203

2.01

4.06

1.6

1.3

9.31

24.34

e6/l

0.47

162

Other (not insulin) diabetes medications

1184

6205

1.13

4.06

1.4

25.82

33.68

e6/l

0.44

909

4801

Hypertrophic disorders of skin

446

1.66

4.02

1.4

1.5

1.89

19.47

e6/l

2.65

348

Infectious mononucleosis

114

771

1.49

4.02

1.6

1.5

32.13

18.20

e6/l

0.52

593

Bruxism

137

2.24

4.01

1.4

1.5

2.52

6.64

e6/l

0.98

112

Other inflammatory liver diseases

493

1.62

4.00

1.2

1.4

6.47

29.70

e6/l

1.16

386

Congenital malformations and deformations of the musculoskeletal system

149

1055

1.42

4.00

1.7

2.0

13.31

27.55

e6/l

1.02

117

804

Other disorders of kidney and ureter

137

961

1.44

3.99

1.3

1.4

40.32

22.95

e6/l

0.48

100

741

Excessive earwax

599

4943

1.19

3.99

1.5

8.46

28.30

e6/l

5.46

472

3842

Sequelae of inflammatory diseases of the central nervous system

5.18

3.99

3.5

1.0

454.73

2.88

e6/l

0.48

Cardiodefibrillation

212

2786

0.76

3.98

1.5

1.4

92.32

28.36

e6/l

0.52

157

2168

Periapical abscess

529

4429

1.20

3.98

1.4

1.5

16.87

33.35

e6/l

1.28

399

3412

Excessive attrition of teeth

691

5918

1.17

3.97

1.3

1.4

42.88

28.46

e6/l

0.31

524

4542

Diseases of spleen

112

2.38

3.97

1.5

1.2

5.17

13.88

e6/l

0.60

Sequelae of injuries of upper limb

117

798

1.48

3.96

1.4

1.5

17.54

28.79

e6/l

0.53

100

615

Use of interferon beta-1a

171

2.09

3.95

1.3

1.6

11.68

10.84

e6/l

0.05

135

Extracorporeal dialysis

433

1.66

3.95

1.4

1.5

3.62

32.22

e6/l

1.33

334

Toxic effect of ethanol

298

1.80

3.95

1.2

1.7

19.59

10.45

e6/l

0.33

228

Other and unspecified local infections of skin and subcutaneous tissue

112

758

1.49

3.94

2.7

1.6

32.22

23.25

e6/l

0.20

587

Rheumatoid arthritis, including avohilmo

401

3272

1.23

3.94

1.3

1.4

27.28

28.64

e6/l

0.06

309

2525

Chronic iridocyclitis

388

1.70

3.93

1.4

1.5

8.12

10.14

e6/l

0.20

303

Acute generalized exanthematous pustulosis

328

1.76

3.93

1.7

29.82

13.86

e6/l

0.39

258

Other and unspecified trigeminal disorders

2.50

3.93

1.3

1.2

78.71

4.68

e6/l

0.50

Crohn disease (strict definition, require KELA)

535

1.59

3.92

1.7

1.5

17.48

34.44

e6/l

0.56

412

Benign neoplasm: Spinal meninges

2.86

3.91

1.8

1.0

67.45

8.40

e6/l

0.52

Certain zoonotic bacterial diseases

213

1.96

3.91

3.1

1.4

23.29

12.65

e6/l

0.35

165

Acute peritonitis

443

1.64

3.87

1.7

1.5

4.93

30.55

e6/l

1.17

343

Vascular diseases of the intestine

242

1.88

3.85

1.3

1.2

130.89

48.29

e6/l

0.42

193

Anorexia (incl.atypical)

482

1.61

3.85

1.2

1.5

3.58

23.11

e6/l

2.93

378

Major coronary heart disease event

981

5188

1.14

3.85

1.3

1.5

26.04

34.10

e6/l

0.41

807

3942

Complications of internal orthopaedic prosthetic devices, implants and grafts

211

1599

1.33

3.82

1.4

1.3

79.68

30.88

e6/l

0.40

158

1237

Other disorders starting during childhood or adolescence

519

1.59

3.79

3.3

2.6

10.46

20.14

e6/l

0.78

393

Open wound of wrist and hand

532

4376

1.19

3.78

1.3

1.5

38.30

28.67

e6/l

0.17

403

3375

Other specified and unspecified strabismus

2.57

3.77

1.9

2.4

24.85

6.54

e6/l

0.50

Specific developmental disorder of motor function

164

2.09

3.77

2.4

4.9

8.88

4.98

e6/l

0.22

111

Personal history of other diseases and conditions

150

1077

1.40

3.76

1.7

1.6

27.21

23.43

e6/l

0.11

110

828

Generalized epilepsy, mode (most common among epilepsy diagnosis)

223

1.91

3.76

1.1

1.8

5.34

14.06

e6/l

0.97

178

Type 1 diabetes, wide definition, subgroup 1

252

1959

1.29

3.76

1.4

1.5

21.29

25.19

e6/l

0.21

204

1514

Achilles tendinitis

106

717

1.49

3.75

1.1

1.4

16.81

17.34

e6/l

0.02

531

Crohn's disease of small intestine

566

1.55

3.72

1.7

1.5

16.79

33.75

e6/l

0.61

440

Other peripheral vertigo

638

1.52

3.71

1.4

1.3

11.14

28.53

e6/l

0.94

488

Other/unspecified enthesopathies, not elsewhere classified

558

1.55

3.71

1.3

1.4

9.52

35.57

e6/l

1.17

416

Other and unspecified mental retardation

168

2.07

3.70

2.6

4.6

40.19

6.28

e6/l

0.54

120

Percutaneous Coronary Intervention

914

4901

1.15

3.70

1.3

1.5

27.51

35.28

e6/l

0.36

753

3712

Other noninflammatory disorders of vulva and perineum

107

728

1.48

3.69

1.6

1.4

12.26

22.41

e6/l

0.61

575

Ischaemic heart disease, wide definition

862

4654

1.15

3.69

1.3

1.4

15.46

33.32

e6/l

2.70

686

3550

Melanocytic naevi of upper limb, including shoulder

169

2.05

3.69

2.1

1.6

7.08

9.81

e6/l

0.19

130

Early syphilis

2.54

3.68

2.0

1.4

26.60

18.66

e6/l

0.17

Crohn disease (strict definition, all UC cases excluded)

403

1.66

3.68

1.6

11.80

30.67

e6/l

0.60

306

Burn and corrosion of hip and lower limb, except ankle and foot

176

2.03

3.68

2.7

1.4

67.96

10.13

e6/l

1.01

135

Crohn disease (strict definition, require KELA, min 2 HDR)

528

1.57

3.68

1.7

1.5

18.05

34.92

e6/l

0.54

406

Diabetic nephropathy, excluding more controls

135

786

1.42

3.67

1.6

1.4

51.05

12.62

e6/l

0.86

112

607

Kidney transplant status

435

1.63

3.65

1.5

1.8

14.06

30.79

e6/l

0.46

327

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1163

6229

1.13

3.65

1.4

23.83

33.33

e6/l

0.79

904

4821

Gastroduodenal ulcer

237

1832

1.30

3.64

1.3

1.4

51.78

22.05

e6/l

0.50

182

1430

Endometriosis ASRM stages 1,2

215

1647

1.31

3.64

1.3

17.45

23.16

e6/l

0.40

164

1256

Hyperkalaemia

313

1.74

3.64

1.5

1.4

8.64

18.57

e6/l

0.46

251

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

262

1.82

3.63

1.3

1.4

10.08

7.74

e6/l

0.20

201

Coronary revascularization (ANGIO or CABG)

914

4903

1.14

3.63

1.3

1.5

27.45

35.27

e6/l

0.37

755

3714

Other/unspecified reactive arthropathies

514

1.57

3.63

1.1

1.4

115.18

19.03

e6/l

0.76

399

Crushed, pushed or stepped on by crowd or human stampede

642

1.51

3.62

1.3

1.9

7.57

17.07

e6/l

1.05

492

Pedestrian injured in collision with pedal cycle

219

1.90

3.62

1.1

1.4

9.66

12.42

e6/l

0.18

173

Biguanides

1150

6232

1.13

3.62

1.3

1.4

26.45

33.71

e6/l

0.38

877

4825

Secondary polycythaemia

150

2.10

3.61

1.3

10.69

12.40

e6/l

0.08

116

Perforation of tympanic membrane

116

806

1.45

3.61

1.4

28.29

14.69

e6/l

0.31

627

Artrosis, including avohilmo

1047

5062

1.13

3.60

1.3

1.4

28.26

30.25

e6/l

0.09

811

3897

Later onset COPD

138

1521

0.72

3.59

1.2

1.3

44.58

23.15

e6/l

0.32

102

1197

Other and unspecified iridocyclitis

345

1.70

3.58

1.3

1.6

7.80

12.13

e6/l

0.42

263

Injuries involving multiple body regions

278

1.79

3.57

1.4

1.5

2.54

12.42

e6/l

1.89

218

Unspecified event, undetermined intent

171

2.02

3.57

1.6

1.5

27.04

14.26

e6/l

0.36

136

Malignant neoplasm of breast, ER-positive, including Hilmo

221

2202

0.77

3.57

1.3

1.4

12.04

37.66

e6/l

2.42

155

1725

Other congenital malformations of brain

3.05

3.55

1.5

4.6

2.70

2.36

e6/l

—

Early syphilis

2.38

3.55

1.9

1.3

23.65

16.67

e6/l

0.17

Other diseases of blood and blood-forming organs

501

1.57

3.55

1.4

14.31

31.82

e6/l

0.69

383

Dementia due to Parkinson's disease

131

2.17

3.54

1.3

1.2

1.90

67.93

e6/l

0.89

108

Infections of genitourinary tract in pregnancy

117

818

1.44

3.53

1.4

1.3

30.43

26.67

e6/l

0.09

609

Coeliac disease

144

1044

1.39

3.53

1.4

1.6

13.14

28.82

e6/l

1.23

112

786

Alcoholic liver disease

107

736

1.47

3.52

1.3

1.4

15.22

21.91

e6/l

0.25

569

Superficial injuries involving multiple body regions

179

1.99

3.52

1.4

1.3

3.00

15.97

e6/l

1.53

144

Status post-ami

147

1527

0.73

3.48

1.3

1.4

16.96

28.61

e6/l

0.45

128

1162

Salpingitis and oophoritis

192

1458

1.32

3.48

1.3

1.4

12.32

41.04

e6/l

1.78

144

1112

Papulosquamous disorders

426

3546

1.21

3.48

1.3

1.4

21.19

31.33

e6/l

0.68

322

2728

Other and unspecified disorders of vitreous body

427

3505

1.21

3.48

1.4

23.27

33.16

e6/l

0.66

331

2689

Other and unspecified injuries of lower leg

632

1.50

3.47

1.3

1.5

41.99

29.64

e6/l

0.15

491

Retinal vascular disorders

110

763

1.45

3.45

1.4

1.3

8.39

27.58

e6/l

1.41

590

Fracture of forearm

629

4954

1.17

3.45

1.4

1.5

21.13

31.93

e6/l

1.08

490

3828

Retinal vascular occlusion

109

755

1.45

3.45

1.4

1.3

8.49

26.81

e6/l

1.30

582

Congenital malformations and deformations of the musculoskeletal system

122

859

1.43

3.45

1.9

2.2

14.58

18.52

e6/l

0.22

653

Drug-induced cataract

160

2.04

3.43

1.6

1.5

31.41

10.93

e6/l

0.49

122

Hypertrophy of breast in women and men

225

1749

1.29

3.43

1.5

1.4

13.32

34.50

e6/l

1.57

177

1332

Ingrowing nail

411

1.62

3.43

1.5

195.22

21.25

e6/l

0.48

318

Exposure to other and unspecified inanimate mechanical forces

634

1.50

3.43

1.4

1.6

9.06

29.40

e6/l

1.15

488

Injury of nerves at shoulder and upper arm level

2.57

3.43

1.1

19.71

10.67

e6/l

0.22

Retinal detachment with retinal break

129

923

1.41

3.42

1.5

1.3

4.59

23.38

e6/l

2.13

716

Diseases of arteries, arterioles and capillaries

690

4407

1.16

3.42

1.5

1.4

32.28

30.66

e6/l

0.05

544

3416

Abnormal results of function studies

675

1.48

3.42

1.2

1.6

4.80

23.93

e6/l

1.42

529

Dependent personality disorder

147

2.08

3.40

1.2

1.4

6.58

5.87

e6/l

0.05

111

Gonococcal infection

261

1.79

3.38

1.7

1.3

17.23

20.59

e6/l

0.14

196

Presence of other functional implants

614

3652

1.17

3.38

1.4

44.87

31.53

e6/l

0.28

478

2831

Pregnancy hypertension

496

3758

1.19

3.35

1.3

1.4

20.58

31.21

e6/l

0.42

396

2887

Preterm labour and delivery

296

2385

1.25

3.35

1.2

1.4

8.77

36.63

e6/l

2.91

226

1840

Dermatophytosis

137

995

1.39

3.34

1.5

1.4

25.95

22.53

e6/l

0.05

111

759

Noninflammatory disorders of female genital tract

512

2164

1.19

3.34

1.4

23.30

23.00

e6/l

0.01

380

1709

Mixed conductive and sensorineural hearing loss

120

852

1.42

3.34

1.3

1.4

119.13

20.95

e6/l

0.50

651

Human immunodeficiency virus [HIV] disease

128

2.15

3.33

1.8

1.3

16.95

14.46

e6/l

0.08

Burns and corrosions of external body surface, specified by site

133

962

1.39

3.33

1.7

21.76

22.56

e6/l

0.03

106

735

Cerebral atherosclerosis

2.76

3.33

1.3

1.1

7.11

14.47

e6/l

—

Viral conjunctivitis

292

1.74

3.33

1.4

1.7

5.03

10.54

e6/l

0.86

228

Malignant melanoma, including Hilmo

171

1286

1.34

3.33

1.2

1.3

9.46

23.02

e6/l

1.47

127

1016

Biomechanical lesions, not elsewhere classified

353

1.66

3.31

1.3

1.5

6.53

36.54

e6/l

1.06

279

Anogenital herpesviral [herpes simplex] infection

526

1.54

3.31

1.4

28.02

26.91

e6/l

0.03

398

Benign neoplasm of eye and adnexa

106

738

1.45

3.30

1.5

1.4

8.01

25.52

e6/l

1.27

565

L02BG Aromatase inhibitors

192

2485

0.77

3.29

1.3

1.4

8.15

37.60

e6/l

3.72

136

1919

Perioral dermatitis

163

2.00

3.28

1.4

6.08

4.45

e6/l

0.17

121

Other congenital malformations

159

1186

1.35

3.28

1.5

1.9

23.07

24.54

e6/l

0.04

119

908

Open wound of ankle and foot

122

873

1.41

3.26

1.4

1.6

25.87

23.48

e6/l

0.07

668

Other diseases of lip and oral mucosa

441

3707

1.19

3.26

1.5

22.29

32.84

e6/l

0.57

316

2875

Infection of intervertebral disc (pyogenic)

2.49

3.25

1.9

1.2

2.69

49.73

e6/l

0.62

Atopic dermatitis, strict definition with reimbursement

375

2998

1.21

3.25

1.4

1.5

15.10

26.21

e6/l

0.96

294

2292

Recurrent aphthous stomatitis , including avohilmo

161

1205

1.34

3.25

3.3

1.4

28.69

24.37

e6/l

0.15

134

912

Ménière disease

658

1.47

3.24

1.2

1.4

12.75

31.53

e6/l

1.06

500

Anaemia in chronic diseases classified elsewhere

150

2.03

3.23

1.3

1.4

43.21

68.89

e6/l

0.24

120

Open wound of abdomen, lower back and pelvis

228

1.82

3.23

1.6

1.8

34.59

15.22

e6/l

0.42

178

Colorectal cancer

123

1656

0.72

3.21

1.3

1.4

16.72

26.10

e6/l

0.39

1305

Malignant melanoma

141

1037

1.37

3.20

1.3

1.4

10.66

23.40

e6/l

1.08

105

816

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

579

1.50

3.19

1.7

1.5

17.21

33.75

e6/l

0.57

445

Thiazolidinediones

111

785

1.42

3.18

1.4

1.3

21.91

22.53

e6/l

0.02

608

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1385

0.70

3.16

1.2

1.4

7.35

28.60

e6/l

2.03

1088

Pruritus

117

837

1.41

3.14

1.5

1.4

59.74

24.21

e6/l

0.35

633

Type 2 diabetes, definitions combined

1142

6012

1.12

3.14

1.4

25.72

34.08

e6/l

0.47

867

4650

Autoimmune thyroiditis

152

2.01

3.14

1.6

1.5

2.72

7.38

e6/l

1.35

113

Charcot foot

118

2.16

3.14

1.8

1.3

176.78

62.37

e6/l

0.36

Iron deficiency

216

1.83

3.13

1.3

1.9

11.67

22.05

e6/l

0.38

168

Disorders of parathyroid gland

188

1429

1.31

3.12

1.4

27.78

34.14

e6/l

0.17

143

1112

Motor disorders

180

1.93

3.11

2.4

5.0

8.88

5.50

e6/l

0.19

123

Coxarthrosis

521

2933

1.18

3.10

1.4

30.55

29.34

e6/l

0.03

400

2251

Injury of unspecified body region

583

1.49

3.09

1.3

1.6

28.78

28.44

e6/l

0.01

448

Use of rotigotine

2.50

3.09

1.6

1.3

3.50

17.79

e6/l

0.79

Artificial opening status

407

1.59

3.09

1.8

1.7

53.86

33.59

e6/l

0.24

300

Injuries to unspecified part of trunk, limb or body region

112

798

1.41

3.09

1.2

1.5

33.58

27.10

e6/l

0.14

614

Other and unspecified epidermal thickening

188

1.89

3.09

1.9

1.7

11.21

30.19

e6/l

0.54

155

Sub-endpoint used in defining T1D endpoints

318

2564

1.22

3.08

1.5

27.74

23.39

e6/l

0.15

259

1965

Disorders of multiple cranial nerves

11.49

3.08

1.4

1.40

4.00

e6/l

—

Gonococcal infection

284

1.71

3.08

1.8

1.3

16.83

19.40

e6/l

0.11

215

Diabetic maculopathy, excluding more controls

116

832

1.40

3.08

1.4

18.17

21.87

e6/l

0.13

646

Other and unspecified diseases of blood and blood-forming organs

174

1.93

3.08

1.6

1.3

4.25

61.39

e6/l

0.98

135

Vulvovaginal ulceration/inflammation in other diseases

479

1.54

3.07

1.2

1.4

23.96

22.69

e6/l

0.04

366

Benign neoplasm: Skin of lower limb, including hip

189

1.88

3.04

1.1

1.4

2.85

31.50

e6/l

0.96

144

Acidosis

147

2.01

3.03

1.2

1.7

1.00

28.11

e6/l

0.69

114

Degenerative macular diseases

110

784

1.41

3.03

1.4

8.87

28.73

e6/l

1.59

609

Type 1 diabetes, wide definition

256

2054

1.25

3.02

1.4

1.6

21.00

24.34

e6/l

0.18

207

1586

Additional codes for the location of defect, injury or illness

441

1.56

3.02

1.3

1.5

54.96

31.24

e6/l

0.19

344

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

658

1.45

3.02

2.0

2.4

2.80

15.03

e6/l

2.59

508

Malignant melanoma of skin, including Hilmo

141

1048

1.35

3.01

1.2

1.3

7.61

23.06

e6/l

1.51

104

823

Abnormal findings in nipple discharge synovial fluid wound secretions

107

2.20

3.00

1.2

1.3

2.73

5.60

e6/l

0.62

Disorders of orbit

309

1.67

3.00

1.5

49.21

14.50

e6/l

0.90

236

Acute pancreatitis

200

1562

1.29

2.99

2.0

1.4

9.66

22.27

e6/l

1.58

145

1215

Hydrocele

106

753

1.42

2.98

1.3

1.6

11.47

24.31

e6/l

0.74

593

Recurrent dislocation of patella

419

1.57

2.97

1.1

1.4

37.11

16.93

e6/l

0.42

325

Acute bronchiolitis

507

1.49

2.96

2.4

2.7

3.42

17.70

e6/l

2.41

382

Gestational [pregnancy-induced] hypertension

304

2490

1.22

2.94

1.3

11.70

31.84

e6/l

1.86

237

1917

Ovarian dysfunction

664

1.44

2.94

1.2

1.4

2.20

20.01

e6/l

4.32

509

Other dialysis

228

1.78

2.94

1.6

1.7

20.80

23.15

e6/l

0.04

177

Coronary artery bypass grafting

149

1468

0.75

2.94

1.2

1.3

17.76

27.28

e6/l

0.39

117

1121

Malignant neoplasm of pancreas, including Hilmo

525

0.53

2.93

1.4

1.3

58.13

30.47

e6/l

0.34

414

Psoriatic and enteropathic arthropathies

126

925

1.37

2.93

1.3

1.4

21.57

15.93

e6/l

0.24

102

710

!Aliquae complicationes praecoces traumatis

319

1.65

2.92

1.5

1.4

26.63

38.18

e6/l

0.20

252

Early complications of trauma

319

1.65

2.92

1.5

1.4

26.63

38.18

e6/l

0.20

252

Type 2 diabetes, strict (exclude DM1)

1143

6046

1.11

2.92

1.4

25.69

34.12

e6/l

0.48

868

4672

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

664

0.58

2.91

1.1

1.3

4.29

25.38

e6/l

1.32

521

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

539

4043

1.16

2.90

1.3

1.4

20.55

30.44

e6/l

0.42

431

3102

Adenocarcinoma and papilloma adenocarcinoma of rectum

638

0.58

2.90

1.1

1.3

4.58

26.20

e6/l

1.29

501

Localized swelling, mass and lump of skin and subcutaneous tissue

324

2681

1.21

2.89

1.7

1.4

18.74

32.33

e6/l

0.85

251

2066

Benign neoplasm: Adrenal gland

584

1.47

2.89

1.3

1.4

6.54

28.62

e6/l

1.32

448

Acne

128

943

1.36

2.89

1.5

11.57

20.84

e6/l

1.11

104

727

Thyrotoxicosis with diffuse goitre

152

1151

1.33

2.88

1.7

1.3

24.85

24.86

e6/l

0.00

122

875

Nonalcoholic fatty liver disease

111

801

1.40

2.88

1.6

1.4

41.65

26.25

e6/l

0.42

621

Asthma mixed form (mode)

320

1.64

2.88

1.2

1.5

32.65

20.69

e6/l

0.25

249

Other articular cartilage disorders

150

1.96

2.87

1.2

2.18

5.16

e6/l

1.12

115

Atrial fibrillation and flutter with reimbursement

235

1188

1.26

2.87

1.3

41.25

23.80

e6/l

0.29

165

894

Atrophic disorders of skin

155

1178

1.32

2.87

1.4

20.80

38.47

e6/l

0.65

114

912

Diabetic retinopathy, strict definition

163

1099

1.32

2.87

1.4

18.46

23.07

e6/l

0.21

129

846

Haemorrhoids and perianal venous thrombosis

319

2632

1.21

2.86

1.3

1.4

11.95

27.68

e6/l

2.08

250

2042

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

146

1101

1.33

2.85

1.4

17.16

21.21

e6/l

0.19

112

836

Emergency coronary revascularization (for ACS)

962

5229

1.12

2.85

1.3

1.5

26.34

33.61

e6/l

0.36

789

3972

Sequelae of injuries of lower limb

106

761

1.40

2.84

1.3

1.4

129.40

28.12

e6/l

0.46

591

Colon adenocarcinoma

771

0.62

2.83

1.4

1.3

14.23

27.23

e6/l

0.51

607

Systemic sclerosis (FG)

158

1.93

2.83

1.2

1.6

2.26

10.56

e6/l

1.09

122

Postprocedural musculoskeletal disorders, not elsewhere classified

513

1.50

2.83

1.5

1.3

19.86

29.51

e6/l

0.22

393

Vascular disorders of the intestines

424

1.54

2.82

1.2

1.3

186.10

30.88

e6/l

0.76

326

Benign neoplasm of other and unspecified sites

231

1.76

2.82

1.2

5.87

47.92

e6/l

0.93

178

119

872

1.37

2.82

1.1

1.3

17.59

17.29

e6/l

0.01

684

Contact with heat and hot substances

433

1.54

2.81

1.4

1.7

3.74

18.25

e6/l

1.17

330

Asthma mixed form (mode), excluding more controls

322

1.63

2.81

1.2

1.5

32.65

20.76

e6/l

0.25

251

Other abnormal findings of blood chemistry

346

1.61

2.81

1.6

1.3

3.11

34.99

e6/l

1.16

272

Pregnancy with abortive outcome

767

3529

1.14

2.81

1.4

20.64

34.97

e6/l

1.16

600

2734

Abscess of anal and rectal regions

704

1.42

2.80

1.4

1.5

37.19

23.56

e6/l

0.28

537

Mixed disorders of conduct and emotions

217

1.78

2.79

1.3

2.4

40.00

21.93

e6/l

0.36

165

Radial styloid tenosynovitis [de Quervain]

378

1.57

2.79

1.4

1.3

9.96

17.52

e6/l

0.51

283

Atopic dermatitis, strict definition

369

3039

1.19

2.78

1.4

1.6

13.30

27.45

e6/l

1.56

289

2319

Other noninflammatory disorders of vagina

597

1.45

2.78

1.6

1.4

53.95

20.10

e6/l

0.65

474

Tularaemia

2.36

2.78

1.8

1.2

1.77

12.60

e6/l

0.66

Other predominantly sexually transmitted diseases, not elsewhere classified

251

2035

1.24

2.77

1.4

17.62

22.82

e6/l

0.42

190

1573

Crohn's disease NAS

532

1.48

2.77

1.5

1.6

35.71

29.67

e6/l

0.09

418

Muscle strain

188

1.83

2.76

1.2

1.4

17.27

26.52

e6/l

0.19

143

Certain zoonotic bacterial diseases

118

2.07

2.74

3.5

1.2

19.58

9.24

e6/l

0.23

Trigger finger

141

1065

1.33

2.74

1.4

21.60

31.51

e6/l

0.51

113

817

Other diseases of pericardium

325

1.62

2.74

1.5

1.6

4.84

18.80

e6/l

0.80

257

Malignant melanoma of skin

107

775

1.39

2.73

1.3

8.86

24.90

e6/l

1.04

605

Dialysis

310

1.63

2.73

1.5

1.8

16.51

18.34

e6/l

0.04

241

Diabetes, insulin treatment (Kela reimbursement)

1210

6633

1.10

2.72

1.4

23.72

33.81

e6/l

0.90

940

5116

Insulin, fast-acting (human)

159

1224

1.31

2.70

1.4

26.51

24.98

e6/l

0.05

126

955

Injury of muscle and tendon at wrist and hand level

148

1129

1.32

2.69

1.4

11.68

18.70

e6/l

0.41

117

875

Other specified and unspecified retinal disorders

242

1.72

2.69

2.4

1.4

13.03

48.85

e6/l

0.77

188

Type 2 diabetes, definitions combined, including avohilmo

1144

6032

1.11

2.69

1.4

24.39

34.39

e6/l

0.61

864

4676

Mental retardation

356

1.58

2.68

2.2

3.3

31.66

9.57

e6/l

0.56

267

Other follicular disorders

610

1.44

2.68

1.3

40.58

33.03

e6/l

0.12

467

Unspecified abortion

382

1.56

2.68

1.2

1.3

17.67

27.88

e6/l

0.33

296

Coxarthrosis [arthrosis of hip](FG)

555

3392

1.15

2.68

1.4

30.44

32.50

e6/l

0.06

431

2610

Acute pancreatitis (for exclusion)

200

1587

1.27

2.68

2.0

1.4

9.66

24.46

e6/l

1.99

145

1220

Other contact dermatitis

627

1.43

2.67

1.3

1.4

6.99

26.51

e6/l

2.20

494

Hypertrophy of breast

193

1526

1.27

2.67

1.4

1.3

7.67

32.13

e6/l

2.16

152

1155

Colonic or urogenital fistula

284

2342

1.22

2.67

1.5

1.4

31.82

28.52

e6/l

0.10

216

1788

Impetigo

359

1.58

2.66

3.1

1.9

7.09

10.96

e6/l

0.36

277

Hordeolum and other deep inflammation of eyelid

447

1.51

2.66

2.2

1.5

16.63

29.50

e6/l

0.33

346

Stomatitis and related lesions

220

1769

1.25

2.63

2.8

1.4

23.62

23.48

e6/l

0.01

183

1340

Disorders of oesophagus in diseases classified elsewhere

134

1.97

2.63

1.9

1.2

4.11

74.71

e6/l

0.91

103

L04AC Interleukin inhibitors

481

1.49

2.63

1.2

1.5

20.06

16.92

e6/l

0.07

367

Generalized skin eruption due to drugs and medicaments

290

1.64

2.62

1.6

34.87

14.58

e6/l

0.43

228

Malignant neoplasm, without specification of site, including Hilmo

274

1.66

2.62

1.4

1.2

32.26

36.46

e6/l

0.06

227

COPD (mode)

269

1731

1.22

2.62

1.4

31.18

21.73

e6/l

0.24

205

1353

Ehlers-Danlos syndrome

2.36

2.62

1.3

1.5

1.08

4.79

e6/l

1.56

Melanocytic naevi of trunk

131

987

1.34

2.62

1.2

1.4

6.24

26.16

e6/l

2.33

772

Diabetic retinopathy

325

1686

1.21

2.61

1.4

15.44

27.51

e6/l

1.01

255

1306

Caries of enamel

1118

7319

1.10

2.61

1.7

1.4

41.88

28.64

e6/l

0.43

822

5672

Other bursopathies

122

910

1.35

2.60

1.3

1.4

26.05

28.28

e6/l

0.07

692

Acute nasopharyngitis (common cold)

131

981

1.33

2.60

1.7

1.4

16.25

35.31

e6/l

0.65

105

750

Allergic urticaria

698

1.40

2.60

1.9

1.7

44.14

32.11

e6/l

0.13

527

Outcome of delivery

204

1000

1.27

2.59

1.2

1.3

36.65

29.22

e6/l

0.16

146

764

Benign neoplasm: Stomach

682

1.40

2.58

1.3

47.27

27.99

e6/l

0.20

519

Chronic pancreatitis

124

930

1.34

2.56

1.2

1.4

18.97

20.89

e6/l

0.06

711

Complications predominantly related to the puerperium

299

2490

1.21

2.56

1.2

1.3

17.64

35.11

e6/l

1.13

220

1923

Lichen simplex chronicus

231

1.71

2.54

1.5

1.3

24.07

23.92

e6/l

0.00

184

Other and unspecified vascular occlusions

583

1.43

2.54

1.5

1.3

9.34

25.30

e6/l

0.79

453

Oligomenorrhoea

285

1.63

2.53

1.8

1.4

15.28

15.95

e6/l

0.02

221

Other specified/unspecified bacterial intestinal infections

477

1.48

2.52

1.8

1.4

12.22

30.65

e6/l

0.72

370

Tuberculosis, wide

428

1.51

2.52

1.5

1.3

21.04

31.29

e6/l

0.25

340

Mental retardation, wide definition

378

1.54

2.52

2.2

3.2

30.37

9.70

e6/l

0.55

283

Systemic sclerosis

165

1.85

2.51

1.2

1.5

2.26

11.50

e6/l

1.30

125

Other diseases of arteries and capillaries

635

1.41

2.51

1.4

19.29

26.43

e6/l

0.20

495

Problems related to social environment

165

1.84

2.50

1.2

1.5

10.79

10.30

e6/l

0.02

135

Erosion of teeth , including avohilmo

291

2423

1.21

2.50

1.6

1.4

10.49

23.02

e6/l

2.07

220

1868

Allergic rhinitis

379

3192

1.18

2.50

1.3

1.6

21.21

29.17

e6/l

0.33

297

2442

Late syphilis

109

2.06

2.49

1.7

1.1

15.31

11.63

e6/l

0.14

Disorders of globe

144

1.90

2.48

1.6

1.3

176.68

16.37

e6/l

0.76

115

Mantle cell lymphoma, including Hilmo

2.18

2.48

1.2

13.58

90.20

e6/l

0.65

Septal defects

591

1.42

2.47

1.4

2.8

5.85

24.46

e6/l

1.01

448

Injury of nerves at forearm level

2.28

2.47

1.1

1.3

95.60

3.68

e6/l

—

Seropositive rheumatoid arthritis

242

1974

1.23

2.46

1.2

1.4

28.64

29.08

e6/l

0.01

190

1535

Ulcer of oesophagus

455

1.48

2.46

1.3

5.70

29.10

e6/l

1.09

359

Heart failure and coronary heart disease

285

2424

0.83

2.46

1.3

1.4

17.94

33.63

e6/l

0.92

235

1862

Foreign body in alimentary tract

423

1.50

2.46

1.3

1.7

39.88

31.30

e6/l

0.14

321

Acute gastritis

521

1.45

2.45

1.5

17.08

28.68

e6/l

0.35

405

Female infertility, associated with anovulation

680

1.39

2.45

1.4

1.3

14.62

19.12

e6/l

0.21

548

Fall involving bed

196

1.76

2.45

1.4

1.7

3.55

36.20

e6/l

0.69

158

Effects of foreign body entering through natural orifice

272

2256

1.21

2.44

1.5

37.68

25.50

e6/l

0.36

209

1719

Tuberculosis, IBD comorbidity

415

1.50

2.44

1.5

1.3

21.04

31.77

e6/l

0.26

331

Exposure to other and unspecified man-made environmental factors

110

2.04

2.43

1.0

1.2

1.71

8.00

e6/l

1.26

Campylobacter enteritis

189

1.77

2.43

1.2

1.4

1.92

10.82

e6/l

1.56

147

Cardiomyopathy in other diseases

3.13

2.39

1.2

5.80

91.70

e6/l

—

Alcohol-induced chronic pancreatitis

483

1.46

2.39

1.1

1.4

15.46

25.68

e6/l

0.25

372

Systemic sclerosis, icd10

168

1.81

2.39

1.2

2.26

16.85

e6/l

1.36

126

Chronic ulcer of skin, not elsewhere classified

450

1.48

2.39

1.3

1.4

2.75

31.80

e6/l

1.53

361

Other and unspecified rosacea

684

1.38

2.38

1.3

4.35

29.70

e6/l

1.98

524

Congenital malformations of the respiratory system

161

1.84

2.38

1.6

3.4

54.32

5.73

e6/l

0.60

117

Other and unspecified disorders of white blood cells

290

1.60

2.38

3.7

1.5

10.72

21.52

e6/l

0.40

224

Viral warts

238

1956

1.22

2.36

1.3

1.5

16.52

22.62

e6/l

0.43

188

1505

Chronic kidney disease

268

2184

1.21

2.36

1.4

1.5

14.46

24.13

e6/l

0.87

212

1689

Pneumonia due to Streptococcus pneumoniae

275

1.62

2.36

1.6

1.4

38.03

13.64

e6/l

0.48

218

Primary angle-closure glaucoma

268

1.62

2.33

1.4

1.3

4.86

43.49

e6/l

1.04

208

Dislocation, sprain and strain of joint and ligaments of hip

245

1.65

2.33

1.6

1.3

1.93

50.40

e6/l

1.28

192

Pilonidal cyst

101

747

1.36

2.32

1.6

1.5

25.95

26.04

e6/l

0.00

588

Arteriovenous malformation of cerebral vessels

2.17

2.32

2.1

1.2

9.92

16.68

e6/l

0.26

Post-traumatic wound infection, not elsewhere classified

192

1.74

2.32

1.2

1.3

33.74

10.49

e6/l

0.44

151

Plantar fascial fibromatosis

696

1.37

2.31

1.3

8.78

33.76

e6/l

1.66

527

Bitten or struck by other mammals

128

981

1.31

2.31

1.2

1.5

13.98

26.54

e6/l

0.57

755

Benign mammary dysplasia

136

1051

1.30

2.31

1.5

1.4

57.12

35.13

e6/l

0.35

109

802

Malignant neoplasm of rectum, including Hilmo

863

0.68

2.31

1.2

1.3

7.00

27.47

e6/l

1.55

678

Other leukaemias of specified cell type

4.12

2.30

8.4

1.1

55.00

2.31

e6/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

663

1.38

2.30

1.2

1.5

26.47

11.69

e6/l

0.55

515

Angina pectoris

587

3452

1.14

2.29

1.3

1.4

11.54

32.67

e6/l

3.27

459

2623

Prepatellar bursitis

301

1.58

2.29

1.1

1.4

82.66

33.53

e6/l

0.30

235

Adalimumab

111

836

1.34

2.27

1.5

1.6

53.32

20.74

e6/l

0.51

642

Other and unspecified disorders of skin and subcutaneous tissue

445

0.56

2.27

1.1

1.4

76.32

32.71

e6/l

0.26

341

Congenital malformations of the respiratory system

171

1.79

2.27

1.6

3.3

54.32

6.93

e6/l

0.58

126

Delayed milestone in childhood

201

1.69

2.27

2.7

5.1

33.37

8.86

e6/l

0.35

137

Endocrine disorders, other/unspecified

128

1.90

2.23

1.3

1.2

16.20

6.12

e6/l

0.34

101

Other diseases of pancreas

599

1.40

2.23

1.2

1.4

83.56

23.16

e6/l

0.36

464

Deviated nasal septum

342

2919

1.17

2.22

1.2

1.4

15.92

31.30

e6/l

1.41

279

2210

Other disorders of penis

693

1.36

2.22

1.4

1.9

3.78

22.16

e6/l

1.98

538

Pyoderma gangrenosum

2.57

2.21

1.1

1.60

10.75

e6/l

—

Presbycusis

712

1.35

2.20

1.2

1.3

39.39

20.05

e6/l

0.25

562

Pneumonia derived septicemia

249

1.62

2.20

1.5

1.8

371.06

41.16

e6/l

1.02

199

Blepharochalasis

266

2227

1.20

2.20

1.2

1.4

24.31

33.06

e6/l

0.24

200

1730

Diseases of external ear

356

3055

1.17

2.20

1.4

1.5

13.96

27.32

e6/l

1.38

272

2365

Entropion and trichiasis of eyelid

501

1.43

2.17

1.2

1.3

54.94

23.08

e6/l

0.31

390

Superficial injury of neck

144

1.83

2.17

1.2

1.5

3.50

8.89

e6/l

1.18

115

Polyarthritis, unspecified

258

1.61

2.16

1.3

1.5

12.94

8.84

e6/l

0.23

204

Female genital prolapse

319

1526

1.19

2.16

1.3

1.4

45.64

25.39

e6/l

0.21

241

1205

Volvulus

174

1.74

2.15

1.1

1.3

2.95

56.01

e6/l

0.91

137

Ankylosing spondylitis, ICD10

732

1.35

2.14

1.4

72.78

21.01

e6/l

0.51

560

ILD, hospital admission 2, with pulmonary infections

578

1.39

2.14

1.2

1.4

21.63

14.14

e6/l

0.26

461

Chronic conjunctivitis

220

1.66

2.14

2.1

1.8

14.21

13.82

e6/l

0.02

175

Thyroiditis

545

1.40

2.14

1.4

53.44

25.11

e6/l

0.31

424

DVT of lower extremities

176

1419

1.25

2.13

1.3

1.4

41.43

25.89

e6/l

0.25

140

1100

Other and unspecified follicular disorders

299

1.55

2.12

1.3

18.56

39.02

e6/l

0.40

237

Polycystic ovarian syndrome

479

1.43

2.12

1.1

1.4

2.57

21.48

e6/l

3.02

375

Tibial collateral bursitis [Pellegrini-Stieda]

2.18

2.11

1.6

1.7

87.60

4.78

e6/l

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

276

1.58

2.11

1.2

1.8

31.44

20.36

e6/l

0.22

211

Wide developmental disorders, excluding more controls

225

1.63

2.10

1.5

2.9

7.48

11.65

e6/l

0.35

171

Other superficial mycoses

117

900

1.31

2.09

1.3

1.5

8.68

28.18

e6/l

1.78

685

Chronic hepatitis, not elsewhere classified

237

1.62

2.09

1.4

45.71

12.98

e6/l

0.72

188

Malignant neoplasm of bronchus and lung

1058

0.75

2.08

1.2

1.3

36.40

24.59

e6/l

0.15

835

Other disorders of male genital organs

253

1.60

2.08

1.3

1.5

8.29

27.75

e6/l

0.80

200

Anxious personality disorder

139

1.82

2.07

1.2

1.3

2.67

8.64

e6/l

1.31

107

Multiple myeloma, including Hilmo

285

1.56

2.07

1.4

1.3

9.40

37.17

e6/l

0.72

228

Embolic stroke

238

1.61

2.04

1.8

1.3

8.65

44.80

e6/l

0.81

189

Erythema multiforme

162

1.75

2.04

1.6

1.4

2.10

10.40

e6/l

1.17

127

Otitis externa, unspecified

125

974

1.29

2.04

1.3

1.6

9.72

26.30

e6/l

1.39

755

Hyperkinetic disorders (excl. ADHD)

183

1.70

2.04

1.4

3.6

56.61

12.10

e6/l

0.70

136

Bacterial, viral and other infectious agents

103

782

1.33

2.04

1.4

1.6

5.87

27.27

e6/l

1.77

600

Chronic myeloproliferative disease

2.09

2.03

1.2

70.08

48.57

e6/l

0.11

Spontaneous abortion

513

3055

1.13

2.02

1.2

1.4

25.95

35.37

e6/l

0.42

397

2359

ILD, hospital admissions 3, with pneumonia sepsis

509

1.40

2.01

1.2

1.4

23.48

21.92

e6/l

0.03

396

Blood alcohol or alcohol intoxication level

178

1.71

2.00

1.3

1.5

6.82

10.28

e6/l

0.43

138

Haemolytic anaemias

264

1.57

1.99

1.3

1.6

2.86

39.44

e6/l

0.97

207

Injury of other and unspecified intrathoracic organs

452

1.43

1.98

1.4

10.78

31.25

e6/l

0.83

359

Hernia of abdominal wall

471

4158

1.14

1.98

1.4

17.90

29.01

e6/l

0.77

361

3233

Vasculitis limited to skin, not elsewhere classified

156

1.75

1.98

1.1

1.6

6.12

34.34

e6/l

0.75

127

Benign neoplasm: Other and unspecified parts of mouth

233

1.61

1.97

1.3

1.2

18.19

26.87

e6/l

0.23

183

Hereditary retinal dystrophy

1.97

1.3

1.7

3.00

7.01

e6/l

0.66

Dysplasia of cervi uteri

272

1665

1.19

1.97

1.2

1.3

82.43

23.42

e6/l

0.67

211

1315

Otitis externa

237

1989

1.20

1.96

1.3

1.5

14.71

23.79

e6/l

0.80

185

1522

Recurrent dislocation and subluxation of joint

563

1.38

1.96

1.3

1.6

16.29

13.29

e6/l

0.16

438

L02BX Other hormone antagonists and related agents

322

0.52

1.95

1.1

1.4

11.82

36.95

e6/l

0.68

256

Mixed specific developmental disorders

223

1.60

1.95

1.8

4.2

7.97

6.94

e6/l

0.05

154

Habitual aborter

172

1.71

1.95

1.2

1.5

26.67

18.89

e6/l

0.19

138

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

157

1.74

1.95

1.3

1.4

22.68

6.60

e6/l

0.40

127

Other and unspecified vasculitis limited to skin

142

1.78

1.94

1.1

1.7

6.38

31.39

e6/l

0.57

113

Hydronephrosis

106

814

1.31

1.94

1.3

1.4

4.54

21.04

e6/l

1.66

636

Lichen sclerosus et atrophicus

100

762

1.32

1.94

1.4

1.3

31.25

27.65

e6/l

0.10

585

Tongue abnormality

446

1.42

1.94

1.2

1.5

2.69

32.06

e6/l

1.44

345

Congenital malformations of cardiac septa

621

1.35

1.93

1.4

2.7

5.78

27.09

e6/l

1.29

466

Other congenital malformations of skin

685

1.34

1.93

1.7

36.54

29.60

e6/l

0.13

524

Biological medication for rheuma

196

1619

1.22

1.93

1.4

1.5

99.21

24.76

e6/l

0.64

150

1237

Seronegative rheumatoid arthritis

109

842

1.30

1.91

1.2

1.4

37.48

17.43

e6/l

0.87

646

Diabetic nephropathy

137

1075

1.26

1.91

1.5

1.4

50.18

20.80

e6/l

0.60

114

819

Pneumococcal septicemia

243

1.58

1.91

1.5

1.9

383.37

41.91

e6/l

1.02

192

Convalescence

356

1.47

1.91

1.4

57.95

36.87

e6/l

0.19

271

Injury of nerves at lower leg level

2.20

1.90

1.0

1.1

2.50

7.78

e6/l

—

Habit and impulse disorders

114

1.87

1.89

2.1

1.9

2.50

10.09

e6/l

1.42

Nasal polyp

187

1541

1.22

1.88

1.3

1.4

27.15

27.51

e6/l

0.01

150

1186

Hyperparathyroidism

154

1229

1.24

1.88

1.4

30.97

35.80

e6/l

0.10

115

957

Malignant neoplasm of colon

1000

0.74

1.88

1.3

23.90

26.73

e6/l

0.06

788

Benign neoplasm: Other/unspecified site

100

1.93

1.87

1.4

1.1

11.21

12.66

e6/l

0.06

Myocardial infarction, strict

352

2881

0.87

1.87

1.3

1.4

18.53

31.95

e6/l

0.85

279

2209

Diabetic maculopathy

115

845

1.29

1.87

1.4

1.3

18.17

21.89

e6/l

0.14

644

Seborrhoeic keratosis

201

1670

1.21

1.86

1.5

1.4

51.90

32.00

e6/l

0.37

153

1299

Dependence on enabling machines and devices, not elsewhere classified

1.97

1.85

3.9

2.4

3.91

41.52

e6/l

0.51

Benign neoplasm: Rectum, anus and anal canal

181

1490

1.22

1.85

1.3

40.71

22.48

e6/l

0.36

126

1143

Other and unspecified injuries of ankle and foot

326

1.49

1.85

1.6

1.8

2.68

17.17

e6/l

2.96

251

Follow-up care involving plastic surgery

250

0.48

1.85

1.5

1.4

0.33

47.58

e6/l

—

187

Psoriatic arthropathies

101

777

1.31

1.84

1.3

1.4

26.01

17.53

e6/l

0.30

592

Unspecified kidney failure

621

1.34

1.84

1.5

1.3

4.88

25.29

e6/l

1.39

490

Gonarthrosis,primary

959

5423

1.09

1.83

1.3

1.4

29.43

32.15

e6/l

0.13

749

4192

Malignant neoplasm of rectum

646

0.68

1.83

1.2

1.3

5.50

25.47

e6/l

1.18

513

Malignant neoplasm of prostate

187

1354

0.82

1.83

1.3

47.14

19.23

e6/l

0.36

137

1059

Other puerperal infections

718

1.32

1.82

1.2

1.3

23.14

19.86

e6/l

0.09

558

Ulcerative colitis

264

2253

1.18

1.82

1.3

1.5

59.49

23.43

e6/l

0.38

201

1727

IBD patients in KELA-register

257

2189

1.18

1.81

1.5

1.4

62.12

24.12

e6/l

0.39

196

1680

Personal history of certain other diseases

153

1.72

1.81

1.5

1.4

8.94

24.81

e6/l

0.53

122

Acne vulgaris

753

1.31

1.81

1.4

1.5

12.51

22.00

e6/l

0.86

586

Vitamin B12 deficiency anaemia

692

1.32

1.81

1.4

13.19

25.17

e6/l

0.55

539

Congenital malformations of spine and bony thorax

2.41

1.81

1.2

3.5

1.18

3.17

e6/l

1.30

Other sexually transmitted chlamydial diseases

589

1.35

1.80

1.6

1.5

32.60

20.64

e6/l

0.38

453

Scoliosis

606

1.34

1.80

1.8

18.62

24.53

e6/l

0.15

468

Dermatitis herpetiformis

116

1.84

1.80

1.5

1.4

47.63

11.89

e6/l

0.38

Malignant neoplasm of mesothelium and soft tissue

271

1.53

1.80

1.1

1.3

36.43

38.78

e6/l

0.03

218

Postprocedural disorders of digestive system, not elsewhere classified

239

1.56

1.80

1.4

1.6

106.13

40.43

e6/l

0.29

188

Malignant neoplasm of endocrine gland

538

1.37

1.80

1.5

1.3

41.93

26.36

e6/l

0.33

422

Other lesions of median nerve

161

1.69

1.79

1.0

1.2

42.19

7.44

e6/l

0.40

124

Achalasia of cardia

109

1.86

1.79

1.2

1.3

2.92

87.73

e6/l

0.95

Persons encountering health services in circumstances related to reproduction

703

4294

1.10

1.79

1.6

1.5

19.23

36.66

e6/l

1.61

541

3238

Systemic sclerosis,strict definition

2.14

1.78

1.2

1.1

3.00

4.22

e6/l

—

Malignant neoplasm of accessory sinuses

3.51

1.78

1.5

1.1

90.00

2.54

e6/l

—

Urethral stricture

337

1.46

1.77

1.2

1.4

2.10

35.93

e6/l

1.26

269

Caught, crushed, jammed or pinched in or between objects

404

1.42

1.77

1.2

1.7

57.90

32.34

e6/l

0.38

310

Non-small cell lung cancer

625

0.68

1.77

1.2

1.3

5.68

27.77

e6/l

1.28

490

Pre-eclampsia or eclampsia

235

1992

1.18

1.77

1.2

1.3

26.50

37.35

e6/l

0.19

191

1530

Benign lipomatous neoplasm

290

2500

1.16

1.77

1.4

1.3

48.24

28.39

e6/l

0.44

230

1932

Nonspecific lymphadenitis

472

1.39

1.76

1.9

1.5

28.31

14.05

e6/l

0.43

371

Burns and corrosions confined to eye and internal organs

201

1.61

1.76

1.7

1.6

13.52

9.40

e6/l

0.21

154

Hepatomegaly and splenomegaly, not elsewhere classified

2.26

1.75

1.4

1.2

83.14

21.70

e6/l

—

Open wound of forearm

757

1.30

1.75

1.3

1.5

60.30

28.24

e6/l

0.35

584

Hypertrichosis

170

1.67

1.75

1.1

1.3

24.86

12.21

e6/l

0.36

135

Peripheral arterial reconstruction

1056

0.75

1.75

1.3

7.66

22.54

e6/l

1.35

814

Female infertility, cervical, vaginal, other or unspecified origin

312

1753

1.16

1.75

1.4

1.3

17.55

25.87

e6/l

0.52

236

1379

Other endocrine disorders

469

1.38

1.74

2.7

2.9

10.55

12.35

e6/l

0.12

343

Polypectomy (DHB20)

499

1.37

1.73

1.3

1.4

3.33

26.42

e6/l

1.25

394

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

323

1.47

1.73

2.6

2.5

3.26

17.94

e6/l

1.33

251

Presence of cardiac and vascular implants and grafts

323

2757

0.87

1.73

1.3

1.4

33.14

31.10

e6/l

0.03

266

2149

Glucosamine medication

434

3069

1.13

1.72

1.4

24.34

32.34

e6/l

0.35

340

2366

Other obstructive and reflux uropathy

323

1.47

1.72

1.2

1.6

6.21

34.27

e6/l

0.91

246

Single delivery by forceps and vacuum extractor

127

956

0.80

1.72

1.2

1.3

23.58

29.34

e6/l

0.15

728

Combinations of oral blood glucose lowering drugs

272

2339

1.17

1.72

1.4

1.3

32.15

31.46

e6/l

0.02

212

1809

Malignant neoplasm of bronchus and lung, including Hilmo

122

1277

0.80

1.72

1.2

1.4

28.80

25.06

e6/l

0.06

1006

Osteomyelitis

449

1.39

1.71

1.4

22.61

31.04

e6/l

0.19

360

Other disorders of the genitourinary system

116

919

1.27

1.71

1.4

1.3

119.51

32.18

e6/l

0.39

706

Prolonged pregnancy

124

1352

0.80

1.71

1.6

1.3

6.04

27.86

e6/l

1.63

100

1060

Other (seronegative) rheumatoid arthritis, wide

176

1459

1.21

1.70

1.2

1.4

30.33

24.18

e6/l

0.25

129

1139

Other pleural conditions

630

1.32

1.69

1.4

37.64

24.74

e6/l

0.17

495

Pituitary-dependent Cushing's disease

2.69

1.69

1.1

2.25

2.91

e6/l

—

Other or ill-defined heart diseases

391

1.42

1.69

2.3

1.4

42.69

21.53

e6/l

0.27

313

Malignant neoplasm of other connective and soft tissue

172

1.65

1.69

1.0

1.2

34.14

58.07

e6/l

0.22

137

Other acquired deformities of musculoskeletal system and connective tissue

333

1.45

1.69

1.3

1.4

5.87

20.94

e6/l

0.85

256

Follicular cysts of skin and subcutaneous tissue

188

1571

1.20

1.68

1.6

1.4

18.24

24.30

e6/l

0.26

160

1204

Disorders resulting from impaired renal tubular function

268

1.51

1.67

1.4

1.5

27.48

39.98

e6/l

0.16

204

Hypoplasia of dental enamel, prenatal

2.43

1.67

5.7

4.6

1.67

3.97

e6/l

—

Helminthiases

309

1.47

1.67

1.6

2.0

29.03

22.62

e6/l

0.18

241

Tumor necrosis factor alpha inhibitors

175

1454

1.21

1.67

1.4

1.5

110.86

25.80

e6/l

0.66

133

1116

Evidence of alcohol involvement determined by level of intoxication

1.96

1.67

1.4

8.55

8.74

e6/l

0.01

Endometriosis of rectovaginal septum and vagina

598

1.33

1.65

1.2

1.4

11.37

36.53

e6/l

1.02

475

Granulomatous disorders of skin and subcutaneous tissue

173

1.64

1.65

1.4

1.2

20.77

9.23

e6/l

0.25

137

Glomerular disorders in diseases classified elsewhere

111

880

1.27

1.64

1.5

1.4

18.74

24.21

e6/l

0.19

687

Other sexually transmitted chlamydial diseases

117

934

1.26

1.63

1.4

27.14

19.79

e6/l

0.31

722

Retinal haemorrhage

158

1.66

1.63

2.7

1.2

5.45

32.13

e6/l

0.73

126

Chromosomal abnormalities, not elsewhere classified

197

1.59

1.63

1.5

3.7

4.14

10.58

e6/l

0.70

140

Lesion of sciatic nerve

237

1.53

1.63

1.2

7.97

11.69

e6/l

0.28

188

Pedestrian injured in collision with car, pick-up truck or van

166

1.64

1.63

1.2

1.67

11.79

e6/l

1.61

135

Haemangioma, any site

679

1.30

1.62

1.4

1.6

20.90

26.60

e6/l

0.14

523

Malignant neoplasm of accessory sinuses, including Hilmo

2.57

1.62

1.6

1.2

68.00

5.88

e6/l

—

Lichen planus

124

998

1.25

1.62

1.4

25.33

28.79

e6/l

0.08

759

AV-block

157

1133

1.22

1.61

1.2

1.5

14.24

15.29

e6/l

0.04

127

890

Myocardial infarction, unclassifiable

111

1241

0.80

1.61

1.3

4.98

21.24

e6/l

2.16

969

Pedal cyclist injured in other and unspecified transport accidents

117

936

1.26

1.61

1.4

9.59

24.82

e6/l

1.17

720

Special screening examination for neoplasms

303

1.46

1.61

1.3

1.4

7.90

22.00

e6/l

0.63

216

Female infertility

338

1795

1.15

1.61

1.4

1.3

16.82

25.67

e6/l

0.62

257

1415

Hip and thigh

3.13

1.61

2.5

1.1

1.00

2.80

e6/l

—

Superficial injury of ankle and foot

136

1107

1.23

1.60

1.7

104.90

25.44

e6/l

0.44

109

846

Sequelae of infectious and parasitic diseases

532

1.34

1.60

1.7

1.4

24.61

28.73

e6/l

0.09

409

Intestinal adhesions without obstruction

593

1.32

1.59

1.4

1.5

14.98

28.36

e6/l

0.50

459

Suggestive for eosinophilic asthma

698

1.30

1.59

1.3

49.24

25.32

e6/l

0.28

538

COPD, hospital admissions 1, only main diagnosis

223

2235

0.85

1.59

1.4

30.07

29.58

e6/l

0.01

179

1728

LSIL lesion of the cervix uteri, vagina or vulva

159

1316

1.21

1.59

1.4

1.3

56.21

23.75

e6/l

0.68

120

1013

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

185

1504

1.20

1.59

1.4

1.9

4.68

23.29

e6/l

3.58

139

1145

Melanoma in situ

296

1.47

1.59

1.0

1.3

10.55

39.02

e6/l

0.77

235

5-aminosalicylic acid

223

1903

1.18

1.58

1.4

76.36

22.89

e6/l

0.50

170

1448

Disorder of external ear, unspecified

231

1.53

1.58

1.2

1.4

5.10

45.32

e6/l

0.90

180

Other disorders of breast

131

1064

1.24

1.58

1.3

6.64

34.16

e6/l

1.53

102

795

Burns and corrosions of multiple and unspecified body regions

152

1.66

1.58

3.0

1.4

19.00

10.13

e6/l

0.20

120

Inflammatory bowel disease, strict (require KELA)

257

2219

1.16

1.58

1.5

1.4

62.12

25.39

e6/l

0.37

196

1704

Congenital malformations of spine and bony thorax

2.16

1.57

1.3

3.1

1.08

8.02

e6/l

0.76

Bronchitis, not specified as acute or chronic

638

1.31

1.57

1.2

1.4

6.19

24.30

e6/l

1.11

490

Bacterial, viral and other infectious agents

735

1.29

1.57

1.4

1.6

6.11

27.70

e6/l

1.62

563

Intercostal neuropathy

2.32

1.57

1.1

1.3

4.40

4.21

e6/l

—

Umbilical hernia

274

2378

1.16

1.57

1.4

15.89

25.76

e6/l

0.47

206

1824

Congenital malformations of the musculoskeletal system, not elsewhere classified

145

1.68

1.56

1.3

2.0

3.35

11.88

e6/l

0.90

110

Amiodarone users

682

0.71

1.56

1.4

47.34

22.72

e6/l

0.40

532

Ankyloglossia

168

1.63

1.55

2.6

3.5

5.76

5.90

e6/l

0.02

121

Inflammatory disorders of breast

544

1.33

1.55

1.2

1.3

5.14

20.91

e6/l

2.25

411

Dissocial personality disorder

100

1.82

1.54

2.9

1.2

6.50

18.77

e6/l

0.66

All dysplastic lesions of the vulva

323

1.44

1.54

2.0

1.4

22.29

12.43

e6/l

0.26

244

Benign neoplasm: Rectum

160

1332

1.21

1.52

1.3

47.06

23.85

e6/l

0.40

108

1020

Diabetes mellitus in pregnancy

381

2161

1.13

1.52

1.3

23.21

27.84

e6/l

0.20

297

1670

Papillary adenocarcinoma of thyroid gland

383

1.39

1.52

1.4

1.3

53.63

18.12

e6/l

0.68

299

Separation of retinal layers (serosa)

308

1.44

1.50

1.2

1.3

270.79

40.14

e6/l

0.40

237

Maternal care for known or suspected abnormality of pelvic organs

291

1727

1.15

1.50

1.3

29.12

26.99

e6/l

0.07

229

1342

Endometriosis diagnosis and infertility diagnosis occurring together

119

963

1.24

1.50

1.4

1.3

20.30

22.88

e6/l

0.09

754

Premature rupture of membranes

187

1581

0.84

1.50

1.3

19.75

26.45

e6/l

0.27

147

1229

Family history of certain disabilities and chronic diseases leading to disablement

401

1.38

1.50

1.3

1.4

100.49

20.97

e6/l

0.40

310

Hirsutism in women

147

1.65

1.49

1.2

1.3

28.28

5.47

e6/l

0.67

116

Peritonsillar abscess

227

1953

1.17

1.48

1.4

31.50

23.72

e6/l

0.21

177

1501

Assault by unspecified means

163

1.61

1.48

1.3

1.5

10.00

15.36

e6/l

0.25

128

Pedal cyclist injured in transport accident

236

2037

1.16

1.48

1.4

1.5

16.57

22.88

e6/l

0.35

179

1566

Other and unspecified psoriasis

488

1.34

1.47

1.3

1.5

9.00

29.01

e6/l

0.88

372

Retinal breaks without detachment

151

1255

1.21

1.47

1.2

1.4

36.37

34.08

e6/l

0.04

111

955

Congenital deformities of feet

195

1.55

1.47

1.6

1.9

2.83

9.97

e6/l

0.92

145

Molar incisor enamel hypoplasia

347

1.40

1.47

7.1

2.7

4.34

13.80

e6/l

0.74

257

Sulfonylureas

215

1994

0.86

1.46

1.4

1.3

25.25

29.75

e6/l

0.12

166

1555

Benign neoplasm: Choroid

446

1.35

1.46

1.6

1.4

8.02

31.74

e6/l

1.02

348

Other predominantly sexually transmitted diseases, not elsewhere classified

194

1651

1.18

1.46

1.4

1.3

19.62

23.48

e6/l

0.23

146

1272

Assault by other specified means

1.95

1.45

1.1

1.2

1.00

10.22

e6/l

—

Congenital hypothyroidism without goiter

2.37

1.45

1.2

2.1

3.11

2.83

e6/l

—

Gout, idiopatic and unspecified

209

1791

1.17

1.44

1.4

1.3

84.25

22.10

e6/l

0.54

157

1395

Abnormal findings on examination of urine, without diagnosis

311

1.43

1.44

1.5

1.6

96.21

38.66

e6/l

0.41

242

Sequelae of other and unspecified infectious and parasitic diseases

413

1.36

1.43

1.7

1.4

31.58

23.12

e6/l

0.20

316

Personal history of malignant neoplasm

534

1.32

1.43

4.2

1.5

13.45

18.74

e6/l

0.21

404

Psoriasis

285

2501

1.14

1.42

1.2

1.4

17.93

32.30

e6/l

0.97

210

1910

Multiple myeloma and malignant plasma cell neoplasms

295

1.43

1.42

1.5

1.3

9.88

39.20

e6/l

0.78

231

Malignant neoplasm of thyroid gland

500

1.33

1.42

1.5

1.3

43.83

28.34

e6/l

0.29

390

Bursitis of shoulder

149

1.63

1.42

2.5

1.3

3.00

28.55

e6/l

0.61

110

Primary open-angle glaucoma, strict

210

1800

1.17

1.40

1.5

1.3

15.97

33.45

e6/l

0.95

167

1405

Other disorders of conjunctiva

128

1053

1.22

1.40

1.2

1.4

9.00

24.11

e6/l

1.55

103

813

Nontoxic multinodular goitre

173

1464

1.19

1.40

1.3

1.4

36.37

34.85

e6/l

0.02

133

1131

Other abnormal products of conception

363

2137

1.13

1.40

1.2

1.4

27.11

30.50

e6/l

0.13

276

1657

Carbimazole or st.post thyroidectomy, condition for graves disease

209

1797

1.17

1.39

1.5

1.3

54.07

31.26

e6/l

0.37

152

1379

Conductive hearing loss, unspecified

642

1.28

1.39

1.9

1.6

52.85

26.48

e6/l

0.42

492

Hereditary spherocytosis

2.71

1.39

1.5

1.1

0.50

3.00

e6/l

—

Other misadventures during surgical and medical care

174

1.57

1.38

1.3

6.67

10.27

e6/l

0.29

130

Melanocytic naevi, other sites/unspecified

643

1.28

1.38

1.2

1.4

19.19

28.83

e6/l

0.21

495

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

3.05

1.38

2.0

1.0

4.20

4.64

e6/l

—

Ventral hernia

220

1902

1.16

1.37

1.4

15.70

22.75

e6/l

0.40

176

1462

Other specified disorders of kidney and ureter

223

1.49

1.37

1.4

1.5

99.67

37.68

e6/l

0.49

170

Adjustment and management of implanted device

140

1165

1.21

1.37

1.2

1.4

6.66

20.94

e6/l

1.69

105

907

Haemangioma and lymphangioma, any site

733

1.26

1.36

1.4

1.6

20.70

26.14

e6/l

0.14

565

Palmar fascial fibromatosis [Dupuytren]

119

975

1.22

1.36

1.4

1.3

74.82

25.60

e6/l

0.62

752

Melanocytic naevi of lower limb, including hip

349

1.39

1.36

1.4

1.6

19.27

21.96

e6/l

0.06

270

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

193

1604

1.17

1.35

1.4

1.9

4.90

24.81

e6/l

3.88

145

1217

Malignant neoplasm of colon, including Hilmo

107

1312

0.81

1.35

1.4

16.78

24.58

e6/l

0.29

1042

Endometriosis ASRM stages 3,4

235

2044

1.15

1.35

1.3

32.40

29.52

e6/l

0.06

189

1578

Carcinoma in situ of breast

0.00

1.35

0.0

1.1

—

2.23

—

Postpartum haemorrhage due to anatomy

991

0.78

1.35

1.2

1.3

16.74

21.59

e6/l

0.19

772

Complications following myocardial infarction

0.00

1.35

0.0

1.2

—

85.24

—

Unspecified human immunodeficiency virus [HIV] disease

1.95

1.35

2.5

1.4

31.13

7.53

e6/l

—

Pre-eclampsia

216

1868

1.16

1.35

1.2

1.3

28.61

37.40

e6/l

0.13

176

1436

Simple and mucopurulent chronic bronchitis

265

1.44

1.35

1.8

1.9

3.00

35.87

e6/l

0.87

213

Hallux rigidus

122

1004

1.22

1.34

1.2

1.4

43.00

22.65

e6/l

0.35

103

769

Macular pucker

128

1059

1.21

1.34

1.3

1.4

15.61

32.12

e6/l

1.01

808

Carcinoma in situ of breast, intraductal

639

0.73

1.33

1.4

1.3

48.46

22.15

e6/l

0.32

480

Malignant neoplasm of thyroid gland, including Hilmo

558

1.30

1.33

1.4

1.3

40.26

33.85

e6/l

0.12

437

Early onset COPD

206

1777

1.16

1.33

1.5

1.4

14.04

28.43

e6/l

1.16

161

1359

Benign neoplasm: Sigmoid colon

164

1389

1.18

1.33

1.5

1.3

37.36

26.27

e6/l

0.26

125

1060

Toxic liver disease

1.76

1.32

1.8

1.3

18.33

6.18

e6/l

0.45

L02BB Anti-androgens

510

0.70

1.31

1.3

6.08

32.08

e6/l

1.22

408

Deep endometriosis

764

1.25

1.31

1.2

1.3

11.13

23.46

e6/l

0.85

569

Female infertility, tubal origin

377

1.36

1.31

1.2

1.4

21.93

19.13

e6/l

0.06

296

Benign neoplasm: Transverse colon

782

1.25

1.31

1.7

1.3

6.57

23.13

e6/l

1.33

604

Other endophthalmitis

2.41

1.31

1.1

1.7

3.75

21.81

e6/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

659

4807

1.09

1.30

1.3

53.30

27.06

e6/l

0.63

501

3716

Endometriosis of ovary

177

1475

1.17

1.30

1.4

1.3

42.91

24.50

e6/l

0.36

138

1170

Oesophagitis

369

1.36

1.30

1.3

1.4

2.18

34.96

e6/l

1.31

286

Congenital dislocation of hip, unilateral

2.05

1.29

1.8

3.0

96.00

2.21

e6/l

—

Other diseases of peritoneum

310

1.40

1.29

1.3

1.5

1.61

44.32

e6/l

1.49

242

Other factor of the environment

1.81

1.28

1.7

1.2

115.13

10.33

e6/l

—

Benign neoplasm of ovary

157

1330

1.18

1.28

1.3

1.4

11.47

39.11

e6/l

1.61

113

1026

Pre-eclampsia or poor fetal growth

337

3002

1.12

1.28

1.2

1.3

29.71

e6/l

0.00

272

2320

Tularaemia

130

1.63

1.28

1.7

1.3

2.13

10.98

e6/l

0.90

100

Other diseases of stomach and duodenum

448

1.32

1.27

1.6

1.5

18.89

31.43

e6/l

0.26

344

Exposure to other specified electric current

186

1.52

1.27

1.2

1.6

12.00

10.69

e6/l

0.05

143

Gluteal tendinitis

252

1.44

1.27

1.5

1.4

26.07

23.75

e6/l

0.04

193

Other surgical follow-up care

219

1.47

1.26

1.1

1.7

95.52

49.77

e6/l

0.29

169

Flat foot [pes planus] (acquired)

714

1.25

1.26

1.4

1.5

143.83

20.07

e6/l

0.45

551

Injury of nerves at wrist and hand level

278

1.41

1.25

1.5

1.3

39.59

24.98

e6/l

0.25

217

Disorders of continuity of bone

769

1.24

1.25

1.6

1.4

5.36

30.39

e6/l

2.23

592

Benign neoplasm: Liver/bile ducts

187

1.51

1.25

1.5

1.6

39.35

9.33

e6/l

0.45

149

Ulcerative colitis, NAS

144

1215

1.19

1.24

1.3

1.5

23.32

23.69

e6/l

0.01

112

945

Congenital deformities of feet

304

1.39

1.24

1.5

1.9

4.47

12.37

e6/l

1.21

229

Other and unspecified nail disorders

147

1.58

1.24

1.3

1.4

6.06

8.77

e6/l

0.19

113

Infective dermatitis

106

869

1.22

1.24

1.4

44.41

23.04

e6/l

0.34

671

Intentional self-harm by smoke, fire and flames

2.75

1.23

1.4

0.20

1.69

e6/l

—

Marasmic kwashiorkor

2.73

1.23

1.6

1.9

602.80

2.50

e6/l

—

Primary open-angle glaucoma

252

2145

1.14

1.23

1.5

1.3

13.98

29.77

e6/l

1.07

203

1680

Nontoxic goitre/thyroid nodule

271

2401

1.13

1.21

1.3

1.4

27.48

30.87

e6/l

0.06

208

1855

Other and unspecified abdominal hernia

263

1.42

1.21

1.3

1.4

25.72

21.88

e6/l

0.06

210

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

585

1.27

1.20

1.8

1.4

17.31

28.43

e6/l

0.44

457

Sleepwalking [somnambulism]

2.38

1.20

1.3

2.2

0.33

2.37

e6/l

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

306

1.38

1.20

1.0

1.3

28.69

36.28

e6/l

0.10

242

Bicipital tendinitis

323

1.37

1.20

1.5

1.3

7.38

34.99

e6/l

0.80

247

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

1.76

1.20

1.3

1.67

3.30

e6/l

—

Hyperaldosteronism

206

1.47

1.18

2.0

1.5

10.77

24.74

e6/l

0.41

159

Complications associated with artificial fertilization

149

1.56

1.18

1.3

1.5

13.72

20.35

e6/l

0.27

122

Acquired haemolytic anaemia

157

1.54

1.18

1.3

4.73

5.30

e6/l

0.08

131

Bullous disorders

393

1.33

1.18

1.3

1.5

21.33

30.90

e6/l

0.17

307

Atrioventricular septal defect

0.00

1.17

0.0

4.3

—

3.35

—

Other menopausal disorders

293

1467

1.13

1.17

1.4

34.15

26.42

e6/l

0.22

215

1152

Malignant neoplasm of skin

480

3005

1.10

1.17

1.3

1.4

74.63

26.71

e6/l

0.71

360

2359

Contusion of toe(s) without damage to nail

182

1.50

1.16

2.0

1.5

17.11

11.65

e6/l

0.17

142

Other osteochondropathies

570

1.27

1.16

1.6

1.5

27.37

27.76

e6/l

0.01

437

Lichen ruber planus, wide definition including periferal and oral lichen planus

205

1790

1.15

1.16

1.3

1.4

21.23

36.02

e6/l

0.57

151

1384

Alopecia areata

207

1.46

1.16

1.1

1.7

14.65

3.73

e6/l

0.48

153

Laparoscopic right hemicolectomy

380

0.68

1.16

2.2

1.3

7.18

36.10

e6/l

1.06

293

Carcinoma in situ of skin of other and unspecified parts of face

473

1.30

1.16

1.3

23.64

28.85

e6/l

0.11

374

Atopic conjunctivitis

360

1.34

1.15

1.9

1.7

43.97

18.72

e6/l

0.27

279

Crohn's disease of large intestine

421

1.31

1.15

1.1

1.6

3.35

24.29

e6/l

1.83

331

Congenital deformities of hip

183

1.49

1.14

2.9

2.7

46.00

5.58

e6/l

0.64

137

Seborrhoeic dermatitis

706

1.24

1.14

1.5

1.4

9.15

18.62

e6/l

0.93

550

malignant neoplasm of male genital organs

206

1436

0.87

1.13

1.3

42.79

19.42

e6/l

0.33

154

1122

Nontoxic diffuse goitre

208

1.45

1.13

1.5

1.4

6.80

13.61

e6/l

0.52

157

Malignant neoplasm of prostate, including Hilmo

207

1407

0.87

1.13

1.3

46.12

18.59

e6/l

0.38

145

1103

Gout, unspecified

166

1431

1.16

1.13

1.4

1.3

34.70

18.99

e6/l

0.35

125

1109

Obstructed labour due to maternal pelvic abnormality

144

1228

1.18

1.12

1.3

17.15

50.80

e6/l

1.35

104

939

Other superficial mycoses

151

1.54

1.12

1.1

1.6

2.80

11.06

e6/l

1.05

120

Benign neoplasm of mouth and pharynx

816

1.22

1.12

1.3

1.4

21.50

23.68

e6/l

0.08

630

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

618

1.25

1.12

1.1

1.4

116.73

19.57

e6/l

0.66

474

Other aneurysm

362

1.33

1.12

2.0

1.4

20.53

34.46

e6/l

0.33

287

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

234

1.42

1.11

1.4

1.5

11.65

15.20

e6/l

0.19

188

Other and unspecified disorders of orbit

2.31

1.11

1.7

1.0

125.00

3.50

e6/l

—

Dislocation, sprain and strain of joints and ligaments of head

328

1.35

1.11

1.9

2.2

29.37

19.73

e6/l

0.22

257

Other renal tubulo-interstitial diseases

160

1.51

1.10

1.8

1.5

10.89

6.22

e6/l

0.24

130

Hair colour and hair shaft abnormalities

2.43

1.10

1.2

1.00

2.86

e6/l

—

Other bullous disorders

193

1.46

1.10

1.4

1.6

36.81

10.36

e6/l

0.37

149

Seropositive rheumatoid arthritis, wide

241

2137

1.13

1.10

1.2

1.4

28.64

31.89

e6/l

0.11

190

1664

Chalazion

109

910

1.20

1.09

1.3

1.4

22.30

23.58

e6/l

0.04

690

Injury of urinary and pelvic organs

136

1.56

1.09

1.8

1.4

1.75

11.68

e6/l

1.25

112

Myocardial infarction, with ST-elevation

1137

0.82

1.09

1.2

1.3

29.37

21.42

e6/l

0.17

873

Lichen planus, including avohilmo

174

1511

1.15

1.09

1.3

1.4

22.24

33.13

e6/l

0.34

131

1167

Ankylosing spondylitis, strict definition

338

1.34

1.08

1.5

1.4

31.63

13.53

e6/l

0.37

265

Congenital deformities of hip

169

1.50

1.08

3.0

2.7

51.87

3.80

e6/l

0.68

127

Certain conditions originating in the perinatal period

103

759

1.21

1.08

3.0

2.1

18.63

16.48

e6/l

0.07

577

Short stature, not elsewhere classified

234

1.40

1.08

4.0

4.5

9.42

14.86

e6/l

0.33

170

Contact with sharp glass

304

1.36

1.08

1.6

1.3

9.15

14.72

e6/l

0.44

236

Postpartum haemorrhage due to retained placenta

1146

0.83

1.07

1.5

1.3

35.34

22.22

e6/l

0.39

899

Hidradenitis suppurativa

287

1.37

1.07

1.2

1.3

71.52

20.21

e6/l

0.54

223

Abnormal spermatozoa

816

0.79

1.07

1.2

1.3

7.56

24.31

e6/l

1.07

626

Contact with other hot fluids

236

1.41

1.07

1.4

2.0

5.07

10.88

e6/l

0.74

173

LSIL lesion of the vulva

228

1.42

1.06

2.4

1.4

8.63

13.56

e6/l

0.35

171

Atrial septal defect

346

1.33

1.06

1.5

3.0

2.06

7.72

e6/l

1.81

263

Calculus of lower urinary tract

331

1.34

1.05

1.4

59.78

33.64

e6/l

0.30

256

Chronic nephritic syndrome

271

1.37

1.05

1.7

1.4

11.42

42.79

e6/l

0.72

210

Corneal scars and opacities

195

1.45

1.05

3.6

1.5

38.57

8.64

e6/l

0.57

153

Lactose intolerance, other/unspecified

195

1.45

1.05

1.2

1.7

1.65

8.18

e6/l

2.73

152

Unspecified parasitic disease

1.99

1.04

1.2

1.3

1.56

25.00

e6/l

—

Other benign neoplasms of connective and other soft tissue

760

1.22

1.04

1.4

33.93

28.63

e6/l

0.08

583

Graves disease, strict definition

100

833

1.21

1.04

1.7

1.3

17.00

19.90

e6/l

0.14

636

Other orthopaedic follow-up care

376

1.31

1.03

1.2

1.5

9.63

37.59

e6/l

0.95

290

Viral warts

816

1.21

1.03

1.3

1.6

23.14

26.92

e6/l

0.10

631

Puerperal sepsis

124

1056

1.18

1.01

1.3

13.71

37.10

e6/l

0.97

799

Polycystic ovarian syndrome, broad definition

123

1047

1.18

1.01

1.2

1.3

5.86

19.58

e6/l

2.87

819

Accidental poisoning by and exposure to alcohol

139

1.53

1.01

1.3

1.2

34.73

11.37

e6/l

0.32

105

Malignant neoplasm of small intestine

139

1.52

1.01

1.5

1.2

12.13

32.70

e6/l

0.42

113

HSIL lesion of the vulva

131

1.54

1.01

1.2

1.4

36.73

4.98

e6/l

0.41

Torsion of testis

139

1.52

1.01

1.3

2.1

81.57

18.74

e6/l

0.36

106

Hypoparathyroidism

248

1.38

1.00

1.4

1.5

10.67

17.17

e6/l

0.29

188

Iron deficiency anaemia secondary to blood loss (chronic)

135

1159

1.17

1.00

1.5

1.4

13.06

25.48

e6/l

0.74

103

892

Lichen simplex chronicus and prurigo

440

1.28

1.00

1.5

1.3

78.12

20.52

e6/l

0.45

341

Spermatocele

440

1.28

0.99

1.6

1.3

21.69

26.46

e6/l

0.11

346

Benign neoplasm of major salivary glands

719

1.21

0.99

1.3

1.4

21.28

26.03

e6/l

0.15

553

LSIL lesion of the cervix uteri

125

1068

1.17

0.99

1.2

1.3

68.65

21.35

e6/l

0.81

827

Benign neoplasm: Ascending colon

115

976

1.18

0.98

1.4

28.92

25.36

e6/l

0.08

745

Other congenital malformations of the digestive system

394

1.29

0.98

2.8

14.73

17.63

e6/l

0.07

298

Neuroendocrine tumor and carcinoma of stomach

0.00

0.98

0.0

1.3

—

2.42

—

Other and unspecified papulosquamous disorders

1.97

0.98

1.4

1.3

1.00

3.68

e6/l

—

Lung transplant status

1.88

0.98

2.1

1.9

6.20

9.61

e6/l

—

Lung transplantation

1.88

0.98

2.1

1.9

6.20

9.61

e6/l

—

Valvular operations

1057

0.83

0.98

1.2

1.6

265.15

16.18

e6/l

0.95

807

Dilated cardiomyopathy

827

0.81

0.97

1.4

103.75

21.09

e6/l

0.45

645

Other noninfective disorders of lymphatic vessels and lymph nodes

258

1.37

0.97

1.2

1.5

165.67

9.85

e6/l

0.64

204

Bronchiectasis

522

1.25

0.97

1.2

1.5

9.85

25.25

e6/l

0.70

413

Exposure to other and unspecified animate mechanical forces

224

1.39

0.97

1.2

1.6

43.87

7.11

e6/l

0.45

174

Lactose intolerance

224

1.39

0.97

1.4

1.7

4.69

7.51

e6/l

0.44

178

Other inflammation of vagina/vulva

293

1.34

0.96

1.2

1.5

3.13

19.76

e6/l

1.45

229

Vasomotor rhinitis (mode)

559

1.24

0.96

1.5

1.4

26.86

29.03

e6/l

0.05

426

All dysplastic lesions of the cervix uteri, vagina or vulva

320

2866

1.10

0.96

1.3

72.53

20.39

e6/l

0.69

245

2220

Other and/or unspecified nontoxic goitre

568

1.24

0.96

1.3

1.4

9.76

28.32

e6/l

1.22

426

Burn and corrosion confined to eye and adnexa

174

1.45

0.96

1.2

1.6

7.20

5.64

e6/l

0.19

134

Hypertensive heart and/or renal disease

206

1362

1.13

0.95

1.3

1.4

32.53

23.58

e6/l

0.15

175

1060

Carcinoma in situ of skin of scalp and neck

141

1.50

0.95

1.3

1.2

8.63

62.95

e6/l

0.74

116

Type1 diabetes, definitions combined, early onset

644

0.79

0.95

2.0

2.3

43.73

16.72

e6/l

0.76

502

Chronic periodontitis, complicated

553

5102

1.08

0.95

1.4

14.97

32.81

e6/l

2.22

402

3952

Postmenopausal bleeding

257

1228

1.12

0.95

1.3

1.4

18.40

27.17

e6/l

0.54

189

966

Maternal care for cervical incompetence

294

1.34

0.95

1.5

1.3

4.16

21.31

e6/l

1.35

221

Acute epiglottitis

1.63

0.94

1.3

1.2

23.89

5.32

e6/l

—

Infective bursitis

183

1.43

0.94

1.3

9.75

52.06

e6/l

0.68

141

Benign neoplasm: salivary glands, exclude unknown (D119)

651

1.22

0.94

1.3

1.4

14.81

27.02

e6/l

0.55

502

Hypertensive Heart Disease

184

1270

1.14

0.94

1.3

1.4

36.77

24.08

e6/l

0.20

155

986

Ectropion of eyelid

200

1.41

0.93

1.3

124.20

39.29

e6/l

0.30

160

Burn and corrosion of wrist and hand

286

1.34

0.93

1.3

1.5

13.73

11.48

e6/l

0.09

222

Gestational diabetes (for exclusion)

423

2709

1.09

0.93

1.3

17.04

26.66

e6/l

0.79

328

2109

Idiopathic urticaria

167

1.45

0.93

1.2

1.7

33.26

12.81

e6/l

0.27

130

Primary adrenocortical insufficiency

1.69

0.92

1.3

1.2

84.38

6.64

e6/l

—

Viral agents as the cause of diseases classified to other chapters

184

1.42

0.92

1.2

1.6

11.38

9.59

e6/l

0.08

146

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

653

1.21

0.92

1.4

1.3

21.41

22.21

e6/l

0.03

510

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

126

1086

1.16

0.91

1.3

1.4

18.54

27.67

e6/l

0.35

831

Hypoplasia of dental enamel , including avohilmo

330

1.30

0.91

7.9

2.6

4.67

14.31

e6/l

0.70

245

Subacute thyroiditis

253

1.35

0.90

1.4

1.5

97.44

13.94

e6/l

0.42

187

Donors of organs and tissues

102

0.49

0.90

1.8

1.2

6.40

8.87

e6/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

546

1.23

0.90

1.8

1.9

13.08

20.37

e6/l

0.40

408

Injury of muscle and tendon at lower leg level

140

1218

1.15

0.90

1.3

1.4

17.01

21.52

e6/l

0.21

103

941

Rhinophyma

2.10

0.90

1.8

1.3

1.17

5.95

e6/l

—

Single delivery by caesarean section

172

1120

0.88

0.89

1.6

1.3

41.89

28.97

e6/l

0.29

139

842

Contusion of ankle

306

1.31

0.89

2.1

1.7

303.50

12.77

e6/l

0.52

230

Hallux valgus (acquired)

317

2078

1.10

0.89

1.5

1.4

67.93

30.69

e6/l

0.46

260

1583

Desensitization to allergens

472

0.76

0.88

1.4

1.9

27.96

18.20

e6/l

0.14

370

Follow-up examination after treatment for malignant neoplasms

529

1.23

0.88

1.6

1.4

16.92

27.56

e6/l

0.34

392

Glucagon-like peptide-1 (GLP-1) analogues

288

2620

1.10

0.88

1.4

1.3

11.92

39.01

e6/l

2.53

226

2017

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

288

2620

1.10

0.88

1.4

1.3

11.92

39.01

e6/l

2.53

226

2017

Foreign body in respiratory tract

395

1.27

0.88

2.4

1.7

24.28

32.71

e6/l

0.13

297

Fibrosis of liver

1.89

0.88

2.3

1.4

28.63

5.38

e6/l

—

Postpartum care and examination

159

882

1.14

0.88

1.3

1.2

34.09

31.98

e6/l

0.04

129

668

Effects of heat and light

1.89

0.88

1.4

1.0

4.75

3.06

e6/l

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

2.04

0.88

1.5

1.3

11.33

2.62

e6/l

—

Injury of intra-abdominal organs

186

1.41

0.88

1.7

1.4

1.95

15.45

e6/l

1.74

150

Hypoplasia of dental enamel, prenatal , including avohilmo

1.72

0.88

5.3

1.71

3.35

e6/l

—

Spontaneous rupture of synovium and tendon

557

1.22

0.87

1.4

1.3

14.35

30.75

e6/l

0.62

416

Anoxic brain damage

1.73

0.86

1.3

1.2

1.73

9.04

e6/l

0.96

Use of ropinirole

264

1.34

0.86

1.3

2.59

44.11

e6/l

1.12

204

Total colectomy

299

1.31

0.86

1.1

1.6

51.28

22.44

e6/l

0.28

232

Total colectomy operation

299

1.31

0.86

1.1

1.6

51.28

22.44

e6/l

0.28

232

Primary hyperparathyroidism

787

1.19

0.86

1.2

1.4

18.75

34.65

e6/l

0.60

595

Spondylopathies in diseases classified elsewhere

1.69

0.86

1.3

27.50

60.85

e6/l

—

Lifestyle-related condition

1.64

0.85

1.8

1.2

131.57

2.38

e6/l

—

Other bursitis of hip

112

1.53

0.85

1.2

1.3

3.64

44.38

e6/l

0.74

Contraceptive management

474

3089

1.08

0.85

1.3

1.4

29.19

37.49

e6/l

0.34

389

2327

Varicose veins of other sites

496

1.24

0.85

1.2

1.6

11.48

28.78

e6/l

0.66

383

Unspecified jaundice

291

1.31

0.85

1.1

1.6

13.45

42.61

e6/l

0.77

233

Congenital malformations of heart and great arteries

138

1169

1.15

0.84

1.5

2.1

5.58

22.95

e6/l

2.20

106

889

Benign neoplasm: Parotid gland

578

1.22

0.84

1.3

1.4

16.30

26.45

e6/l

0.37

447

Other disorders of prostate

179

1.40

0.84

1.4

1.3

4.85

28.85

e6/l

0.79

146

Foreign body entering into or through eye or natural orifice

679

1.20

0.84

1.8

1.7

64.23

23.76

e6/l

0.41

520

Postpartum haemorrhage

240

2232

0.90

0.83

1.3

29.48

27.07

e6/l

0.07

190

1731

Congenital nasolacrimal duct obstruction or stenosis

1.77

0.83

3.1

4.3

1.50

3.30

e6/l

—

Emphysema

470

1.24

0.83

1.6

1.4

5.86

26.05

e6/l

0.92

371

Disorder of pancreatic internal secretion, other and/or unspecified

1.76

0.83

1.4

1.3

67.37

3.68

e6/l

—

Supervision of high-risk pregnancy

231

1251

1.11

0.83

1.2

1.3

30.76

30.28

e6/l

0.01

177

946

Degeneration of macula and posterior pole

402

2959

1.08

0.83

1.3

1.4

41.10

33.26

e6/l

0.10

294

2317

Malignant neoplasm of corpus uteri, including Hilmo

623

0.80

0.83

1.4

6.61

21.07

e6/l

1.43

482

Other blood glucose lowering drugs, excl. Insulins

133

1163

1.15

0.82

1.6

1.3

17.48

26.60

e6/l

0.42

100

886

Other congenital malformations of the digestive system

459

1.24

0.82

2.6

2.7

13.90

30.13

e6/l

0.44

339

Maternal care related to the fetus and amniotic cavity and possible delivery problems

503

2752

1.07

0.82

1.4

1.3

20.80

32.06

e6/l

0.73

393

2105

Gonarthrosis, primary, with knee surgery

469

4005

0.93

0.82

1.4

27.97

29.35

e6/l

0.04

352

3110

Fall on and from ladder

544

1.22

0.81

1.2

1.3

6.20

25.38

e6/l

1.03

427

Tuberculosis

355

1.27

0.81

1.5

1.3

29.41

35.80

e6/l

0.11

283

Open wound of shoulder and upper arm

130

1.47

0.81

1.2

1.3

10.29

12.31

e6/l

0.10

105

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.81

0.0

4.5

—

4.56

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

283

0.70

0.81

1.3

1.85

36.04

e6/l

1.03

232

Other disorders of veins

400

3688

1.08

0.81

1.3

1.4

23.96

32.18

e6/l

0.44

285

2856

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

231

2091

1.11

0.80

1.3

1.4

29.82

31.98

e6/l

0.07

182

1624

Type 1 diabetes, strict definition, subgroup 2

0.00

0.80

0.0

5.5

—

2.67

—

Other/unspecified seropositive rheumatoid arthritis

234

2120

1.11

0.80

1.3

1.4

29.35

32.07

e6/l

0.09

185

1650

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.80

0.0

1.2

—

3.18

—

Adrenomedullary hyperfunction

0.00

0.80

0.0

1.1

—

2.72

—

Myeloproliferative diseases

591

1.21

0.80

1.5

1.4

29.33

26.75

e6/l

0.05

450

Chondrosarcoma, including Hilmo

1.85

0.80

1.7

1.3

294.83

3.42

e6/l

—

Use of antiglaucoma preparations and miotics

482

1.23

0.79

1.2

1.3

67.15

27.77

e6/l

0.26

379

Acute posthaemorrhagic anaemia

207

1.36

0.79

1.7

1.3

5.52

49.66

e6/l

0.93

169

Malignant neoplasm of vagina, including Hilmo

0.00

0.79

0.0

1.0

—

2.86

—

Coxarthrosis, primary, with hip surgery

351

3554

0.92

0.79

1.4

38.60

30.08

e6/l

0.19

267

2751

Respiratory tuberculosis

321

1.28

0.79

1.6

1.3

32.19

36.79

e6/l

0.07

253

Respiratory tuberculosis, confirmed and not-confirmed

321

1.28

0.79

1.6

1.3

32.19

36.79

e6/l

0.07

253

Chronic tubulo-interstitial nephritis

242

1.33

0.79

1.4

4.08

13.93

e6/l

1.34

190

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.78

0.0

4.7

—

11.16

—

Childhood allergy (age < 16)

177

1302

1.12

0.78

1.8

1.9

16.04

20.36

e6/l

0.29

144

992

Interstitial cystitis (chronic), drug-induced

0.00

0.78

0.0

1.0

—

1.30

—

Skin changes due to chronic exposure to nonionizing radiation

307

2601

1.09

0.78

1.3

28.70

31.40

e6/l

0.07

230

2044

Maternal care for known or suspected malpresentation of fetus

167

1357

0.89

0.77

1.3

25.27

26.77

e6/l

0.04

128

1061

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

115

1.49

0.77

2.1

1.3

34.00

70.74

e6/l

—

Mumps

174

1.39

0.77

1.3

1.4

14.40

11.16

e6/l

0.15

135

Paget disease

0.00

0.77

0.0

1.1

—

11.82

—

Other mycoses, not elsewhere classified/unspecified

107

1.51

0.76

1.7

1.3

7.00

15.08

e6/l

0.54

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

494

1.22

0.76

1.6

1.4

17.26

27.08

e6/l

0.26

384

Labour and delivery complicated by fetal stress [distress]

239

1721

0.91

0.76

1.2

1.3

15.91

26.55

e6/l

0.65

187

1349

Congenital malformations of the musculoskeletal system, not elsewhere classified

124

1.47

0.76

1.3

2.2

1.23

7.17

e6/l

1.62

Gout, strict definition

138

1218

1.14

0.76

1.3

121.37

19.54

e6/l

0.61

104

953

Other diseases of appendix

1.62

0.75

1.1

74.43

3.09

e6/l

—

Cyst of kidney

504

1.22

0.75

1.3

1.4

41.22

30.22

e6/l

0.15

387

Toxic effect of other noxious substances eaten as food

2.12

0.75

1.2

1.0

1.60

3.44

e6/l

—

Contact with sharp object, undetermined intent

175

1.38

0.75

1.4

7.47

10.35

e6/l

0.18

134

Gout due to impairment of renal function

1.68

0.75

1.0

1.2

0.56

8.86

e6/l

—

Disorders of eyelid in diseases classified elsewhere

227

1.33

0.75

1.4

5.95

12.29

e6/l

0.52

181

Anisometropia and aniseikonia

236

1.32

0.74

1.8

12.30

13.26

e6/l

0.04

173

Benign neoplasm: Ill-defined sites within the digestive system

1.87

0.74

1.1

0.57

2.41

e6/l

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.87

0.74

3.3

2.1

28.29

10.77

e6/l

—

Mantle cell lymphoma

1.65

0.74

1.2

1.3

12.22

139.04

e6/l

—

Non-small cell lung cancer, including Hilmo

986

0.86

0.74

1.2

1.3

5.93

25.87

e6/l

1.87

777

Wet age-related macular degeneration

952

0.85

0.73

1.5

1.3

137.61

27.80

e6/l

0.39

741

Male infertility

352

1.26

0.73

1.5

34.97

26.49

e6/l

0.13

272

Arthropathic psoriasis

106

922

1.15

0.73

1.3

1.4

26.41

24.10

e6/l

0.06

711

Idiopathic gout

616

1.19

0.73

1.2

1.3

168.54

19.71

e6/l

0.47

492

Medical treatment for female infertility

192

2111

0.90

0.73

1.4

1.3

24.89

25.49

e6/l

0.02

151

1657

Other diseases of gallbladder

281

1.29

0.73

1.4

1.3

19.93

37.65

e6/l

0.28

224

Family history of malignant neoplasm

958

0.85

0.72

1.3

6.53

33.79

e6/l

3.01

737

Diseases caused by chlamydiae

117

1.47

0.72

1.1

1.5

1.33

10.27

e6/l

1.16

Other and unspecified nonscarring hair loss

1.60

0.72

1.2

1.1

4.44

2.34

e6/l

—

Acute nephritic syndrome

134

1.43

0.71

1.5

1.3

3.86

11.96

e6/l

0.80

107

Sudden idiopathic hearing loss

730

1.17

0.70

1.6

1.4

51.00

22.17

e6/l

0.35

561

conjunctival haemorrhage

546

1.19

0.69

1.2

1.5

3.49

23.82

e6/l

1.38

424

Injury of blood vessels at abdomen, lower back and pelvis level

1.88

0.69

2.4

1.4

1.40

3.57

e6/l

—

Drowning and submersion while in natural water

1.88

0.69

1.0

1.4

4.20

2.76

e6/l

—

Psoriatic arthropathies, ICD10

100

871

1.15

0.69

1.3

1.4

26.33

23.93

e6/l

0.06

667

Congenital malformations of aortic and mitral valves

341

0.76

0.68

1.6

2.2

4.00

37.41

e6/l

1.15

258

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

397

0.78

0.68

1.2

1.3

2.00

27.56

e6/l

1.07

320

ILD, hospital admissions

115

1013

1.14

0.67

1.2

1.3

16.69

24.49

e6/l

0.31

784

Alcohol-induced acute pancreatitis

258

1.29

0.67

1.2

1.3

12.61

40.50

e6/l

0.62

204

COPD, early/later onset

343

3104

0.93

0.67

1.4

25.97

34.81

e6/l

0.28

262

2427

Toxic colitis

1.82

0.67

1.6

1.5

4.00

2.50

e6/l

—

Corns and callosities

475

1.20

0.67

1.8

1.4

12.22

31.75

e6/l

0.72

373

Abnormalities of forces of labour

907

0.86

0.66

1.1

1.3

9.06

40.51

e6/l

1.43

695

Other disorders of pigmentation

303

1.26

0.66

1.1

1.3

9.28

17.31

e6/l

0.54

239

Contact with nonpowered hand tool

330

1.25

0.66

1.0

1.4

26.18

35.00

e6/l

0.14

256

COPD, hospital admissions

340

3085

0.93

0.66

1.4

25.32

32.97

e6/l

0.23

260

2410

Major anomalies of jaw size

206

1.32

0.66

1.3

1.9

4.00

6.51

e6/l

0.43

161

Tooth eruption problems

159

1396

1.11

0.65

2.5

1.7

22.42

18.32

e6/l

0.15

121

1075

Other chronic obstructive pulmonary disease, including avohilmo

429

3774

0.94

0.65

1.4

24.90

31.46

e6/l

0.25

329

2950

Abnormal findings in secretions and smears from cervix uteri vagina vulva

545

3892

1.06

0.65

1.3

1.4

51.65

27.60

e6/l

0.49

420

3012

Normotensive glaucoma

559

1.18

0.65

1.4

1.3

22.21

30.68

e6/l

0.19

430

Other respiratory diseases principally affecting the interstitium

138

1233

1.12

0.65

1.2

1.4

76.39

23.66

e6/l

0.51

946

Cardiomyopathy (excluding other)

948

0.86

0.65

1.5

91.44

20.09

e6/l

0.47

726

Abscess of Bartholin gland

224

1.30

0.65

1.1

1.4

4.73

12.15

e6/l

1.04

171

Impacted teeth

183

1792

0.91

0.65

1.6

1.5

15.21

21.34

e6/l

0.40

146

1384

Other congenital malformations of tongue, mouth and pharynx

145

1.39

0.65

4.1

3.8

2.93

6.58

e6/l

1.03

106

327

2789

1.08

0.65

1.4

27.33

30.10

e6/l

0.08

246

2192

Pneumothorax

486

1.20

0.65

1.4

1.3

6.79

27.83

e6/l

1.02

387

Malignant neoplasm of breast, ER-negative, including Hilmo

157

1658

0.90

0.64

1.4

26.12

33.18

e6/l

0.21

105

1302

Benign neoplasm: Colon, unspecified

207

1891

1.10

0.64

1.4

1.3

17.25

22.51

e6/l

0.35

169

1458

Disorders of sphingolipid metabolism and other lipid storage disorders

1.75

0.64

1.2

1.0

1.40

4.04

e6/l

—

Other and unspecified diseases of spleen

1.75

0.64

1.2

1.4

2.00

12.95

e6/l

—

Hypothermia

112

1.44

0.64

1.1

1.4

0.80

14.15

e6/l

—

Other and unspecified glaucoma

441

1.21

0.64

1.5

1.3

66.32

29.43

e6/l

0.25

345

Malignant neoplasm of oral cavity, including Hilmo

305

1.25

0.63

1.3

1.4

31.71

34.47

e6/l

0.04

244

Other specified/unspecified spondylopathies

129

1.40

0.63

1.2

1.3

13.30

37.83

e6/l

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

155

1.36

0.63

1.1

2.4

1.69

5.92

e6/l

1.71

118

Idiopathic pulmonary fibrosis

458

0.81

0.62

1.2

1.3

9.00

30.48

e6/l

0.87

362

Asthma and opportunity respiratory infection

315

1.24

0.62

1.3

1.4

7.70

35.35

e6/l

0.82

250

Use of selegiline

297

1.25

0.62

1.4

1.3

1.46

39.29

e6/l

1.18

232

Pediculosis, acariasis and other infestations

172

1561

1.10

0.62

1.2

1.5

11.72

23.66

e6/l

1.33

133

1191

Squamous cell neoplasms and carcinomas of the skin

442

1.20

0.62

1.3

1.97

35.11

e6/l

1.53

359

Cysts of oral region, not elsewhere classified

452

1.20

0.62

1.4

71.68

31.83

e6/l

0.33

349

Abscess of lung

1.47

0.62

4.2

1.7

126.00

14.29

e6/l

—

Presence of other devices

195

1775

1.10

0.61

1.5

1.3

12.16

25.03

e6/l

1.40

157

1392

Allergic colitis

244

1.28

0.61

1.8

3.7

0.74

12.21

e6/l

1.91

180

Other diseases of biliary tract

609

0.84

0.61

1.2

1.6

12.12

24.87

e6/l

0.57

476

Ectopic pregnancy

170

1544

1.10

0.61

1.3

12.07

46.72

e6/l

2.05

128

1188

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

719

1.15

0.61

1.4

1.3

3.21

25.57

e6/l

1.69

582

Malignant neoplasm of heart, mediastinum and pleura

1.49

0.61

2.3

1.3

41.88

87.86

e6/l

—

Malignant neoplasm of other and unspecified urinary organs

0.00

0.61

0.0

1.3

—

2.29

—

Mental and behavioural disorders due to tobacco

703

1.16

0.61

1.4

42.95

24.60

e6/l

0.32

544

Maternal care for known or suspected fetal abnormality and damage

170

1327

1.10

0.61

1.2

1.3

17.35

28.65

e6/l

0.43

117

1039

Pollen allergy

214

1940

1.09

0.61

1.3

1.8

14.97

23.80

e6/l

0.66

164

1489

Complications of labour and delivery

693

3671

1.05

0.61

1.3

1.4

17.86

34.17

e6/l

1.70

515

2840

Carcinoma in situ, bladder

221

0.72

0.60

1.9

1.3

16.82

44.20

e6/l

0.49

178

Thyroid crisis or storm

0.00

0.60

0.0

1.2

—

1.87

—

Smoking dependency

704

1.15

0.60

1.4

42.95

24.94

e6/l

0.32

543

Other protozoal intestinal diseases

148

1.36

0.60

1.2

1.7

37.14

10.60

e6/l

0.33

118

Actinic keratosis

292

2515

1.08

0.60

1.4

1.3

29.30

31.90

e6/l

0.06

219

1983

Monoarthritis, not elsewhere classified

308

1.24

0.60

1.2

1.4

3.74

8.33

e6/l

0.85

245

In situ neoplasms

341

3192

1.07

0.59

1.3

54.44

29.33

e6/l

0.29

252

2500

Pedal cyclist injured in noncollision transport accidents

112

996

1.13

0.59

1.3

1.6

25.92

24.96

e6/l

0.02

766

Disorders of iron metabolism

1.45

0.59

1.1

1.3

2.50

7.95

e6/l

—

Generalized pustular psoriasis

0.00

0.59

0.0

1.5

—

2.81

—

Malignant neoplasm of bladder, including Hilmo

741

0.86

0.58

1.4

1.3

17.19

22.02

e6/l

0.18

593

Haemorrhagic and haematological disorders of fetus and newborn

218

1.28

0.58

5.7

4.4

40.05

6.21

e6/l

0.42

155

Family history of other conditions

115

0.60

0.58

1.0

1.6

2.71

5.33

e6/l

—

Interstitial lung disease endpoints

115

1026

1.12

0.58

1.2

1.3

16.69

24.34

e6/l

0.30

795

Interstitial lung disease

115

1026

1.12

0.58

1.2

1.3

16.69

24.34

e6/l

0.30

795

Juvenile arthritis (FINNGEN)

398

0.80

0.58

1.4

2.3

28.71

14.09

e6/l

0.33

307

Other interstitial pulmonary diseases

115

1027

1.12

0.57

1.2

1.3

16.69

24.31

e6/l

0.30

796

Left ventricular outflow tract obstruction, narrow definition

419

0.81

0.57

1.6

2.4

3.31

32.03

e6/l

1.20

309

Other complications of labour and delivery, not elsewhere classified

106

1092

0.89

0.57

1.2

1.3

45.02

17.91

e6/l

0.81

858

Seropositive rheumatoid arthritis, strict definition

132

1189

1.11

0.57

1.2

1.3

22.78

25.49

e6/l

0.09

100

910

Myocardial infarction

411

3064

0.94

0.57

1.3

1.4

16.58

31.99

e6/l

1.21

330

2343

Benign neoplasm: Descending colon

503

1.18

0.56

1.2

1.4

5.12

29.12

e6/l

1.25

385

Toxic effect of alcohol

141

1.36

0.56

1.4

1.3

7.68

10.47

e6/l

0.14

109

Mandibular hypoplasia

1.47

0.56

1.1

2.1

1.88

2.79

e6/l

—

Type 1 diabetes, strict definition

773

0.86

0.56

1.4

2.0

32.72

17.79

e6/l

0.49

603

Other congenital malformations of tongue, mouth and pharynx

184

1.31

0.56

3.6

3.4

3.63

5.41

e6/l

0.44

133

Other psoriatic arthropathies

850

1.13

0.56

1.3

1.4

26.73

24.50

e6/l

0.06

650

Other and unspecified injuries of thorax

107

1.41

0.55

1.1

1.2

1.10

11.86

e6/l

—

Placenta praevia

395

0.81

0.55

1.6

1.3

8.88

23.02

e6/l

0.86

302

Rheumatic valve diseases

123

0.65

0.55

2.9

1.3

6.38

10.95

e6/l

—

Pediculosis, acariasis and other infestations

468

1.18

0.54

1.3

1.5

18.81

28.93

e6/l

0.28

362

Carcinoma in situ of other and unspecified sites

239

0.75

0.54

1.8

1.3

15.67

42.43

e6/l

0.51

188

Mucosal proctocolitis

124

1117

1.11

0.54

1.3

1.5

25.37

25.16

e6/l

0.00

862

D07AA Corticosteroids, weak (group I)

160

1458

1.10

0.54

1.7

1.8

21.69

23.85

e6/l

0.08

130

1118

Benign neoplasm: Small intestine

285

1.23

0.54

1.5

1.3

18.59

44.11

e6/l

0.53

221

Viral agents as the cause of diseases classified to other chapters

160

1.32

0.54

1.2

1.7

14.62

10.20

e6/l

0.16

126

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

160

1.32

0.54

1.0

1.3

17.63

59.19

e6/l

0.59

133

Multiple myeloma

160

1.32

0.54

1.0

1.3

17.63

59.19

e6/l

0.59

133

Artificial joint re-operation

469

1.18

0.53

1.3

273.02

31.82

e6/l

0.55

353

Sequelae of burns, corrosions and frostbite

1.56

0.53

8.2

1.1

58.67

2.85

e6/l

—

Mandibular retrognathia

576

0.85

0.53

2.1

1.7

2.12

18.64

e6/l

3.02

445

Other disorders of choroid

1.44

0.53

1.1

1.5

3.38

13.96

e6/l

—

Synovial cyst of popliteal space [Baker]

488

1.17

0.53

1.2

1.4

44.98

39.56

e6/l

0.08

367

Other obstructed labour

631

0.85

0.53

1.3

7.60

24.64

e6/l

1.73

484

Antepartum haemorrhage, not elsewhere classified

769

1.13

0.53

1.2

1.3

35.37

15.36

e6/l

0.86

592

Benign neoplasm: Pancreas

196

1.28

0.53

1.2

20.17

55.77

e6/l

0.53

154

Benign neoplasm of bone and articular cartilage

675

1.14

0.53

1.2

1.4

6.65

27.24

e6/l

1.44

517

Polyp of the female genital tract

309

1662

1.07

0.52

1.4

28.43

24.13

e6/l

0.19

228

1316

Occupational exposure to risk-factors

241

1.25

0.52

1.1

1.3

1.84

42.76

e6/l

1.02

192

Malignant neoplasm of breast, HER-negative

137

1479

0.91

0.52

1.5

1.4

26.51

34.33

e6/l

0.20

1171

Other diseases caused by chlamydiae

126

1.36

0.52

1.1

1.5

1.33

11.99

e6/l

1.45

101

Acne conglobata

1.51

0.52

1.0

2.1

3.17

7.97

e6/l

—

Bicuspidal aortic valve syndrome

281

0.78

0.51

1.7

4.06

44.00

e6/l

1.12

212

Other/unspecified rheumatoid arthritis

875

1.12

0.51

1.2

1.3

10.33

30.84

e6/l

1.68

676

Other nonscarring hair loss

1.48

0.51

1.2

1.1

3.64

2.29

e6/l

0.27

Malignant neoplasm of oesophagus, including Hilmo

225

0.75

0.51

1.1

1.3

19.73

45.55

e6/l

0.37

179

Malignant neoplasm of respiratory system and intrathoracic organs

135

1235

0.91

0.51

1.4

1.3

40.53

22.36

e6/l

0.39

971

Anomalies of dental arch relationship, including avohilmo

210

1756

1.08

0.50

2.3

1.6

12.56

25.57

e6/l

1.06

165

1326

180

1699

0.92

0.50

1.4

1.3

76.31

36.71

e6/l

0.27

137

1321

Open wound of hip and thigh

243

1.24

0.50

1.3

1.6

154.21

15.95

e6/l

0.62

190

Other disorders of Eustachian tube

216

1.26

0.49

1.3

1.4

4.09

14.59

e6/l

1.10

165

Benign neoplasm: Caecum

745

1.13

0.49

1.3

5.94

26.99

e6/l

1.74

569

Other disorders of skin and subcutaneous tissue, not elsewhere classified

119

1077

1.11

0.49

1.2

1.4

19.24

26.27

e6/l

0.17

841

Allergic contact dermatitis

127

1154

1.10

0.49

1.2

1.4

12.34

26.17

e6/l

1.13

104

881

Venous complications and haemorrhoids in the puerperium

1.41

0.48

1.3

1.2

21.57

3.07

e6/l

—

Disorders of parathyroid gland, other and/or unspecified

1.54

0.48

1.1

33.57

5.20

e6/l

—

Etanercept

521

1.16

0.48

1.2

1.6

23.38

16.02

e6/l

0.16

395

Acute alcohol intoxication ICD-9

217

1.25

0.48

1.2

1.3

14.71

46.49

e6/l

0.55

170

Contact with lifting and transmission devices, not elsewhere classified

128

1.34

0.48

1.6

1.3

33.33

36.11

e6/l

0.03

101

Thyrotoxicosis with toxic multinodular goitre

420

0.83

0.48

1.3

1.4

162.40

23.43

e6/l

0.40

318

Moderate mental retardation

1.47

0.47

2.3

2.9

4.43

3.26

e6/l

—

All dysplastic lesions of the cervix uteri

273

2544

1.07

0.47

1.2

1.3

82.08

20.63

e6/l

0.71

212

1961

Congenital malformations of great arteries

228

0.77

0.47

1.3

4.2

9.85

7.15

e6/l

0.14

165

Macular cyst

199

0.75

0.47

1.2

1.3

10.00

57.40

e6/l

—

156

Postpartum hemorraghe, parous women as controls

240

2182

0.93

0.46

1.3

29.48

22.83

e6/l

0.24

190

1701

Otosclerosis

542

1.15

0.46

1.5

1.4

23.44

30.90

e6/l

0.19

409

Nonischemic cardiomyopathy

696

0.87

0.46

1.4

1.5

97.79

23.50

e6/l

0.38

532

Injury of muscle and tendon at hip and thigh level

797

1.12

0.46

1.4

18.42

25.28

e6/l

0.27

611

Other juvenile arthritis

342

0.82

0.46

1.5

2.4

31.05

14.63

e6/l

0.35

268

Postpartum hemorraghe, all women as controls

240

2520

0.94

0.46

1.3

29.48

25.04

e6/l

0.14

190

1957

Unspecified urinary incontinence

627

1.13

0.46

1.5

1.4

11.04

22.08

e6/l

0.80

475

Perichondritis of external ear

103

1.37

0.45

1.4

1.3

2.11

12.95

e6/l

—

Other congenital malformations of face and neck

219

1.24

0.45

1.2

1.7

3.05

6.73

e6/l

0.80

172

Uterine polyps

769

0.88

0.45

1.2

1.4

36.86

31.34

e6/l

0.09

608

Ulcerative colitis (strict definition, all Crohn cases excluded)

116

1273

0.91

0.45

1.3

1.4

102.97

24.39

e6/l

0.38

978

Cardiomyopathies, Primary/intrinsic

906

0.89

0.45

1.5

92.84

16.43

e6/l

0.50

694

Aortic aneurysm

154

1636

0.92

0.44

1.5

1.3

9.83

24.46

e6/l

1.31

121

1274

Antenatal screening

220

1322

0.93

0.44

1.3

11.46

27.50

e6/l

0.78

168

995

Gingival hyperplasia

284

1.20

0.44

2.8

2.1

4.63

19.93

e6/l

0.74

219

Embedded and impacted teeth

270

2363

0.94

0.43

1.6

1.5

15.44

22.51

e6/l

0.53

216

1819

Inguinal hernia

608

3906

1.04

0.43

1.4

1.5

32.79

30.26

e6/l

0.08

478

3022

Other salmonella infections

303

1.19

0.43

1.7

1.6

3.29

21.28

e6/l

1.08

241

Motorcycle rider injured in noncollision transport accidents

230

1.22

0.42

1.1

1.6

8.39

18.31

e6/l

0.84

180

Other, unspecified and serous retinal detachments

221

1.23

0.42

1.6

1.4

1.86

48.92

e6/l

1.10

177

Melanocytic naevi of other and unspecified parts of face

462

1.15

0.42

1.5

1.4

24.44

39.08

e6/l

0.38

361

Colorectal neuroendocrine tumor and carcinoma

0.63

0.42

1.5

1.2

9.50

4.82

e6/l

—

Mild mental retardation

203

1.24

0.42

1.2

2.3

69.63

6.91

e6/l

0.75

156

Other disorders of skin and subcutaneous tissue related to radiation

0.00

0.42

0.0

1.2

—

4.22

—

Folliculitis decalvans

0.00

0.42

0.0

1.1

—

1.89

—

UC patients in KELA-register (code 208), prior to 1994

323

1.18

0.41

1.2

1.4

1.38

22.36

e6/l

1.34

247

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

286

1.19

0.41

1.5

1.4

30.07

40.18

e6/l

0.15

220

Multiple system atrophy (rare forms of Parkinsonism)

0.00

0.41

0.0

1.0

—

1.64

—

Pregnancy, childbirth and the puerperium

283

1395

1.06

0.41

1.4

13.44

34.42

e6/l

1.18

217

1076

Foreign body on external eye

140

1293

1.08

0.41

1.4

34.68

26.79

e6/l

0.12

107

991

Coxarthrosis, primary

535

4351

1.04

0.41

1.4

30.46

31.79

e6/l

0.04

413

3376

Rheumatic fever incl heart disease

172

0.75

0.41

2.2

1.2

4.62

27.08

e6/l

0.66

137

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

168

0.75

0.40

3.5

5.1

0.88

7.70

e6/l

—

122

Pustular psoriasis

358

0.84

0.40

1.2

1.5

3.36

21.96

e6/l

1.29

278

Juvenile osteochondrosis

250

1.20

0.40

2.0

1.5

5.50

9.73

e6/l

0.62

190

Other and unspecified cicatricial alopecia

0.00

0.40

0.0

1.0

—

3.15

—

Other disorders of amniotic fluid and membranes

140

1264

1.08

0.40

1.2

1.3

12.69

28.42

e6/l

0.81

109

989

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

390

1.16

0.39

1.6

1.3

17.97

31.19

e6/l

0.42

302

Changes in corneal membranes

0.00

0.39

0.0

1.0

—

2.86

—

Drug-induced gout

0.00

0.39

0.0

1.2

—

1.79

—

Benign leiomyoma with endometriosis

130

1200

1.09

0.39

1.3

1.4

56.71

31.34

e6/l

0.37

107

920

Unspecified chronic bronchitis

215

0.79

0.39

1.3

1.4

10.75

45.47

e6/l

0.64

172

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

178

1.24

0.39

1.2

1.3

6.13

54.27

e6/l

0.84

143

Chronic lymphocytic leukaemia

178

1.24

0.39

1.2

1.3

6.12

54.27

e6/l

0.84

143

Chronic lymphocytic leukaemia, helper endpoint

178

1.24

0.39

1.2

1.3

6.13

54.27

e6/l

0.84

143

Myelodysplastic syndrome, including Hilmo

178

1.24

0.39

1.1

1.3

8.71

51.18

e6/l

0.76

152

Inguinal hernia, bilateral

722

1.11

0.38

1.3

1.4

17.95

13.27

e6/l

0.21

559

Abnormality of red blood cells

1.40

0.38

1.2

1.8

1.00

2.54

e6/l

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

476

1.14

0.38

1.3

1.4

12.30

21.21

e6/l

0.43

367

Scabies

143

1327

1.08

0.38

1.2

1.6

10.27

24.00

e6/l

1.58

111

1006

Traction detachment of retina

1.33

0.38

1.4

1.1

12.56

16.54

e6/l

—

Multiple delivery

737

0.89

0.38

1.7

1.3

102.47

37.84

e6/l

0.36

549

Non-small cell lung cancer, adenocarcinoma, helper endpoint

387

0.85

0.37

1.2

1.3

5.84

34.26

e6/l

1.14

308

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

1.31

0.37

1.0

1.2

1.89

3.65

e6/l

—

Chronic laryngitis and laryngotracheitis

1071

0.91

0.37

1.4

20.42

25.15

e6/l

0.20

809

Pleural plaque with presence of asbestos

408

0.86

0.37

1.1

1.3

14.20

38.01

e6/l

0.69

326

COPD-related respiratory insufficiency

743

1.11

0.37

1.4

1.3

9.19

22.37

e6/l

0.81

579

Benign neoplasm of breast

955

0.91

0.36

1.3

14.83

24.14

e6/l

0.62

726

Whooping cough

1.47

0.36

1.5

1.0

17.00

2.94

e6/l

—

Inguinal or femoral hernia, bilateral

735

1.10

0.36

1.3

1.4

17.68

13.18

e6/l

0.20

570

Abrasion of teeth

302

3168

0.95

0.36

1.3

1.4

13.20

33.92

e6/l

2.12

216

2436

Respiratory tuberculosis, not confirmed

226

1.20

0.36

1.6

1.2

27.21

48.83

e6/l

0.25

178

Hepatocellular carcinoma, including Hilmo

179

0.78

0.35

1.3

0.89

48.45

e6/l

—

146

Carcinoma in situ of skin of trunk

190

0.79

0.35

1.1

1.2

1.00

53.98

e6/l

—

156

Gastrointestinal stromal tumor and sarcoma

0.62

0.35

1.2

1.1

81.60

66.27

e6/l

—

Benign neoplasm: Bronchus and lung

0.62

0.35

1.2

2.40

12.19

e6/l

—

Impacted maxillary molar

543

0.88

0.35

1.9

1.6

8.76

23.20

e6/l

1.17

420

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

190

1.22

0.35

1.1

1.2

10.44

9.89

e6/l

0.02

150

Psoriasis vulgaris

171

1605

1.07

0.35

1.2

1.4

20.28

22.29

e6/l

0.07

125

1233

Use of rasagiline

181

1.22

0.34

1.5

1.2

3.00

60.02

e6/l

1.06

143

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

198

1844

1.06

0.34

1.4

1.3

27.49

25.26

e6/l

0.05

152

1441

Other corneal oedema

1.37

0.34

1.2

1.1

2.00

17.64

e6/l

—

Malignant neoplasm of corpus uteri

532

0.88

0.34

1.4

6.87

22.09

e6/l

1.30

416

Retained placenta and membranes, without haemorrhage

1055

0.92

0.34

1.3

17.44

37.20

e6/l

0.61

802

Complications of the puerperium, not elsewhere classified

339

1.15

0.34

1.3

1.4

11.28

23.23

e6/l

0.48

265

Stenosis and insufficiency of lacrimal passages

661

1.11

0.34

1.7

1.4

34.43

21.78

e6/l

0.33

498

Idiopathic thrombocytopenic purpura

218

1.20

0.34

1.7

1.4

25.90

13.03

e6/l

0.22

167

Non-ischemic cardiomyopathy

259

1981

1.05

0.34

1.5

1.4

15.14

40.23

e6/l

1.77

210

1502

Atherosclerosis, excluding cerebral and coronary sclerosis

296

2456

0.95

0.34

1.3

20.63

23.40

e6/l

0.15

238

1914

Coronary atherosclerosis

634

3884

1.03

0.33

1.3

1.4

16.37

32.57

e6/l

1.78

500

2950

Inflammation of lacrimal passages (chronic)

0.67

0.33

1.5

1.2

33.17

16.75

e6/l

—

Malignant neoplasm of small intestine, including Hilmo

210

1.19

0.33

1.4

1.2

10.76

47.12

e6/l

0.71

173

Unstable angina pectoris

313

2361

1.05

0.32

1.3

1.4

12.41

32.32

e6/l

1.69

256

1817

Ankylosing hyperostosis [Forestier]

1.36

0.32

1.0

1.2

2.00

53.37

e6/l

—

Toxic effect of contact with venomous animals

313

1.15

0.32

1.3

1.6

44.32

13.82

e6/l

0.74

242

Maternal care for other known or suspected fetal problems

260

1567

1.05

0.32

1.2

1.3

19.21

26.30

e6/l

0.31

208

1224

Heart failure,strict

476

3240

1.04

0.32

1.4

15.87

32.14

e6/l

1.42

388

2500

Conduction disorders

268

2071

1.05

0.32

1.2

1.5

13.45

24.08

e6/l

0.61

212

1597

Congenital malformations of genital organs

861

1.09

0.32

1.4

2.0

46.51

18.29

e6/l

0.33

648

Colectomy operation

133

1243

1.07

0.32

1.4

32.60

26.13

e6/l

0.15

101

956

Delayed puberty

1.35

0.31

1.4

2.8

3.43

8.59

e6/l

—

Contact with other sharp object(s)

570

1.11

0.31

1.1

1.5

13.10

31.54

e6/l

0.81

439

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

174

1643

1.06

0.31

1.4

82.29

23.22

e6/l

0.43

135

1269

Other assisted single delivery

147

1.23

0.31

1.1

1.4

2.00

18.86

e6/l

—

112

Atrial septal defect, secundum type

271

0.84

0.30

2.0

3.0

1.47

5.13

e6/l

2.45

202

Benign lipomatous neoplasm of other sites/unspecified

610

0.90

0.30

1.7

1.4

41.62

24.86

e6/l

0.31

472

Preparatory care for dialysis

315

1.15

0.30

1.3

1.5

6.62

37.65

e6/l

0.93

242

Erectile dysfunction

484

0.89

0.30

1.4

1.5

4.67

26.31

e6/l

1.04

379

Endometriosis of fallopian tube

1.28

0.30

2.9

1.6

36.00

15.24

e6/l

—

Granuloma annulare

102

1.28

0.30

1.2

1.25

2.96

e6/l

—

Congenital malformations of the urinary system

486

1.11

0.30

1.2

2.2

3.85

28.54

e6/l

1.23

370

Benign neoplasm: Skin of eyelid, including canthus

109

1170

0.93

0.30

1.3

21.30

25.26

e6/l

0.16

891

Transitory endocrine and metabolic disorders specific to fetus and newborn

170

0.80

0.30

3.3

5.0

1.56

7.57

e6/l

—

124

Other obstetric trauma

462

0.89

0.29

1.2

1.3

50.34

19.09

e6/l

0.33

357

Wide developmental disorders

325

1.14

0.29

1.5

3.1

7.48

14.89

e6/l

0.66

239

Secondary malignant neoplasm of respiratory and digestive organs

110

0.72

0.29

1.3

1.2

1.38

82.01

e6/l

—

Other nutritional anaemias

1.23

0.29

3.1

1.2

1.57

7.43

e6/l

—

Unspecified lump in breast

133

1249

1.07

0.29

1.3

1.4

17.29

30.29

e6/l

0.39

106

950

Type 1 diabetes, strict definition, subgroup 1

731

0.91

0.29

1.4

1.9

32.72

18.12

e6/l

0.47

573

Myocardial infarction, without ST-elevation

310

2713

1.04

0.28

1.3

14.43

25.24

e6/l

0.92

246

2110

Abdominal aortic aneurysm (AAA)

519

0.90

0.28

1.4

1.3

5.35

34.11

e6/l

1.44

410

Benign neoplasm: Bones of skull and face

1.32

0.28

1.1

2.50

3.37

e6/l

—

Herpesviral keratitis and keratoconjunctivitis

317

1.14

0.28

1.4

1.5

5.79

7.56

e6/l

0.26

246

Vitiligo

1.30

0.28

1.4

5.73

5.91

e6/l

0.01

Amputation

622

1.09

0.28

2.0

1.4

20.98

26.17

e6/l

0.13

492

Other otitis externa (chronic)

498

1.11

0.28

1.4

1.6

8.67

28.69

e6/l

0.88

387

Type 1 diabetes, strict (exclude DM2)

102

948

1.07

0.28

1.7

1.9

23.35

22.15

e6/l

0.04

733

Obstructed labour due to malposition and malpresentation of fetus

218

2130

0.95

0.28

1.4

1.3

21.54

27.14

e6/l

0.28

166

1653

Type 1 diabetes, definitions combined

102

948

1.07

0.28

1.7

1.9

23.35

22.15

e6/l

0.04

733

Serous carcinoma of ovary, including Hilmo

237

0.84

0.28

1.0

1.3

4.14

14.63

e6/l

1.16

185

Psoriasis (vulgaris), strict definition

237

0.84

0.28

1.5

1.4

56.87

24.82

e6/l

0.25

185

Other acute skin changes due to ultraviolet radiation

237

0.84

0.28

2.4

1.4

7.93

25.16

e6/l

0.63

188

Barrett oesophagus

346

1.13

0.27

1.2

1.4

2.59

32.83

e6/l

1.04

263

Primary coxarthrosis, bilateral

221

2111

1.05

0.27

1.4

1.3

42.11

28.76

e6/l

0.22

168

1653

Benign neoplasm: Conjunctiva

234

1.16

0.26

1.1

1.4

2.90

9.85

e6/l

1.30

183

Deep bite that required surgery

1.27

0.26

1.1

1.3

2.33

5.56

e6/l

0.50

Peripheral artery operations in Hilmo

779

1.08

0.26

1.8

1.3

17.36

26.25

e6/l

0.30

612

Thoracic aortic aneurysm

1059

0.93

0.26

1.6

1.3

13.86

25.32

e6/l

0.58

825

Myeloproliferative diseases (CML excluded)

539

1.10

0.26

1.3

1.4

35.96

28.97

e6/l

0.12

412

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

693

1.08

0.26

1.3

51.45

24.70

e6/l

0.27

550

Olecranon bursitis

386

1.12

0.26

1.2

1.3

6.91

30.22

e6/l

0.82

299

Pulmonary eosinophilia, not elsewhere classified

1.26

0.26

1.0

1.2

141.67

5.00

e6/l

—

Malignant neoplasm of kidney, except renal pelvis

578

1.09

0.25

1.3

1.2

53.85

27.67

e6/l

0.23

460

Non-small cell lung cancer, adenocarcinoma

372

0.89

0.25

1.2

1.3

5.84

32.60

e6/l

0.99

295

Congenital malformations of the urinary system

512

1.10

0.24

1.3

2.2

3.76

28.62

e6/l

1.34

389

therapeutic use

217

1.16

0.24

1.4

1.2

4.46

23.62

e6/l

0.73

171

L01XE Protein kinase inhibitors

388

1.11

0.24

3.6

1.4

7.82

36.47

e6/l

1.08

295

Calcific aortic valvular stenosis

187

1897

0.95

0.24

1.3

1.4

11.90

23.40

e6/l

0.93

153

1477

Calcific aortic valvular stenosis, operated

187

1897

0.95

0.24

1.3

1.4

11.90

23.40

e6/l

0.93

153

1477

161

1.18

0.24

1.3

1.8

16.40

10.68

e6/l

—

117

Intrahepatic Cholestasis of Pregnancy (ICP)

609

1.09

0.24

1.2

1.3

3.04

18.49

e6/l

3.11

466

Right hemicolectomy

379

1.11

0.24

1.4

1.3

44.67

34.74

e6/l

0.12

298

Malignant neoplasm of urinary organs

629

1.08

0.23

1.3

53.49

26.26

e6/l

0.27

504

Other specified disorders of external ear

254

0.86

0.23

1.7

1.3

7.47

39.43

e6/l

0.75

204

Familial hypercholesterolemia, with ischemic heart disease

591

1.08

0.23

1.3

15.07

31.88

e6/l

0.67

449

Other infective otitis externa

466

1.10

0.23

1.2

1.5

17.95

30.57

e6/l

0.33

362

All-cause Heart Failure

481

3488

0.97

0.23

1.4

15.30

34.51

e6/l

1.83

396

2694

572

1.09

0.23

1.2

1.3

26.10

24.00

e6/l

0.05

451

ILD-related respiratory insufficiency

211

0.85

0.23

1.2

1.3

7.69

50.43

e6/l

0.86

168

Peripheral retinal degeneration

228

1.14

0.23

2.5

1.4

7.81

12.87

e6/l

0.35

183

132

1177

1.05

0.22

1.3

99.71

23.64

e6/l

0.42

102

920

Congenital aortic valve stenosis

1.23

0.22

1.0

4.2

1.40

3.27

e6/l

—

Pemphigus

1.22

0.22

1.6

1.1

19.40

21.43

e6/l

—

Ascorbic acid deficiency

0.00

0.22

0.0

2.9

—

2.80

—

Operations 2 for CAVS

187

1890

0.96

0.22

1.3

1.4

11.90

23.49

e6/l

0.93

153

1471

Calcific aortic valvular stenosis, diagnosis (helper)

187

1890

0.96

0.22

1.3

1.4

11.90

23.49

e6/l

0.93

153

1471

Obstetric embolism

0.00

0.21

0.0

1.0

—

2.17

—

Follicular keratosis (Darier-White)

0.00

0.21

0.0

1.0

—

1.60

—

Transepidermal elimination disorders

0.00

0.21

0.0

1.1

—

2.18

—

Calcium deposit in bursa

0.00

0.21

0.0

1.9

—

5.20

—

Other retinal disorders in diseases classified elsewhere

0.00

0.21

0.0

1.2

—

3.50

—

Open bite

478

1.09

0.21

1.7

2.3

24.35

20.72

e6/l

0.06

370

Hirsprung

0.00

0.21

0.0

4.8

—

4.17

—

Calcific aortic valvular stenosis, including rheumatic fever

188

1897

0.96

0.21

1.3

1.4

12.05

23.40

e6/l

0.91

154

1477

Alport

0.00

0.21

0.0

4.3

—

4.25

—

Ulcerative colitis (strict definition, require KELA)

158

1510

1.05

0.21

1.2

1.4

90.20

21.37

e6/l

0.46

123

1161

Clear cell adenocarcinoma of kidney

315

1.11

0.21

1.5

1.3

94.88

33.72

e6/l

0.30

257

Distal bite

351

1.11

0.21

3.4

2.8

5.59

12.59

e6/l

0.72

270

Poor fetal growth

124

1178

1.05

0.21

1.2

1.3

31.02

17.89

e6/l

0.53

100

923

Iodine-deficiency-related goitre

0.00

0.21

0.0

1.0

—

3.31

—

Crossbite

621

1.07

0.21

3.8

2.3

3.54

16.37

e6/l

3.05

469

Aortic valve malfunction, age under 60 years

791

0.93

0.21

1.6

1.7

17.98

23.28

e6/l

0.16

599

Eustachian salpingitis and obstruction

682

1.07

0.21

1.5

13.37

25.66

e6/l

0.74

527

Infections of breast associated with childbirth

306

1.11

0.21

1.1

1.4

11.63

21.03

e6/l

0.44

241

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

402

1.10

0.21

1.4

1.3

6.61

16.99

e6/l

1.00

303

Pleural plaque

574

0.92

0.20

1.2

1.3

9.67

29.24

e6/l

0.86

453

Exfoliative dermatitis

1.25

0.20

1.5

1.3

91.00

14.74

e6/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.20

0.20

1.0

1.1

3.67

3.03

e6/l

—

Congenital malformations of eye, ear, face and neck

587

1.07

0.19

1.3

2.2

9.74

22.30

e6/l

0.88

445

Pleural effusion

109

1035

1.05

0.19

1.4

1.3

8.51

23.69

e6/l

1.21

801

Dermatitis due to ingested food

350

1.10

0.19

1.7

3.0

32.97

15.50

e6/l

0.31

260

Other deformity of hallux (acquired)

1.18

0.19

2.0

1.3

1.33

2.69

e6/l

—

Basal cell carcinoma

383

2580

1.03

0.19

1.4

88.26

27.31

e6/l

0.74

291

2030

Benign neoplasm: Rectosigmoid junction

279

1.11

0.19

1.3

3.73

40.28

e6/l

1.02

218

Extreme obesity with alveolar hypoventilation

312

0.90

0.19

1.2

1.4

10.89

27.56

e6/l

0.46

244

Other chronic obstructive pulmonary disease

342

2896

0.97

0.19

1.4

26.07

29.72

e6/l

0.10

261

2272

Duodenal ulcer

676

1.07

0.18

1.2

1.4

109.79

23.60

e6/l

0.42

535

Scar conditions and fibrosis of skin

309

1.10

0.18

1.6

1.5

2.80

12.30

e6/l

1.80

243

Contact with machinery

878

0.94

0.18

1.3

1.4

4.42

19.67

e6/l

1.41

670

Pustulosis palmaris et plantaris

321

0.90

0.18

1.2

1.4

3.36

14.29

e6/l

1.88

246

Other hammer toe(s) (acquired)

130

1147

1.05

0.18

1.4

131.10

24.54

e6/l

0.54

883

Pyothorax

279

0.89

0.18

1.9

1.3

44.41

36.45

e6/l

0.10

222

Mixed hyperlipidaemia

262

1.11

0.17

1.5

1.3

17.29

19.45

e6/l

0.05

211

Benign neoplasm: Appendix

1.13

0.17

1.7

1.2

16.29

7.49

e6/l

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

671

0.94

0.17

1.4

43.82

27.93

e6/l

0.17

519

Secondary right heart disease

257

0.89

0.17

1.3

54.18

47.75

e6/l

0.04

204

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

621

1.06

0.17

1.2

1.3

3.04

23.56

e6/l

3.91

486

malignant neoplasm of female genital organs

104

1083

0.95

0.17

1.2

1.4

11.77

29.51

e6/l

0.98

856

Left ventricular outflow tract obstruction (LVOTO), broad definition

885

0.95

0.16

1.6

1.9

15.90

21.85

e6/l

0.21

661

Pedal cyclist injured in collision with motor vehicle

234

1.11

0.16

1.3

1.2

17.87

10.63

e6/l

0.18

182

Carcinoma in situ of skin

536

0.93

0.16

1.3

14.49

28.32

e6/l

0.53

413

Nephrotic syndrome

244

1.11

0.16

1.8

2.0

107.63

27.95

e6/l

0.36

187

Left bundle-branch block

515

0.93

0.16

1.4

13.26

17.05

e6/l

0.14

395

Cystic kidney disease

256

0.90

0.16

1.3

1.8

7.13

45.46

e6/l

0.93

197

Other congenital malformations of female genitalia

1.10

0.16

1.4

2.25

5.45

e6/l

—

Inflammatory disease of cervix uteri

448

1.07

0.15

1.2

1.4

3.89

19.53

e6/l

2.92

341

Benign neoplasm: Larynx

203

0.89

0.15

1.6

1.4

11.31

49.35

e6/l

0.69

161

Acquired absence of organs, not elsewhere classified

1.13

0.15

1.7

1.3

10.56

44.78

e6/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

397

2664

1.02

0.15

1.3

1.4

88.78

27.06

e6/l

0.77

295

2090

Other pulmonary heart/vessel disease

286

0.91

0.15

1.5

1.4

47.55

43.35

e6/l

0.03

226

Cardiomyopathy

144

1389

1.04

0.15

1.4

1.5

52.86

17.46

e6/l

0.44

109

1053

Primary gonarthrosis, bilateral

448

3762

1.02

0.15

1.3

1.4

24.16

30.45

e6/l

0.29

343

2921

Glaucoma-related operations

352

1.08

0.14

1.3

2.88

37.02

e6/l

1.30

276

Heart failure, strict

493

3540

0.98

0.14

1.4

15.55

34.63

e6/l

1.85

405

2733

Malignant neoplasm of ovary

337

0.92

0.14

1.1

1.3

3.05

14.54

e6/l

1.95

263

Congenital ovarian cysts

372

1.08

0.14

1.2

1.4

16.19

18.84

e6/l

0.08

289

Scabies

353

1.08

0.14

1.2

1.5

14.94

20.13

e6/l

0.18

268

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

726

0.95

0.14

1.3

22.58

29.22

e6/l

0.21

544

Failed induction of labour

552

0.94

0.14

1.4

1.3

24.43

19.09

e6/l

0.13

425

Benign neoplasm: Skin of ear and external auricular canal

266

1.09

0.14

1.6

1.4

24.87

41.50

e6/l

0.25

212

Malignant cancer of tonsil and base of tongue, including Hilmo

170

1.12

0.13

1.3

1.2

3.08

54.31

e6/l

0.85

134

Other noninflammatory disorders of cervix uteri

346

0.92

0.13

1.1

1.3

138.48

24.63

e6/l

0.55

273

Chondromalacia

199

1.11

0.13

1.2

1.5

4.12

12.45

e6/l

1.02

157

Cardiomyopathy, other and unspecified

588

1.06

0.13

1.4

101.21

15.17

e6/l

0.48

459

Deficiency of other B group vitamins

132

1.14

0.13

1.3

1.5

12.60

11.00

e6/l

—

105

Polycystic kidney disease

180

1.11

0.13

1.3

1.8

7.43

15.76

e6/l

0.51

140

ILD, hospital admissions 1, main diag only

922

1.04

0.13

1.2

1.4

18.07

26.17

e6/l

0.28

712

HSIL lesion of the cervix uteri, vagina or vulva

195

1899

1.03

0.12

1.2

1.3

77.08

23.36

e6/l

0.40

151

1476

Autism

219

1.10

0.12

1.1

2.5

9.58

16.73

e6/l

0.37

164

Foreign body or object entering through skin

511

1.06

0.12

1.9

1.4

16.05

31.43

e6/l

0.38

397

Major coronary heart disease event excluding revascularizations

566

3715

1.02

0.12

1.3

1.4

14.43

31.59

e6/l

2.00

457

2820

Lesion of plantar nerve

414

1.06

0.12

1.2

1.3

10.71

18.16

e6/l

0.57

304

Benign neoplasm: Skin of upper limb, including shoulder

137

0.87

0.12

1.2

22.29

12.52

e6/l

—

105

Right bundle-branch block

251

0.92

0.12

1.2

1.4

1.82

21.94

e6/l

0.95

199

Ethmoidectomy

108

1118

0.97

0.12

1.3

1.4

52.57

24.51

e6/l

0.42

859

Respiratory distress of newborn

177

1.10

0.12

5.9

4.9

53.38

7.05

e6/l

0.42

123

Struck by thrown, projected or falling objec

405

1.06

0.11

1.3

1.5

1.26

33.11

e6/l

1.42

310

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

151

1468

1.03

0.11

1.2

1.4

93.96

21.83

e6/l

0.47

118

1128

Other secondary gonarthrosis

386

1.06

0.11

1.3

1.4

6.00

17.51

e6/l

0.70

294

Macular hole

377

1.06

0.11

1.4

1.3

4.54

35.88

e6/l

1.20

286

IgA nephropathy (IgA glomerulonephritis)

167

0.90

0.10

1.3

66.11

28.57

e6/l

—

135

Delivery, wide proxy

323

1684

1.02

0.10

1.4

23.79

32.74

e6/l

0.34

249

1311

Acute appendicitis, with complications

157

1611

0.97

0.10

1.3

1.4

18.33

29.06

e6/l

0.49

116

1234

Arterial embolism and thrombosis

348

1.06

0.10

1.3

15.56

34.85

e6/l

0.52

275

Malignant neoplasm of tongue, including Hilmo

183

1.09

0.10

1.2

1.3

21.00

53.25

e6/l

0.46

150

Retinoschisis and retinal cysts

156

0.90

0.10

1.1

1.4

9.33

68.69

e6/l

—

122

Prurigo nodularis

154

1.11

0.10

1.8

1.1

207.08

27.69

e6/l

0.40

122

Juvenile rheumatoid arthirtis

154

1.11

0.10

1.4

1.6

50.08

11.94

e6/l

0.47

125

Malignant neoplasm of tongue

135

1.11

0.09

1.1

1.2

9.90

61.44

e6/l

—

113

277

1.07

0.09

2.3

4.1

39.20

13.96

e6/l

0.34

195

Heart failure and bmi 25plus

261

1730

1.02

0.09

1.3

1.4

21.57

47.36

e6/l

1.14

206

1344

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

733

1.04

0.09

1.2

1.3

3.31

20.85

e6/l

4.24

555

Cardiovascular disorders originating in the perinatal period

1.04

0.09

2.0

6.1

171.00

3.25

e6/l

—

Delivery

399

2076

1.01

0.09

1.3

1.4

22.03

30.42

e6/l

0.39

301

1587

Basal cell carcinoma, including avohilmo

396

2691

1.01

0.09

1.3

1.4

86.45

26.88

e6/l

0.74

297

2108

Other specified/unspecified nutritional deficiencies

1.09

0.09

1.0

1.1

1.17

3.00

e6/l

—

Pityriasis rosea

1.05

0.08

1.0

1.4

100.83

2.72

e6/l

—

Glaucoma, exfoliation

613

0.96

0.08

1.5

1.3

17.86

26.34

e6/l

0.21

480

Polycythaemia vera

226

0.93

0.08

1.1

1.3

1.33

43.80

e6/l

1.02

186

Contusion of other and unspecified parts of foot

430

1.05

0.08

1.5

1.7

3.45

28.49

e6/l

2.11

336

Tooth agenesis EXCLUDE clefts and syndromes

322

1.06

0.08

2.7

2.5

8.85

11.50

e6/l

0.22

246

Oesophageal varices

287

0.94

0.08

1.3

1.7

13.06

37.13

e6/l

0.52

221

Deep bite

109

931

1.03

0.08

2.5

2.0

19.75

29.47

e6/l

0.31

712

Other appendicitis

667

1.04

0.08

1.4

11.91

32.12

e6/l

0.94

519

Benign neoplasm: Short bones of lower limb

0.84

0.07

1.3

1.1

3.00

3.95

e6/l

—

Other disorders of cornea

733

0.97

0.07

1.6

1.4

20.50

15.37

e6/l

0.13

555

Injury of muscle and tendon at ankle and foot level

176

1.08

0.07

1.2

1.4

3.29

10.38

e6/l

0.94

133

Golimumab

276

0.94

0.07

1.1

1.7

149.76

9.52

e6/l

0.46

220

HSIL lesion of the cervix uteri

174

1772

0.98

0.07

1.2

1.3

80.98

23.77

e6/l

0.38

137

1386

Benign neoplasm: Skin of lip

0.84

0.07

1.3

1.2

3.43

12.21

e6/l

—

Nontoxic single thyroid nodule

531

1.04

0.07

1.3

1.4

8.32

30.30

e6/l

1.46

395

Malignant neoplasm of other and ill-defined sites, including Hilmo

0.89

0.07

4.8

1.2

3.75

66.00

e6/l

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

138

1.09

0.06

1.3

2.0

4.00

7.01

e6/l

—

106

Ulcerative ileocolitis

305

1.05

0.06

1.0

1.4

20.63

18.71

e6/l

0.05

238

Graves ophthalmopathy, strict

168

1.07

0.06

1.4

10.27

11.52

e6/l

0.04

132

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

425

2856

1.01

0.06

1.3

1.4

82.58

26.43

e6/l

0.76

320

2237

FESS (DNB20)

106

1081

0.98

0.05

1.3

1.4

53.69

25.00

e6/l

0.42

829

Embolic stroke with flimmer

139

1.08

0.05

1.4

1.3

2.30

39.30

e6/l

—

112

Benign neoplasm: Skin of other and unspecified parts of face

762

1.02

0.05

1.3

1.4

9.59

25.09

e6/l

0.95

584

Malignant cancer of tonsil and base of tongue

149

1.08

0.05

1.3

1.2

3.20

60.90

e6/l

—

119

COPD

364

3001

0.99

0.05

1.4

25.21

29.33

e6/l

0.12

275

2354

Cholangitis (primary sclerosing, PSC)

426

1.03

0.05

1.2

1.7

16.77

27.02

e6/l

0.28

337

All dysplastic lesions of the vagina

211

0.95

0.04

1.3

1.5

61.07

10.43

e6/l

0.66

168

Ulcerative rectosigmoiditis

685

1.02

0.04

1.2

1.5

167.02

29.40

e6/l

0.42

530

Crowding of teeth, including avohilmo

755

1.02

0.04

3.0

2.0

5.90

24.02

e6/l

2.82

581

Leiomyoma of uterus

622

3544

0.99

0.04

1.3

1.4

24.98

33.93

e6/l

0.56

484

2739

Pacemaker

233

2211

1.01

0.04

1.3

1.4

7.53

21.63

e6/l

2.27

191

1725

Ascites

477

1.03

0.04

1.6

1.4

3.03

35.19

e6/l

1.83

370

Suppurative and necrotic conditions of lower respiratory tract

368

1.03

0.04

2.8

1.4

68.08

29.18

e6/l

0.57

293

COPD, hospital admission 2, with asthma infections

242

2055

1.01

0.04

1.4

7.88

23.17

e6/l

3.06

182

1595

Long labour

246

2124

0.99

0.04

1.4

1.3

44.18

28.06

e6/l

0.29

179

1645

Benign neoplasm: Tongue

190

0.95

0.04

1.3

1.4

1.50

31.31

e6/l

—

149

Supervision of normal pregnancy

227

1284

1.01

0.03

1.5

1.3

16.26

28.18

e6/l

0.47

161

969

Artificial joint operation, meniscal resection

945

6109

1.00

0.03

1.3

1.4

35.77

32.64

e6/l

0.08

721

4731

Pleural plaque without asbestos

210

1.05

0.03

1.4

1.3

2.13

45.99

e6/l

0.94

169

Varicose veins

574

4311

1.01

0.03

1.4

29.03

34.04

e6/l

0.16

462

3345

Motorcycle rider injured in other and unspecified transport accidents

468

1.03

0.03

1.2

1.5

14.32

11.95

e6/l

0.13

345

Cystic kidney disease

230

0.96

0.03

1.3

1.8

7.33

50.12

e6/l

0.94

177

Rubella [German measles]

250

1.04

0.03

1.8

1.3

28.88

35.98

e6/l

0.09

197

Pathological resorption of teeth

270

0.96

0.03

1.2

1.5

20.55

20.31

e6/l

0.00

209

Twin gestation

803

0.98

0.03

1.7

1.3

82.34

30.23

e6/l

0.33

623

Single spontaneous delivery

389

2072

0.99

0.03

1.2

1.4

17.77

30.50

e6/l

0.84

292

1583

Other abnormal uterine and vaginal bleeding

202

1434

1.01

0.03

1.3

1.4

94.53

26.40

e6/l

0.54

152

1136

Malignant neoplasm of bladder

370

0.97

0.03

1.3

21.68

39.69

e6/l

0.40

297

Malignant neoplasm of head and neck

541

0.98

0.03

1.4

1.3

13.27

29.05

e6/l

0.55

431

Ulcerative enterocolitis

221

1.04

0.03

1.0

1.5

14.22

23.69

e6/l

0.21

176

COPD, hospital admissions 3, with asthma pneumonia sepsis

193

1636

1.01

0.02

1.5

1.3

9.21

24.82

e6/l

2.22

143

1274

Fibrosis and cirrhosis of liver

540

0.98

0.02

1.5

13.35

28.37

e6/l

0.55

417

Overjet

247

0.97

0.02

4.1

3.1

3.83

10.73

e6/l

0.80

194

Postmenopausal atrophic vaginitis

232

1288

0.99

0.02

1.3

1.4

22.27

27.81

e6/l

0.20

171

1016

Benign neoplasm: Long bones of lower limb

238

0.97

0.02

1.4

12.75

10.46

e6/l

0.08

185

Multiple gestation

830

0.99

0.02

1.7

1.3

78.91

30.58

e6/l

0.32

644

Cardiac arrest

326

1.02

0.02

1.1

1.3

6.34

17.12

e6/l

0.42

247

Cirrhosis of liver, NAS

372

1.02

0.01

1.6

1.4

9.14

33.37

e6/l

0.74

286

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

751

1.01

0.01

1.2

1.3

3.31

26.04

e6/l

3.56

573

Embedded teeth, including avohilmo

871

1.01

0.01

1.8

1.5

16.40

21.20

e6/l

0.16

678

Amputation of toe

468

0.98

0.01

2.2

1.3

11.38

29.71

e6/l

0.60

365

Other benign neoplasms of skin

317

3182

1.00

0.01

1.3

1.4

15.29

28.94

e6/l

1.47

240

2477

Oral lichen planus, including avohilmo , including avohilmo

502

1.02

0.01

1.2

1.3

51.97

21.24

e6/l

0.32

382

Ulcerative proctitis

518

0.98

0.01

1.1

1.4

201.98

35.82

e6/l

0.39

408

Isolated proteinuria

203

1.04

0.01

1.2

1.4

148.07

28.35

e6/l

0.44

162

COPD related to multimorbidity

304

2557

1.00

0.01

1.4

24.76

31.30

e6/l

0.18

232

2000

Other other unspecified disorders of the circulatory system

263

1.03

0.01

1.3

1.7

26.90

42.61

e6/l

0.20

205

Noise effects on inner ear

277

0.97

0.01

1.4

1.3

33.10

38.81

e6/l

0.07

215

Other infestations

124

1.05

0.00

1.2

1.7

49.38

11.82

e6/l

—

Carcinoma in situ of skin of lower limb, including hip

124

1.05

0.00

1.1

1.2

3.29

50.28

e6/l

—

Neonatal jaundice from other and unspecified causes

178

1.03

0.00

6.7

5.0

2.38

7.24

e6/l

0.59

126

Non-allergic asthma

703

1.01

0.00

1.2

2.0

8.43

25.31

e6/l

1.11

552

L01XX Other antineoplastic agents

384

1.02

0.00

1.2

1.3

17.90

35.39

e6/l

0.43

293

Malignant neoplasm of ovary, including Hilmo

456

0.99

0.00

1.2

1.4

2.31

24.69

e6/l

2.23

354

Peripheral artery disease

335

2669

1.00

0.00

1.5

1.4

25.05

29.98

e6/l

0.23

269

2074

Other noninflammatory disorders of uterus, except cervix

183

1231

1.00

0.00

1.5

1.4

76.13

28.64

e6/l

0.34

150

980

Chronic suppurative otitis media, including avohilmo

632

1.00

0.00

1.4

1.9

94.46

25.84

e6/l

0.54

493

Benign neoplasm of middle ear and respiratory system

569

1.00

0.00

1.5

1.4

21.62

24.00

e6/l

0.06

443

Scissor bite

255

1.01

0.00

3.0

2.6

10.80

17.29

e6/l

0.29

195

Complications of cardiac and vascular prosthetic devices, implants and grafts

135

1.04

0.00

1.2

1.4

18.36

31.22

e6/l

0.23

111

Graves ophthalmopathy

184

0.98

0.00

1.4

10.27

14.41

e6/l

0.15

143

Oral lichen planus

196

1.02

0.00

1.5

1.4

98.50

12.95

e6/l

0.41

151

Other secondary coxarthrosis

244

0.98

0.00

1.3

1.4

2.37

25.18

e6/l

1.01

187

Pericarditis

254

0.98

0.00

1.1

1.7

6.79

19.52

e6/l

0.50

200

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

281

0.99

0.00

1.0

3.3

10.48

11.94

e6/l

0.07

209

Lung cancer and mesothelioma

125

1068

1.00

0.00

1.2

1.4

31.94

11.26

e6/l

0.43

842

Respiratory and cardiovascular disorders specific to the perinatal period

257

1.01

0.00

5.5

4.0

37.78

8.55

e6/l

0.37

183

Carcinoma in situ of cervix uteri

843

1.00

0.00

1.2

1.3

153.16

19.52

e6/l

0.46

649

Other ulcerative colitis

472

1.00

0.00

1.6

1.4

52.05

26.66

e6/l

0.31

367

Thyroiditis, unspecified

111

0.99

0.00

1.2

1.8

17.00

7.76

e6/l

0.32

Non-rheumatic valve diseases

436

3141

1.00

0.00

1.4

1.5

55.46

27.48

e6/l

0.47

357

2425

Impacted cerumen

722

1.00

0.00

1.8

1.6

4.60

23.75

e6/l

1.53

558

Valvular heart disease excluding rheumatic fever

441

3183

1.00

0.00

1.4

1.5

61.43

27.17

e6/l

0.60

361

2458

Later onset COPD, excluding more controls

130

1007

1.00

0.00

1.2

1.4

47.20

9.42

e6/l

0.62

804

249

1.01

0.00

1.8

4.4

47.60

10.83

e6/l

0.41

179

Disorders of lacrimal system and orbit in diseases classified elsewhere

181

0.99

0.00

1.4

1.5

10.27

14.26

e6/l

0.14

140

Carcinoma in situ of other and unspecified digestive organs

233

0.99

0.00

1.5

1.2

1.75

47.06

e6/l

1.09

183

Benign neoplasm: Skin of trunk

303

0.99

0.00

1.2

1.4

3.76

22.50

e6/l

1.05

236

Chronic suppurative otitis media

534

0.99

0.00

1.5

1.7

50.02

14.87

e6/l

0.37

417

Maternal care for known or suspected disproportion

353

0.99

0.00

1.4

26.93

20.74

e6/l

0.13

273

Malignant neoplasm of oral cavity

231

1.00

0.00

1.1

1.4

6.18

43.28

e6/l

0.84

189

Other congenital malformations of limb(s)

1.01

0.00

1.5

2.6

1.50

6.92

e6/l

—

Staphylococcal scalded skin syndrome

0.00

0.0

2.7

—

1.29

—

Myxoedema coma

0.00

-0.00

0.0

1.0

—

2.67

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.00

-0.00

0.0

1.0

—

3.43

—

Traumatic amputation of forearm

0.00

-0.00

0.0

1.1

—

2.00

—

Carcinoma in situ of bronchus and lung

0.00

-0.00

0.0

1.0

—

3.40

—

Lipid storage disorder, other/unspecified

0.00

-0.00

0.0

1.2

—

1.40

—

Choroidal degeneration

0.00

-0.00

0.0

1.0

—

3.00

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

1.0

—

2.20

—

Benign neoplasm: Oesophagus

0.94

-0.00

1.1

1.4

1.63

15.29

e6/l

—

Deficiency of other/unspecified nutrient elements

0.00

-0.00

0.0

1.0

—

3.60

—

Other and unspecified disorders of pigmentation

0.94

-0.00

1.4

1.0

2.60

3.07

e6/l

—

Myelofibrosis

0.00

-0.00

0.0

1.0

—

1.40

—

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

1.2

—

3.20

—

Other birth injuries

0.00

-0.00

0.0

1.0

—

1.50

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Leukocytes [#/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS